Index RUT P/E - EPS (ttm) -0.17 Insider Own 88.17% Shs Outstand 701.66M Perf Week 5.92%
Market Cap 3.26B Forward P/E - EPS next Y -0.28 Insider Trans 0.04% Shs Float 83.02M Perf Month 15.38%
Income -116.06M PEG - EPS next Q -0.06 Inst Own 4.64% Short Float 28.18% Perf Quarter 3.33%
Sales 0.00M P/S - EPS this Y 75.18% Inst Trans -29.20% Short Ratio 10.25 Perf Half Y 154.79%
Book/sh 0.06 P/B 73.83 EPS next Y -12.97% ROA -53.77% Short Interest 23.40M Perf Year 119.34%
Cash/sh 0.22 P/C 20.79 EPS next 5Y - ROE -130.63% 52W Range 1.50 - 5.39 Perf YTD 78.16%
Dividend Est. - P/FCF - EPS past 5Y - ROI -77.35% 52W High -13.73% Beta -1.26
Dividend TTM - Quick Ratio 6.97 Sales past 5Y -28.65% Gross Margin - 52W Low 210.00% ATR (14) 0.42
Dividend Ex-Date - Current Ratio 6.97 EPS Y/Y TTM 90.98% Oper. Margin 0.00% RSI (14) 56.91 Volatility 10.66% 9.43%
Employees 105 Debt/Eq 2.48 Sales Y/Y TTM -100.00% Profit Margin - Recom 1.00 Target Price 7.50
Option/Short Yes / Yes LT Debt/Eq 2.39 EPS Q/Q 95.68% Payout - Rel Volume 0.78 Prev Close 4.78
Sales Surprise - EPS Surprise 0.00% Sales Q/Q - Earnings May 01 BMO Avg Volume 2.28M Price 4.65
SMA20 16.05% SMA50 13.97% SMA200 62.25% Trades
Volume 1,780,668 Change -2.72%
Date
Action
Analyst
Rating Change
Price Target Change
May-07-24 Initiated Citigroup
Buy
$7
Mar-26-24 Initiated Stifel
Buy
$8
Jun-28-18 Downgrade Janney
Buy → Neutral
May-02-18 Initiated Janney
Buy
Apr-12-18 Reiterated Needham
Buy
$30 → $27
Feb-13-18 Initiated BTIG Research
Buy
$33
Jan-04-18 Initiated SunTrust
Buy
$24
Dec-01-17 Resumed H.C. Wainwright
Buy
$16
Nov-16-16 Reiterated RBC Capital Mkts
Outperform
$26 → $29
Oct-05-16 Reiterated Needham
Buy
$22 → $30
Sep-16-16 Initiated H.C. Wainwright
Buy
$26
Mar-30-15 Initiated Oppenheimer
Outperform
$28
Mar-30-15 Initiated Needham
Buy
$22
Show Previous Ratings
May-02-24 11:42AM
03:15AM
12:00AM
(Thomson Reuters StreetEvents)
May-01-24 11:55AM
07:00AM
04:30PM
Loading…
Apr-24-24 04:30PM
Apr-11-24 04:30PM
Apr-10-24 07:00AM
Apr-09-24 04:18PM
04:05PM
Apr-02-24 05:41PM
Mar-29-24 05:43PM
01:35PM
Mar-22-24 07:00AM
Mar-19-24 09:32AM
07:00AM
Loading…
Mar-14-24 07:00AM
Mar-05-24 07:00AM
Feb-21-24 08:53AM
01:56AM
(Thomson Reuters StreetEvents)
Feb-20-24 08:31AM
07:00AM
Feb-14-24 10:29AM
07:00AM
Feb-07-24 07:00AM
Jan-08-24 09:00AM
Jan-03-24 07:30AM
Nov-08-23 12:27PM
Nov-07-23 09:07AM
07:00AM
Nov-02-23 04:41PM
08:00AM
Loading…
08:00AM
Oct-31-23 08:00AM
Oct-26-23 08:00AM
Oct-19-23 08:00AM
Oct-16-23 11:01PM
07:00AM
Sep-29-23 12:43PM
Aug-09-23 10:19PM
(Thomson Reuters StreetEvents) +10.86%
07:00AM
Aug-02-23 08:00AM
Jul-11-23 11:48AM
Jun-04-23 08:00AM
Jun-01-23 07:30AM
May-22-23 09:30AM
May-18-23 09:46AM
May-16-23 01:21PM
11:44AM
May-11-23 11:18PM
(Thomson Reuters StreetEvents) -9.20%
12:20PM
07:30AM
May-09-23 07:30AM
May-05-23 05:08PM
May-03-23 08:30AM
Mar-09-23 03:42PM
07:30AM
Mar-03-23 08:00AM
Feb-23-23 08:00AM
Feb-01-23 10:25AM
Jan-30-23 08:00AM
Jan-20-23 08:00AM
Jan-05-23 09:59AM
07:00AM
Dec-30-22 01:25PM
Dec-09-22 08:27AM
Dec-08-22 04:45PM
Dec-06-22 09:54AM
07:30AM
Nov-17-22 04:15PM
Nov-12-22 07:10AM
Nov-09-22 08:30AM
Oct-20-22 05:15PM
Oct-18-22 08:16AM
Oct-13-22 08:00AM
Oct-04-22 11:49AM
Oct-03-22 04:37PM
Sep-12-22 09:17AM
Aug-22-22 01:16PM
Aug-20-22 08:37AM
Aug-19-22 11:58AM
Aug-11-22 08:00AM
Aug-09-22 01:37PM
Aug-02-22 09:25AM
Jul-26-22 04:15PM
Jul-18-22 04:05PM
Jul-14-22 11:35AM
08:30AM
Jun-22-22 04:30PM
Jun-03-22 08:30AM
Jun-01-22 08:30AM
May-11-22 04:30PM
May-08-22 09:44AM
Apr-10-22 08:36AM
Mar-17-22 04:14PM
Feb-24-22 04:51AM
(Simply Wall St.) +18.84%
Feb-09-22 08:00AM
Jan-25-22 07:30AM
Jan-10-22 08:00AM
Jan-05-22 07:30AM
Dec-31-21 02:30PM
Dec-28-21 04:04PM
Summit Therapeutics, Inc. a biopharmaceutical company, which discovers, develops, and commercializes medicines to treat infectious diseases. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Menlo Park, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Zanganeh Mahkam Chief Executive Officer Mar 27 '24 Buy 3.72 54,321 201,874 24,923,800 Mar 27 08:28 PM Zanganeh Mahkam Chief Executive Officer Mar 27 '24 Buy 3.72 26,000 96,720 520,814 Mar 27 08:28 PM Dhingra Ankur Chief Financial Officer Mar 26 '24 Buy 3.75 100,000 375,000 354,958 Mar 27 08:27 PM Zanganeh Mahkam Chief Executive Officer Mar 26 '24 Buy 3.75 30,000 112,500 30,000 Mar 27 08:28 PM Dhingra Ankur Chief Financial Officer Dec 13 '23 Buy 2.17 20,400 44,254 254,958 Dec 13 04:49 PM Zanganeh Mahkam Chief Executive Officer Dec 12 '23 Buy 2.07 5,000 10,350 494,814 Dec 13 05:11 PM Soni Manmeet Singh Chief Operating Officer Oct 13 '23 Buy 1.68 2,976,190 4,999,999 2,976,190 Oct 16 04:06 PM
Index - P/E 5.13 EPS (ttm) 0.48 Insider Own 9.83% Shs Outstand 49.55M Perf Week 17.06%
Market Cap 122.59M Forward P/E 5.81 EPS next Y 0.42 Insider Trans 0.49% Shs Float 44.76M Perf Month 22.28%
Income 24.11M PEG - EPS next Q 0.05 Inst Own 14.38% Short Float 9.45% Perf Quarter -14.24%
Sales 242.48M P/S 0.51 EPS this Y -35.42% Inst Trans -6.39% Short Ratio 66.78 Perf Half Y -13.94%
Book/sh 3.94 P/B 0.63 EPS next Y 37.10% ROA 1.46% Short Interest 4.23M Perf Year 44.44%
Cash/sh - P/C - EPS next 5Y - ROE 13.80% 52W Range 1.64 - 3.69 Perf YTD -8.18%
Dividend Est. - P/FCF 5.82 EPS past 5Y - ROI 12.35% 52W High -33.06% Beta 0.15
Dividend TTM - Quick Ratio - Sales past 5Y -0.19% Gross Margin - 52W Low 50.61% ATR (14) 0.18
Dividend Ex-Date - Current Ratio 8.18 EPS Y/Y TTM 6666.22% Oper. Margin 10.06% RSI (14) 63.61 Volatility 9.95% 7.88%
Employees 232 Debt/Eq 0.00 Sales Y/Y TTM 4.03% Profit Margin 9.94% Recom 1.00 Target Price 3.75
Option/Short Yes / Yes LT Debt/Eq 0.00 EPS Q/Q -6.75% Payout 0.00% Rel Volume 1.74 Prev Close 2.34
Sales Surprise 3.16% EPS Surprise 38.46% Sales Q/Q 3.22% Earnings May 08 BMO Avg Volume 63.31K Price 2.47
SMA20 17.03% SMA50 13.06% SMA200 -10.83% Trades
Volume 110,014 Change 5.56%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-10-08 Initiated KeyBanc Capital Mkts
Buy
$8.50
Jan-11-08 Initiated Oppenheimer
Buy
$6.50
May-08-24 08:52AM
May-07-24 07:54PM
(Associated Press Finance) -8.23%
06:19PM
04:05PM
Apr-03-24 07:00AM
04:01PM
Loading…
Apr-02-24 04:01PM
07:00AM
Mar-18-24 01:00PM
Mar-14-24 04:01PM
Mar-06-24 07:00AM
Mar-05-24 09:20AM
07:00AM
Feb-06-24 07:00AM
Jan-29-24 04:06AM
Jan-10-24 07:00AM
07:00AM
Loading…
Jan-09-24 07:00AM
Jan-08-24 09:20AM
Dec-06-23 07:00AM
Dec-05-23 07:00AM
Dec-04-23 04:01PM
Nov-06-23 04:01PM
Oct-04-23 07:00AM
Oct-03-23 07:00AM
Oct-02-23 04:01PM
Sep-06-23 08:00AM
Sep-05-23 07:00AM
Aug-16-23 04:01PM
Aug-15-23 10:20AM
Aug-04-23 09:20AM
Aug-01-23 09:20AM
09:20AM
Loading…
Jul-17-23 09:20AM
Jul-10-23 04:48PM
Jun-16-23 11:36AM
Jun-12-23 07:07PM
Jun-01-23 08:48AM
May-31-23 10:15AM
May-18-23 08:30AM
May-08-23 05:19PM
04:15PM
Mar-13-23 04:05PM
Mar-12-23 08:03AM
Mar-06-23 10:41AM
Feb-22-23 10:15AM
Dec-07-22 12:53PM
Dec-01-22 06:56AM
Nov-28-22 10:55AM
Nov-16-22 06:45PM
Nov-04-22 04:01PM
Nov-03-22 10:18AM
Oct-17-22 11:48AM
Oct-06-22 09:03AM
Aug-04-22 04:05PM
Jul-14-22 10:55AM
Jun-13-22 12:23PM
May-10-22 04:15PM
May-05-22 04:48PM
Apr-29-22 08:58AM
Apr-11-22 12:19AM
Mar-22-22 09:00AM
Mar-18-22 06:50PM
Mar-17-22 09:00AM
Mar-11-22 05:30PM
Jan-21-22 09:30AM
Dec-21-21 11:35AM
Dec-01-21 10:01AM
Nov-04-21 03:55PM
Aug-05-21 04:09PM
Aug-02-21 04:12PM
Jul-13-21 09:29AM
Jul-01-21 10:20AM
Jun-22-21 07:17PM
Jun-21-21 08:00AM
Jun-07-21 04:27PM
May-28-21 07:37AM
(The Wall Street Journal)
May-27-21 01:46PM
May-05-21 04:12PM
May-04-21 02:10AM
Apr-16-21 04:05PM
Mar-22-21 04:07PM
Mar-10-21 04:35PM
Feb-09-21 05:36PM
Nov-05-20 06:40AM
Nov-04-20 05:10PM
Aug-05-20 05:11PM
Jul-30-20 04:36PM
May-27-20 05:25PM
May-08-20 11:16AM
Mar-31-20 07:46AM
Mar-11-20 06:01PM
Feb-13-20 02:45PM
Jan-31-20 08:52AM
Dec-02-19 01:07PM
Nov-18-19 10:04AM
Sep-30-19 11:53AM
Sep-25-19 05:05PM
Aug-16-19 03:50PM
Jun-27-19 12:54PM
Jun-19-19 06:02AM
Dec-08-18 07:21PM
Nov-20-18 08:00AM
Citizens, Inc. is a holding company, which engages in the provision of insurance and reinsurance services. It operates through the Life Insurance and Home Service Insurance segments. The Life Insurance segment primarily issues ordinary whole life insurance and endowment policies in U.S. dollar-denominated amounts to foreign residents. The Home Service Insurance segment focuses on the life insurance needs of the middle- and lower-income markets. The company was founded by Harold Eugene Riley in 1969 and is headquartered in Austin, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MANESS TERRY SAM Director Apr 05 '24 Buy 2.14 1,000 2,137 15,947 Apr 08 05:28 PM MORGAN JAMES KEITH Director Mar 26 '24 Buy 2.11 5,899 12,469 61,965 Mar 27 03:01 PM MORGAN JAMES KEITH Director Mar 22 '24 Buy 1.98 1,101 2,180 56,066 Mar 25 11:52 AM Shields Gerald President & CEO Mar 21 '24 Buy 2.22 16,000 35,520 168,724 Mar 22 03:45 PM MORGAN JAMES KEITH Director Aug 09 '23 Buy 2.92 3,110 9,081 54,965 Aug 10 02:01 PM MORGAN JAMES KEITH Director Aug 08 '23 Buy 2.90 11,890 34,481 51,855 Aug 10 02:01 PM Claus Christopher W Director Jun 07 '23 Buy 2.28 15,909 36,198 40,176 Jun 09 03:35 PM Conklin Jeffery P. VP, CFO & Treasurer May 12 '23 Buy 1.93 14,000 27,020 115,782 May 16 12:32 PM
Index - P/E - EPS (ttm) -0.35 Insider Own 65.16% Shs Outstand 13.32M Perf Week -4.88%
Market Cap 70.09M Forward P/E - EPS next Y -0.20 Insider Trans 0.49% Shs Float 6.96M Perf Month -18.56%
Income -3.85M PEG - EPS next Q -0.23 Inst Own 6.72% Short Float 4.07% Perf Quarter -29.38%
Sales 79.18M P/S 0.89 EPS this Y -252.38% Inst Trans 6.31% Short Ratio 1.92 Perf Half Y -6.65%
Book/sh 1.05 P/B 3.33 EPS next Y 72.97% ROA -4.23% Short Interest 0.28M Perf Year 110.15%
Cash/sh 1.37 P/C 2.55 EPS next 5Y - ROE -20.64% 52W Range 1.02 - 8.11 Perf YTD -39.06%
Dividend Est. - P/FCF 13.38 EPS past 5Y - ROI -11.01% 52W High -56.72% Beta 0.76
Dividend TTM - Quick Ratio 1.10 Sales past 5Y 23.37% Gross Margin 66.33% 52W Low 244.12% ATR (14) 0.31
Dividend Ex-Date - Current Ratio 1.35 EPS Y/Y TTM 86.16% Oper. Margin 1.98% RSI (14) 46.88 Volatility 6.45% 7.50%
Employees 58 Debt/Eq 0.87 Sales Y/Y TTM 7.48% Profit Margin -4.87% Recom 1.00 Target Price 8.25
Option/Short No / Yes LT Debt/Eq 0.72 EPS Q/Q 81.52% Payout - Rel Volume 0.32 Prev Close 3.53
Sales Surprise 2.05% EPS Surprise -594.12% Sales Q/Q -4.44% Earnings May 13 AMC Avg Volume 147.55K Price 3.51
SMA20 -3.15% SMA50 -4.34% SMA200 -7.88% Trades
Volume 47,705 Change -0.57%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-07-21 Initiated B. Riley Securities
Buy
$14
May-07-24 08:30AM
May-01-24 04:01PM
Apr-29-24 09:00AM
Apr-25-24 08:30AM
Mar-28-24 04:05PM
07:01PM
Loading…
Mar-25-24 07:01PM
Mar-22-24 06:01AM
(Thomson Reuters StreetEvents) -13.61%
Mar-21-24 09:53PM
04:01PM
Mar-19-24 08:49AM
Mar-18-24 08:30AM
Mar-15-24 08:30AM
Mar-13-24 08:30AM
Mar-11-24 08:30AM
Feb-26-24 11:35AM
08:30AM
Loading…
Jan-05-24 08:30AM
Jan-02-24 04:05PM
Dec-27-23 08:50AM
Dec-13-23 08:09AM
Dec-07-23 09:16AM
Dec-06-23 08:00AM
Nov-30-23 12:00PM
Nov-29-23 08:50AM
Nov-14-23 04:10PM
Nov-12-23 09:36AM
Nov-07-23 04:01PM
Nov-01-23 08:00AM
Oct-31-23 08:30AM
Oct-20-23 08:30AM
Sep-09-23 01:04AM
11:45AM
Loading…
Sep-07-23 11:45AM
Sep-06-23 08:00AM
Aug-14-23 04:01PM
Aug-08-23 06:05PM
04:01PM
Aug-03-23 05:35PM
Aug-02-23 04:01PM
Jul-19-23 08:30AM
Jul-11-23 08:30AM
Jul-04-23 07:34AM
Jul-03-23 08:00AM
Jun-14-23 12:03PM
Jun-13-23 12:11PM
08:30AM
May-22-23 05:15PM
04:01PM
May-19-23 04:01PM
May-15-23 04:01PM
May-11-23 04:01PM
May-04-23 09:00AM
Apr-19-23 02:22PM
Apr-01-23 09:41PM
Mar-30-23 04:10PM
Mar-29-23 05:15PM
04:01PM
Mar-28-23 05:35PM
Mar-22-23 09:00AM
Mar-16-23 08:30AM
Mar-07-23 08:30AM
Jan-20-23 04:01PM
Jan-10-23 08:30AM
Dec-20-22 10:02AM
08:30AM
Dec-05-22 04:05PM
Nov-13-22 07:38AM
Nov-10-22 05:25PM
04:01PM
Nov-03-22 08:52AM
Oct-04-22 08:30AM
Aug-30-22 08:30AM
Aug-12-22 06:14AM
Aug-09-22 05:55PM
04:01PM
Aug-04-22 10:00AM
Aug-03-22 08:00AM
Jul-18-22 07:05AM
May-24-22 08:30AM
May-23-22 08:30AM
May-16-22 01:20PM
08:00AM
May-10-22 04:01PM
May-03-22 04:15PM
Apr-15-22 09:55AM
Apr-04-22 08:30AM
Apr-01-22 08:30AM
Mar-23-22 04:01PM
Mar-18-22 01:15PM
Mar-17-22 08:30AM
Mar-09-22 08:30AM
Feb-11-22 08:00AM
Jan-13-22 08:38AM
07:00AM
07:00AM
Dec-27-21 07:15AM
(American City Business Journals)
Dec-10-21 08:00AM
Dec-07-21 04:05PM
Nov-29-21 08:00AM
Nov-16-21 07:21PM
(American City Business Journals) -8.89%
04:01PM
Nov-12-21 07:00AM
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ROSENWALD LINDSAY A MD Director Mar 25 '24 Buy 3.04 10,000 30,400 144,245 Mar 27 07:00 AM Smith Justin Adam Director Mar 22 '24 Buy 3.47 30,000 104,100 134,717 Mar 25 04:02 PM ROSENWALD LINDSAY A MD Director Mar 22 '24 Buy 3.40 20,000 68,000 134,245 Mar 25 04:01 PM Maraoui Claude President & CEO Mar 22 '24 Buy 3.48 10,000 34,790 2,163,430 Mar 25 04:03 PM Benesch Joseph Interim CFO Feb 22 '24 Sale 3.75 2,450 9,188 60,710 Feb 23 05:54 PM Paley Jeffrey Director Nov 28 '23 Sale 5.22 1,745 9,109 70,727 Nov 29 04:42 PM Paley Jeffrey Director Nov 08 '23 Sale 3.76 255 959 114,217 Dec 08 05:01 PM Paley Jeffrey Director Nov 07 '23 Sale 3.48 2,245 7,813 114,472 Dec 08 05:01 PM Smith Justin Adam Director Oct 13 '23 Buy 2.98 33,000 98,340 104,717 Oct 17 04:01 PM Paley Jeffrey Director Oct 06 '23 Buy 2.98 15,000 44,700 72,472 Oct 10 04:41 PM Paley Jeffrey Director Sep 21 '23 Buy 2.97 30,000 89,100 57,472 Sep 25 04:01 PM ROSENWALD LINDSAY A MD Director Sep 06 '23 Buy 2.23 100,000 223,000 114,245 Sep 08 01:25 PM Maraoui Claude President & CEO Sep 06 '23 Buy 2.52 26,044 65,631 2,153,430 Sep 08 01:26 PM Maraoui Claude President & CEO Jul 24 '23 Sale 1.76 20,767 36,550 2,127,386 Jul 25 04:05 PM Benesch Joseph See Remarks Jul 24 '23 Sale 1.76 4,072 7,167 63,160 Jul 25 04:05 PM Maraoui Claude President & CEO May 17 '23 Sale 1.34 24,377 32,665 2,148,153 May 18 04:31 PM Maraoui Claude President & CEO May 16 '23 Sale 1.25 20,000 25,000 2,172,530 May 18 04:31 PM
Index - P/E 28.73 EPS (ttm) 0.12 Insider Own 23.26% Shs Outstand 35.99M Perf Week -2.07%
Market Cap 123.93M Forward P/E 12.63 EPS next Y 0.26 Insider Trans -15.09% Shs Float 28.73M Perf Month -1.19%
Income 4.18M PEG - EPS next Q 0.03 Inst Own 37.72% Short Float 0.41% Perf Quarter 10.70%
Sales 31.64M P/S 3.92 EPS this Y -61.31% Inst Trans -1.53% Short Ratio 2.66 Perf Half Y 0.30%
Book/sh 3.41 P/B 0.97 EPS next Y 79.13% ROA 2.62% Short Interest 0.12M Perf Year 21.25%
Cash/sh 0.04 P/C 76.03 EPS next 5Y - ROE 3.45% 52W Range 2.63 - 3.89 Perf YTD 2.80%
Dividend Est. 0.12 (3.63%) P/FCF - EPS past 5Y -14.83% ROI 2.72% 52W High -14.91% Beta 0.56
Dividend TTM 0.10 (3.17%) Quick Ratio 4.51 Sales past 5Y 7.41% Gross Margin 51.01% 52W Low 25.86% ATR (14) 0.10
Dividend Ex-Date Mar 15, 2024 Current Ratio 4.51 EPS Y/Y TTM -82.23% Oper. Margin 12.02% RSI (14) 48.43 Volatility 2.96% 2.86%
Employees 20 Debt/Eq 0.26 Sales Y/Y TTM -52.35% Profit Margin 13.22% Recom 1.00 Target Price 4.71
Option/Short Yes / Yes LT Debt/Eq 0.26 EPS Q/Q -101.92% Payout 22.62% Rel Volume 0.42 Prev Close 3.30
Sales Surprise -1.79% EPS Surprise -202.27% Sales Q/Q -51.71% Earnings May 08 AMC Avg Volume 44.07K Price 3.31
SMA20 -1.15% SMA50 1.76% SMA200 -0.59% Trades
Volume 18,695 Change 0.30%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-15-23 Initiated Johnson Rice
Buy
$5.50
Oct-03-22 Resumed Northland Capital
Outperform
$6
Jun-18-09 Reiterated Wunderlich
Buy
$26 → $30
Feb-13-09 Upgrade Wunderlich
Hold → Buy
$23.50
Jan-30-09 Initiated Wunderlich
Hold
$21
May-08-24 09:55PM
04:15PM
May-01-24 10:01AM
Apr-24-24 01:12PM
08:23AM
12:10PM
Loading…
Apr-23-24 12:10PM
Apr-22-24 04:15PM
Apr-18-24 04:15PM
01:45PM
Apr-04-24 02:55PM
Mar-12-24 05:53PM
05:35PM
04:15PM
Feb-05-24 04:15PM
Nov-10-23 04:12PM
05:40AM
Loading…
05:40AM
Nov-08-23 04:15PM
Oct-24-23 04:15PM
Sep-11-23 05:31PM
Sep-10-23 02:48PM
Aug-24-23 04:15PM
Aug-15-23 09:15AM
Aug-12-23 08:02AM
Aug-09-23 09:37AM
Aug-08-23 04:15PM
Aug-07-23 06:50AM
Jul-26-23 01:30PM
Jul-24-23 04:15PM
Jun-26-23 04:33PM
Jun-08-23 11:26AM
06:15AM
Loading…
May-19-23 06:15AM
May-13-23 09:02AM
08:13AM
May-09-23 04:30PM
Apr-24-23 09:30AM
Apr-17-23 01:56PM
Mar-29-23 06:31AM
Mar-23-23 09:15AM
Mar-13-23 04:10PM
Feb-27-23 12:12PM
Feb-11-23 07:09AM
Feb-08-23 04:15PM
Feb-01-23 04:15PM
10:00AM
05:22AM
Jan-26-23 11:48AM
Jan-21-23 07:45AM
Dec-27-22 09:15AM
Dec-15-22 05:55AM
Dec-13-22 04:15PM
Nov-07-22 01:21PM
Nov-03-22 04:15PM
Oct-12-22 11:42AM
Oct-06-22 06:24AM
Sep-27-22 09:05AM
Sep-26-22 01:51PM
Aug-20-22 10:09AM
Aug-08-22 04:15PM
Jul-21-22 04:15PM
Jul-02-22 08:10AM
Jun-14-22 09:40AM
Jun-10-22 12:00PM
Jun-06-22 04:15PM
May-29-22 08:56AM
May-18-22 04:15PM
May-09-22 04:15PM
May-04-22 03:37PM
(Investor's Business Daily) +7.20%
Apr-28-22 03:55PM
Apr-25-22 04:15PM
Apr-21-22 04:15PM
Apr-19-22 09:00AM
Apr-04-22 04:21PM
Mar-17-22 04:15PM
Feb-24-22 04:19AM
Feb-15-22 10:54AM
Feb-14-22 06:05PM
04:15PM
Feb-07-22 03:00PM
Feb-01-22 04:15PM
Jan-21-22 09:07AM
Dec-31-21 10:06AM
Dec-17-21 05:02AM
Dec-16-21 10:15AM
04:59AM
Dec-13-21 04:15PM
Dec-09-21 04:15PM
Dec-06-21 03:00PM
Dec-01-21 04:15PM
Nov-18-21 08:50AM
Nov-17-21 12:10PM
Nov-11-21 04:15PM
Nov-10-21 07:42PM
Nov-01-21 09:15AM
Oct-25-21 07:58AM
Oct-22-21 12:00PM
Oct-20-21 09:02AM
Sep-24-21 02:30PM
Sep-16-21 04:15PM
Sep-03-21 08:45AM
Aug-25-21 04:20PM
PHX Minerals, Inc. engages in the acquisition, management, and development of non-operated oil and natural gas properties, including wells located on the firm's mineral and leasehold acreage. The company was founded on December 3, 1926 and is headquartered in Fort Worth, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
True Chad Principal Accounting Officer Mar 26 '24 Buy 3.22 1,000 3,220 74,020 Mar 26 01:59 PM BEHRMAN MARK T Director Mar 25 '24 Buy 3.22 23,000 74,047 173,704 Mar 26 11:27 AM D'Amico Raphael SVP - CFO Mar 14 '24 Buy 3.04 3,500 10,640 514,124 Mar 14 02:57 PM Edenbrook Capital, LLC 10% Owner Dec 21 '23 Sale 3.11 1,575,000 4,898,408 3,679,546 Dec 26 04:56 PM
Index - P/E - EPS (ttm) -0.49 Insider Own 7.63% Shs Outstand 23.98M Perf Week -13.57%
Market Cap 44.05M Forward P/E 1.68 EPS next Y 1.03 Insider Trans 1.93% Shs Float 23.65M Perf Month -3.91%
Income -11.30M PEG - EPS next Q -0.16 Inst Own 12.70% Short Float 5.17% Perf Quarter -34.35%
Sales 19.01M P/S 2.32 EPS this Y 11.59% Inst Trans 12.95% Short Ratio 5.40 Perf Half Y -43.42%
Book/sh 1.84 P/B 0.94 EPS next Y 352.46% ROA -23.24% Short Interest 1.22M Perf Year -72.44%
Cash/sh 1.84 P/C 0.93 EPS next 5Y - ROE -25.89% 52W Range 1.50 - 6.60 Perf YTD -42.86%
Dividend Est. - P/FCF - EPS past 5Y 53.36% ROI -22.64% 52W High -73.94% Beta 0.37
Dividend TTM - Quick Ratio 13.35 Sales past 5Y 1322.70% Gross Margin 99.97% 52W Low 14.67% ATR (14) 0.15
Dividend Ex-Date - Current Ratio 8.96 EPS Y/Y TTM -154.01% Oper. Margin -63.86% RSI (14) 45.37 Volatility 9.52% 7.72%
Employees 14 Debt/Eq 0.00 Sales Y/Y TTM -54.30% Profit Margin -59.44% Recom 1.00 Target Price 19.33
Option/Short Yes / Yes LT Debt/Eq 0.00 EPS Q/Q -4.77% Payout - Rel Volume 2.02 Prev Close 1.96
Sales Surprise -67.96% EPS Surprise -163.64% Sales Q/Q -2.17% Earnings May 10 BMO Avg Volume 226.19K Price 1.72
SMA20 -0.53% SMA50 -11.20% SMA200 -40.77% Trades
Volume 456,065 Change -12.24%
May-10-24 01:53PM
08:00AM
May-06-24 08:00AM
May-03-24 08:00AM
Apr-22-24 08:00AM
10:03AM
Loading…
Apr-11-24 10:03AM
Apr-01-24 07:14AM
Mar-15-24 11:53AM
Mar-09-24 01:09PM
Mar-08-24 08:00AM
Mar-04-24 08:18AM
Feb-23-24 08:00AM
Feb-15-24 04:10PM
Feb-14-24 08:00AM
Feb-05-24 08:00AM
04:10PM
Loading…
Jan-24-24 04:10PM
Jan-11-24 07:41AM
Jan-04-24 08:00AM
Nov-30-23 08:00AM
Nov-27-23 04:38PM
08:00AM
Nov-13-23 08:00AM
Nov-02-23 08:00AM
Nov-01-23 04:52PM
08:05AM
Oct-26-23 08:00AM
Oct-06-23 08:00AM
Sep-27-23 08:00AM
08:00AM
Sep-11-23 09:41AM
09:00AM
Loading…
Sep-07-23 09:00AM
Aug-28-23 08:00AM
Aug-11-23 08:00AM
Aug-08-23 08:00AM
Jul-26-23 08:00AM
Jul-10-23 05:19PM
Jun-27-23 08:00AM
Jun-21-23 08:00AM
Jun-12-23 08:00AM
May-24-23 04:05PM
May-15-23 08:00AM
May-02-23 08:30AM
Apr-25-23 08:00AM
Apr-21-23 08:00AM
Mar-30-23 08:00AM
Mar-23-23 08:00AM
Feb-16-23 08:30AM
Feb-13-23 08:00AM
Jan-25-23 04:01PM
Jan-09-23 07:00AM
Dec-06-22 06:00AM
Dec-05-22 08:30AM
Nov-21-22 08:00AM
Nov-07-22 04:05PM
Nov-04-22 04:30PM
Nov-02-22 08:10AM
Oct-24-22 08:56AM
Oct-07-22 07:00AM
Oct-06-22 09:27AM
Sep-29-22 08:00AM
Sep-27-22 09:05AM
Sep-15-22 07:00AM
Sep-12-22 08:00AM
Sep-08-22 08:00AM
Sep-06-22 09:00AM
Aug-12-22 07:00AM
Aug-08-22 01:16PM
07:00AM
Aug-03-22 08:00AM
Jul-07-22 08:00AM
Jun-29-22 09:00AM
Jun-24-22 08:59AM
Jun-08-22 08:00AM
May-19-22 07:00AM
May-13-22 08:00AM
May-11-22 08:00AM
Apr-28-22 07:00AM
Apr-26-22 09:00AM
Apr-19-22 08:00AM
Apr-06-22 08:00AM
Mar-29-22 07:00AM
Mar-24-22 08:00AM
Mar-16-22 07:30AM
Mar-10-22 09:27AM
Mar-08-22 08:00AM
Feb-08-22 08:00AM
Jan-31-22 06:00AM
Jan-25-22 07:00AM
Jan-05-22 07:00AM
Dec-08-21 08:00AM
Nov-23-21 09:00AM
Nov-15-21 01:32PM
Nov-12-21 07:00AM
Nov-01-21 09:30AM
Oct-07-21 07:00AM
Oct-01-21 08:49AM
Sep-27-21 07:00AM
Sep-03-21 05:00PM
Sep-02-21 07:00AM
Aug-12-21 07:00AM
Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Jhaveri Nirav S. Chief Financial Officer Mar 21 '24 Buy 2.10 10,000 21,000 150,000 Mar 25 04:40 PM SCHACHLE JOSEPH K Chief Operating Officer Mar 21 '24 Buy 2.05 2,000 4,100 2,000 Mar 25 04:44 PM Magrath George Chief Executive Officer Mar 18 '24 Buy 1.96 25,000 49,050 425,000 Mar 20 04:18 PM
Index RUT P/E - EPS (ttm) -1.86 Insider Own 29.56% Shs Outstand 29.27M Perf Week -11.59%
Market Cap 42.99M Forward P/E - EPS next Y -1.85 Insider Trans -11.26% Shs Float 20.89M Perf Month -30.29%
Income -54.18M PEG - EPS next Q -0.52 Inst Own 37.69% Short Float 15.36% Perf Quarter -78.06%
Sales 0.00M P/S - EPS this Y -5.85% Inst Trans -2.73% Short Ratio 4.14 Perf Half Y -75.42%
Book/sh 2.65 P/B 0.55 EPS next Y 7.11% ROA -55.37% Short Interest 3.21M Perf Year -79.86%
Cash/sh 2.40 P/C 0.60 EPS next 5Y - ROE -61.38% 52W Range 1.38 - 11.92 Perf YTD -80.27%
Dividend Est. - P/FCF - EPS past 5Y -57.97% ROI -65.42% 52W High -87.84% Beta -0.56
Dividend TTM - Quick Ratio 14.38 Sales past 5Y -43.59% Gross Margin -168734.95% 52W Low 5.07% ATR (14) 0.21
Dividend Ex-Date - Current Ratio 14.38 EPS Y/Y TTM 4.19% Oper. Margin 0.00% RSI (14) 31.05 Volatility 11.00% 10.16%
Employees 68 Debt/Eq 0.06 Sales Y/Y TTM -100.00% Profit Margin - Recom 1.75 Target Price 13.07
Option/Short No / Yes LT Debt/Eq 0.05 EPS Q/Q 5.31% Payout - Rel Volume 0.32 Prev Close 1.56
Sales Surprise - EPS Surprise 2.57% Sales Q/Q - Earnings May 07 AMC Avg Volume 775.04K Price 1.45
SMA20 -12.29% SMA50 -49.62% SMA200 -76.54% Trades
Volume 250,084 Change -7.05%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-15-24 Reiterated Needham
Buy
$20 → $15
Mar-15-24 Downgrade TD Cowen
Outperform → Market Perform
Mar-15-24 Downgrade Jefferies
Buy → Hold
$16 → $3
Dec-01-23 Initiated Needham
Buy
$20
Jun-26-23 Resumed Oppenheimer
Outperform
$25
Apr-19-23 Upgrade Morgan Stanley
Underweight → Equal-Weight
$5 → $14
Apr-19-23 Upgrade Mizuho
Neutral → Buy
$10 → $20
Mar-30-23 Initiated Mizuho
Neutral
$10
Feb-03-23 Downgrade Morgan Stanley
Equal-Weight → Underweight
$12 → $5
Jul-08-22 Initiated Chardan Capital Markets
Buy
$18
Apr-01-22 Initiated Oppenheimer
Outperform
$25
Jan-07-22 Initiated Piper Sandler
Overweight
$41
Show Previous Ratings
May-07-24 10:55PM
04:05PM
May-06-24 04:30PM
Apr-09-24 12:00PM
Apr-03-24 04:05PM
08:00AM
Loading…
Mar-27-24 08:00AM
Mar-18-24 11:02AM
Mar-14-24 07:00AM
Mar-12-24 08:00AM
Mar-11-24 08:00AM
Mar-06-24 08:00AM
Mar-05-24 05:00PM
Mar-04-24 08:00AM
Mar-03-24 07:01PM
Mar-01-24 08:00AM
08:00AM
Loading…
Feb-20-24 08:00AM
Feb-14-24 03:45PM
Feb-01-24 08:00AM
Dec-12-23 08:00AM
Nov-20-23 04:05PM
Nov-09-23 04:05PM
Oct-12-23 04:05PM
Oct-04-23 04:05PM
Sep-06-23 08:00AM
Aug-03-23 04:05PM
Aug-02-23 06:09AM
Jul-05-23 09:55AM
Jun-05-23 08:00AM
May-30-23 08:00AM
May-04-23 07:25PM
04:05PM
Loading…
04:05PM
Apr-18-23 09:24AM
09:00AM
04:20AM
Apr-12-23 04:05PM
Apr-11-23 03:56AM
Apr-05-23 08:00AM
Mar-28-23 08:00AM
Mar-27-23 09:55AM
Mar-24-23 01:25PM
Mar-23-23 06:18AM
Mar-14-23 04:30PM
Mar-09-23 09:55AM
Mar-08-23 07:14AM
Mar-06-23 05:45PM
04:05PM
Mar-05-23 06:30PM
Feb-28-23 08:00AM
Feb-27-23 08:00AM
Feb-05-23 07:18AM
Jan-31-23 06:50AM
Nov-28-22 06:50AM
Nov-16-22 06:35AM
Nov-10-22 10:15AM
09:00AM
09:00AM
Nov-03-22 06:50AM
Oct-20-22 06:50AM
Oct-05-22 08:05AM
Sep-30-22 12:00PM
06:50AM
Sep-12-22 09:55AM
Sep-05-22 10:21AM
Sep-02-22 08:09AM
Aug-25-22 09:55AM
06:50AM
Aug-10-22 05:55PM
04:05PM
Aug-08-22 12:24PM
(Simply Wall St.) +11.25%
Jul-22-22 10:01AM
Jul-11-22 07:57AM
Jul-08-22 11:40AM
Jul-06-22 06:50AM
May-26-22 05:26PM
May-20-22 06:50AM
May-10-22 06:30AM
May-09-22 08:54AM
(Simply Wall St.) -12.63%
May-05-22 06:50AM
Apr-07-22 10:46AM
Apr-01-22 06:50AM
Mar-24-22 06:55AM
Mar-10-22 08:46AM
06:30AM
Feb-24-22 06:50AM
Feb-07-22 08:30AM
Jan-31-22 12:24PM
Jan-24-22 06:50AM
Jan-19-22 08:00AM
Jan-18-22 06:50AM
Jan-06-22 04:10PM
Jan-03-22 06:50AM
Dec-16-21 06:50AM
Nov-18-21 06:35AM
Nov-10-21 06:50AM
Nov-09-21 06:30AM
Nov-01-21 09:20AM
Oct-11-21 06:50AM
Oct-01-21 06:50AM
Sep-20-21 04:10PM
Sep-09-21 06:30AM
Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Cormorant Asset Management, LP 10% Owner Apr 01 '24 Sale 2.90 400,000 1,160,181 2,895,273 Apr 03 05:37 PM Feinberg Peter Director Mar 22 '24 Buy 2.55 25,000 63,713 111,766 Mar 25 09:13 AM Brakewood Harold Eugene Chief Business Officer Mar 22 '24 Buy 2.57 3,900 10,015 3,900 Mar 25 09:10 AM Schall Thomas J. Director Mar 22 '24 Buy 2.55 2,900 7,385 2,900 Mar 25 04:03 PM Morales Mallory Chief Accounting Officer Mar 22 '24 Buy 2.55 393 1,000 8,278 Mar 25 09:04 AM Morales Mallory Chief Accounting Officer Mar 21 '24 Buy 2.72 1,107 3,009 7,885 Mar 25 09:04 AM Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Mar 20 '24 Buy 2.86 7,000 20,020 345,896 Mar 21 09:06 AM Neufeld Leah R CHIEF PEOPLE OFFICER Mar 20 '24 Buy 2.88 3,818 10,993 10,029 Mar 21 09:11 AM Feinberg Peter Director Mar 19 '24 Buy 2.56 25,000 64,000 86,766 Mar 19 07:04 PM Zeskind Benjamin J. PRESIDENT AND CEO Mar 19 '24 Buy 2.77 20,000 55,326 2,281,852 Mar 19 06:59 PM BERMAN ANN E Director Mar 18 '24 Buy 2.13 57,965 123,436 67,465 Mar 19 07:10 PM Feinberg Peter Director Mar 18 '24 Buy 2.38 50,000 119,058 61,766 Mar 19 07:04 PM Cormorant Asset Management, LP 10% Owner Mar 15 '24 Sale 2.14 400,000 856,400 3,295,273 Mar 18 05:59 PM Cormorant Asset Management, LP 10% Owner Mar 14 '24 Sale 3.72 509,091 1,892,603 3,695,273 Mar 18 05:59 PM
Index - P/E - EPS (ttm) -0.59 Insider Own 9.37% Shs Outstand 49.10M Perf Week -1.19%
Market Cap 20.36M Forward P/E - EPS next Y -0.46 Insider Trans 8.40% Shs Float 46.12M Perf Month -34.86%
Income -28.96M PEG - EPS next Q -0.11 Inst Own 8.09% Short Float 0.91% Perf Quarter 0.48%
Sales 0.20M P/S 101.78 EPS this Y 18.33% Inst Trans -3.56% Short Ratio 1.88 Perf Half Y -14.53%
Book/sh 0.19 P/B 2.06 EPS next Y 7.14% ROA -64.84% Short Interest 0.42M Perf Year -14.88%
Cash/sh 0.26 P/C 1.56 EPS next 5Y 25.00% ROE -118.94% 52W Range 0.32 - 0.75 Perf YTD -9.07%
Dividend Est. - P/FCF - EPS past 5Y 42.86% ROI -269.94% 52W High -46.57% Beta -0.33
Dividend TTM - Quick Ratio 1.68 Sales past 5Y -2.98% Gross Margin -62.38% 52W Low 24.96% ATR (14) 0.04
Dividend Ex-Date - Current Ratio 1.68 EPS Y/Y TTM -46.75% Oper. Margin -15793.56% RSI (14) 42.72 Volatility 8.50% 10.34%
Employees 26 Debt/Eq 0.07 Sales Y/Y TTM 44.29% Profit Margin -14337.62% Recom 1.00 Target Price 3.50
Option/Short No / Yes LT Debt/Eq 0.05 EPS Q/Q -180.50% Payout - Rel Volume 0.40 Prev Close 0.44
Sales Surprise 69.86% EPS Surprise -116.67% Sales Q/Q 16.07% Earnings May 16 BMO Avg Volume 224.76K Price 0.40
SMA20 -9.05% SMA50 -7.70% SMA200 -17.08% Trades
Volume 89,136 Change -8.38%
May-09-24 08:50AM
May-06-24 08:30AM
Apr-29-24 08:55AM
Apr-25-24 08:45AM
Apr-18-24 08:45AM
08:55AM
Loading…
Apr-15-24 08:55AM
Apr-11-24 11:00AM
Apr-10-24 08:21AM
Apr-02-24 07:30AM
Mar-28-24 08:05AM
Mar-26-24 09:05AM
Mar-25-24 09:05AM
Mar-22-24 08:55AM
Mar-20-24 09:25AM
Mar-15-24 08:45AM
08:45AM
Loading…
Mar-07-24 08:45AM
Feb-29-24 08:45AM
Feb-14-24 08:55AM
Feb-08-24 08:50AM
Jan-24-24 09:10AM
Jan-22-24 08:55AM
Jan-10-24 08:45AM
Jan-05-24 01:32PM
Jan-03-24 04:05PM
Dec-29-23 08:00AM
Nov-28-23 04:30PM
Nov-27-23 09:00PM
Nov-21-23 12:00PM
Nov-16-23 08:45AM
Nov-15-23 07:30AM
10:00AM
Loading…
Nov-14-23 10:00AM
Nov-09-23 08:05AM
Nov-08-23 08:45AM
Nov-06-23 09:25AM
Oct-30-23 08:55AM
Oct-17-23 08:45AM
Sep-22-23 09:05AM
Sep-11-23 01:00PM
Sep-05-23 09:05AM
Aug-23-23 08:00AM
Aug-15-23 06:45AM
Aug-09-23 09:05AM
Aug-08-23 08:05AM
Jul-18-23 07:30PM
06:53AM
Jul-10-23 08:05AM
Jul-05-23 08:35AM
Jun-27-23 11:16AM
08:45AM
Jun-14-23 08:45AM
Jun-12-23 08:45AM
Jun-07-23 07:11PM
May-15-23 08:45AM
May-09-23 08:50AM
08:46AM
Apr-20-23 03:56PM
Apr-12-23 08:35AM
07:30AM
Apr-10-23 07:30AM
Apr-04-23 08:45AM
Apr-03-23 06:30AM
Mar-30-23 08:45AM
Mar-27-23 09:05AM
Mar-16-23 08:45AM
07:00AM
07:00AM
Mar-08-23 08:45AM
Mar-06-23 08:45AM
Feb-28-23 08:45AM
Feb-17-23 08:55AM
Jan-17-23 08:45AM
Jan-11-23 01:00PM
Jan-09-23 08:05AM
Jan-05-23 08:45AM
Dec-12-22 09:00AM
Dec-08-22 08:05AM
Dec-02-22 10:45AM
Nov-15-22 07:00AM
Nov-14-22 07:00AM
Nov-09-22 09:00AM
Nov-03-22 12:34PM
Nov-02-22 07:05AM
Nov-01-22 05:19PM
Oct-31-22 07:30AM
Oct-26-22 05:12PM
Oct-24-22 08:30AM
Oct-13-22 10:32AM
Oct-12-22 04:32PM
Sep-21-22 08:45AM
Sep-19-22 08:05AM
Sep-07-22 07:25AM
Sep-06-22 07:30AM
Aug-30-22 07:30AM
Aug-18-22 09:05AM
Aug-16-22 04:05PM
Aug-15-22 04:05PM
08:05AM
Jul-28-22 09:10AM
Jul-21-22 12:26PM
Jul-20-22 08:05AM
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Equels Thomas K CEO & President May 06 '24 Buy 0.41 61,729 25,000 778,184 May 07 08:30 AM Rodino Peter W III COO, Secretary, Gen. Counsel May 06 '24 Buy 0.41 30,865 12,500 212,583 May 07 08:30 AM BRYAN NANCY Director Mar 21 '24 Buy 0.39 38,462 15,000 38,462 Mar 22 01:30 PM APPELROUTH STEWART Director Mar 15 '24 Buy 0.33 90,910 30,000 239,765 Mar 18 03:01 PM Equels Thomas K CEO & President Mar 15 '24 Buy 0.33 75,758 25,000 716,455 Mar 18 03:01 PM Rodino Peter W III COO, Secretary, Gen. Counsel Mar 15 '24 Buy 0.33 37,879 12,500 181,718 Mar 18 03:01 PM Equels Thomas K CEO & President Nov 27 '23 Buy 0.44 33,861 15,000 640,697 Nov 27 12:56 PM Equels Thomas K CEO & President Sep 29 '23 Buy 0.44 22,676 10,000 606,836 Sep 29 03:29 PM Equels Thomas K CEO & President Aug 25 '23 Buy 0.67 8,222 5,501 584,160 Aug 25 02:26 PM Equels Thomas K CEO & President Aug 24 '23 Buy 0.67 14,993 10,000 575,938 Aug 24 01:52 PM Equels Thomas K CEO & President Jul 17 '23 Buy 0.59 16,950 10,000 560,945 Jul 17 07:20 PM
Index RUT P/E - EPS (ttm) -2.43 Insider Own 5.79% Shs Outstand 89.45M Perf Week 19.44%
Market Cap 115.43M Forward P/E 5.16 EPS next Y 0.25 Insider Trans 7.91% Shs Float 84.30M Perf Month 25.24%
Income -216.35M PEG - EPS next Q -0.01 Inst Own 81.40% Short Float 5.71% Perf Quarter -0.77%
Sales 979.36M P/S 0.12 EPS this Y 102.62% Inst Trans 5.89% Short Ratio 2.96 Perf Half Y -44.87%
Book/sh -2.49 P/B - EPS next Y 809.09% ROA -9.94% Short Interest 4.82M Perf Year -78.32%
Cash/sh 0.68 P/C 1.90 EPS next 5Y 6.99% ROE -657.27% 52W Range 0.75 - 6.64 Perf YTD -11.64%
Dividend Est. - P/FCF - EPS past 5Y 46.93% ROI -81.36% 52W High -80.57% Beta 1.58
Dividend TTM - Quick Ratio 1.11 Sales past 5Y 1.94% Gross Margin 21.84% 52W Low 71.31% ATR (14) 0.11
Dividend Ex-Date - Current Ratio 1.45 EPS Y/Y TTM -411.02% Oper. Margin 2.36% RSI (14) 64.82 Volatility 11.49% 9.46%
Employees 2250 Debt/Eq - Sales Y/Y TTM 3.85% Profit Margin -22.09% Recom 1.50 Target Price 4.50
Option/Short Yes / Yes LT Debt/Eq - EPS Q/Q -25.67% Payout - Rel Volume 0.83 Prev Close 1.22
Sales Surprise 0.45% EPS Surprise -72.55% Sales Q/Q -19.32% Earnings May 09 AMC Avg Volume 1.63M Price 1.29
SMA20 23.38% SMA50 13.95% SMA200 -45.78% Trades
Volume 1,349,571 Change 5.74%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-10-23 Downgrade Craig Hallum
Buy → Hold
$10 → $2
Jul-19-22 Initiated Craig Hallum
Buy
$11
Mar-25-21 Initiated Lake Street
Buy
$12
Mar-25-21 Initiated DA Davidson
Buy
$10
Feb-18-21 Initiated B. Riley Securities
Buy
$12
Mar-01-17 Downgrade KeyBanc Capital Mkts
Overweight → Sector Weight
Oct-13-16 Downgrade Credit Suisse
Neutral → Underperform
Dec-15-15 Initiated Sidoti
Buy
Today 11:07AM
May-10-24 04:02PM
May-09-24 04:51PM
(Associated Press Finance)
04:15PM
Apr-25-24 04:15PM
09:55AM
Loading…
Apr-23-24 09:55AM
Apr-22-24 06:30AM
Apr-16-24 12:00PM
Apr-15-24 06:30AM
Apr-10-24 04:52PM
Mar-21-24 03:39PM
Mar-20-24 06:30AM
Mar-18-24 06:30AM
Mar-15-24 01:53PM
09:23AM
(Thomson Reuters StreetEvents)
06:40PM
Loading…
Mar-14-24 06:40PM
(Associated Press Finance)
05:53PM
04:15PM
Feb-29-24 04:15PM
Feb-12-24 06:30AM
Jan-25-24 06:30AM
Jan-24-24 06:30AM
Jan-22-24 04:15PM
Nov-21-23 04:05PM
Nov-16-23 05:03PM
Nov-14-23 06:30AM
Nov-10-23 10:37AM
Nov-09-23 05:52PM
(Associated Press Finance)
04:45PM
Oct-26-23 04:15PM
06:30AM
Loading…
Oct-04-23 06:30AM
Sep-26-23 06:30AM
Aug-31-23 04:05PM
Aug-30-23 06:30AM
Aug-16-23 01:47PM
Aug-08-23 07:15PM
06:07PM
04:15PM
Aug-07-23 04:05PM
Jul-31-23 06:30AM
Jul-26-23 06:30AM
Jul-25-23 04:15PM
Jun-28-23 07:13AM
Jun-21-23 03:47AM
Jun-04-23 08:34AM
May-18-23 07:01AM
May-17-23 04:05PM
06:35AM
May-10-23 07:45AM
06:37AM
06:30AM
May-03-23 02:53PM
May-01-23 04:01PM
Apr-26-23 04:15PM
Apr-17-23 08:44AM
Apr-02-23 08:34AM
Mar-27-23 06:30AM
Mar-26-23 12:24PM
Mar-24-23 06:42AM
Mar-20-23 06:30AM
Mar-19-23 11:15PM
Mar-16-23 07:09AM
Mar-15-23 06:30AM
Mar-01-23 04:05PM
Feb-10-23 06:42AM
Feb-09-23 06:51AM
Feb-08-23 06:45AM
Jan-30-23 06:42AM
06:30AM
Jan-27-23 07:00AM
Jan-26-23 06:44AM
Jan-24-23 07:58AM
06:48AM
06:30AM
Jan-23-23 06:58AM
Jan-20-23 06:55AM
Jan-19-23 06:43AM
Jan-18-23 06:28AM
Jan-17-23 06:27AM
Jan-11-23 04:01PM
Jan-10-23 04:01PM
Jan-03-23 06:26AM
Dec-30-22 07:17AM
Dec-28-22 06:58AM
Dec-25-22 07:26AM
Dec-22-22 06:34AM
Dec-21-22 06:46AM
Dec-20-22 06:29AM
Dec-19-22 08:09AM
Dec-13-22 06:30AM
Dec-01-22 06:45PM
06:30AM
Nov-25-22 09:00AM
Nov-21-22 06:30AM
Nov-17-22 06:30AM
Nov-14-22 09:00AM
06:30AM
Nov-10-22 05:17AM
Nov-08-22 07:55PM
04:41PM
Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Morgan Jimmy B Chief Operating Officer May 02 '24 Option Exercise 1.05 49,010 51,460 518,717 May 03 04:33 PM Moeller Philip D Director Mar 21 '24 Buy 1.10 20,000 22,000 85,774 Mar 22 08:04 AM Young Kenneth M Chief Executive Officer Mar 20 '24 Buy 1.03 29,229 30,001 241,745 Mar 22 08:00 AM Salamone Louis Jr Chief Financial Officer Mar 20 '24 Buy 1.02 4,000 4,080 636,711 Mar 22 08:01 AM Tato Joseph A Director Mar 18 '24 Buy 0.97 6,000 5,811 67,303 Mar 20 04:32 PM Bartoli Henry E Director Nov 16 '23 Buy 1.51 10,000 15,078 278,049 Nov 17 07:52 AM B. Riley Financial, Inc. 10% Owner Nov 14 '23 Buy 1.16 157,883 182,907 7,602,348 Nov 16 09:23 AM Salamone Louis Jr Chief Financial Officer Nov 14 '23 Buy 1.15 50,000 57,435 632,711 Nov 15 07:53 AM Riker Christopher S Senior Vice President Nov 14 '23 Buy 1.12 20,000 22,400 77,597 Nov 15 07:51 AM Tato Joseph A Director Nov 14 '23 Buy 1.17 10,000 11,673 61,303 Nov 16 07:51 AM Young Kenneth M Chief Executive Officer Nov 13 '23 Buy 1.00 49,803 49,997 212,516 Nov 14 07:51 AM Bartoli Henry E Director Nov 13 '23 Buy 1.20 20,000 24,000 268,049 Nov 14 07:53 AM Howe Alan B Director Nov 13 '23 Buy 1.00 3,000 3,015 72,606 Nov 14 07:55 AM Young Kenneth M Chief Executive Officer Nov 03 '23 Option Exercise 2.55 66,667 170,001 1,279,667 Nov 17 08:35 AM Dziewisz John J General Counsel & Secretary Aug 31 '23 Sale 5.06 2,551 12,908 196,390 Sep 01 04:31 PM Dziewisz John J General Counsel & Secretary Aug 30 '23 Sale 5.09 2,733 13,911 198,941 Sep 01 04:31 PM Young Kenneth M Chief Executive Officer Aug 25 '23 Option Exercise 4.88 66,667 325,335 1,213,000 Aug 29 04:44 PM Salamone Louis Jr Chief Financial Officer Aug 25 '23 Option Exercise 4.88 50,000 244,000 601,730 Aug 29 04:42 PM Morgan Jimmy B Chief Operating Officer Aug 25 '23 Option Exercise 4.88 50,000 244,000 492,632 Aug 29 04:36 PM Dziewisz John J General Counsel & Secretary Aug 25 '23 Option Exercise 4.88 33,334 162,670 216,790 Aug 29 04:34 PM Buckler Joseph T Senior Vice President Aug 25 '23 Option Exercise 4.88 15,000 73,200 125,305 Aug 29 04:31 PM Riker Christopher S Senior Vice President Aug 25 '23 Option Exercise 4.88 15,000 73,200 64,399 Aug 29 04:39 PM Buckler Joseph T Senior Vice President Aug 25 '23 Sale 4.79 3,500 16,765 115,003 Aug 29 04:31 PM Dziewisz John J General Counsel & Secretary Aug 16 '23 Sale 5.10 2,050 10,455 183,456 Aug 18 04:32 PM Salamone Louis Jr Chief Financial Officer Aug 11 '23 Option Exercise 5.54 33,333 184,665 564,343 Aug 15 04:40 PM Morgan Jimmy B Chief Operating Officer Aug 11 '23 Option Exercise 5.54 33,333 184,665 457,915 Aug 15 04:36 PM Dziewisz John J General Counsel & Secretary Aug 11 '23 Option Exercise 5.54 25,000 138,500 196,843 Aug 15 04:34 PM Buckler Joseph T Senior Vice President Aug 11 '23 Option Exercise 5.54 10,000 55,400 114,840 Aug 15 04:31 PM Riker Christopher S Senior Vice President Aug 11 '23 Option Exercise 5.54 10,000 55,400 53,934 Aug 15 04:39 PM Buckler Joseph T Senior Vice President Aug 11 '23 Sale 5.33 2,500 13,325 104,840 Aug 15 04:31 PM Young Kenneth M Chief Executive Officer Jul 28 '23 Option Exercise 5.34 50,000 267,000 1,146,333 Aug 01 04:43 PM Morgan Jimmy B Chief Operating Officer Jul 28 '23 Option Exercise 5.34 33,333 177,998 439,865 Aug 01 04:36 PM Salamone Louis Jr Chief Financial Officer Jul 28 '23 Option Exercise 5.34 31,666 169,096 542,969 Aug 01 04:41 PM Dziewisz John J General Counsel & Secretary Jul 28 '23 Option Exercise 5.34 23,333 124,598 182,424 Aug 01 04:34 PM Riker Christopher S Senior Vice President Jul 28 '23 Option Exercise 5.34 16,666 88,996 51,492 Aug 01 04:39 PM Buckler Joseph T Senior Vice President Jul 28 '23 Option Exercise 5.34 16,666 88,996 118,898 Aug 01 04:31 PM Buckler Joseph T Senior Vice President Jul 28 '23 Sale 5.42 4,000 21,680 107,340 Aug 01 04:31 PM B. Riley Financial, Inc. 10% Owner Jun 27 '23 Buy 5.73 50,000 286,620 519,848 Jun 27 12:09 PM B. Riley Financial, Inc. 10% Owner Jun 26 '23 Buy 5.83 50,000 291,525 469,848 Jun 27 12:09 PM B. Riley Financial, Inc. 10% Owner Jun 06 '23 Buy 5.51 21,583 118,983 43,926 Jun 07 09:00 AM B. Riley Financial, Inc. 10% Owner Jun 06 '23 Buy 5.52 18,417 101,573 419,848 Jun 07 09:00 AM B. Riley Financial, Inc. 10% Owner Jun 02 '23 Buy 5.05 9,536 48,110 38,461 Jun 02 12:05 PM B. Riley Financial, Inc. 10% Owner Jun 02 '23 Buy 5.05 7,464 37,657 401,431 Jun 02 12:05 PM Tato Joseph A Director May 18 '23 Option Exercise 5.60 15,273 85,529 51,303 May 22 04:42 PM Stahl Rebecca L Director May 18 '23 Option Exercise 5.60 15,273 85,529 43,978 May 22 04:40 PM Moeller Philip D Director May 18 '23 Option Exercise 5.60 15,273 85,529 65,774 May 22 04:37 PM Howe Alan B Director May 18 '23 Option Exercise 5.60 15,273 85,529 25,959 May 22 04:35 PM Bartoli Henry E Director May 18 '23 Option Exercise 5.60 15,273 85,529 248,049 May 22 04:33 PM B. Riley Financial, Inc. 10% Owner May 15 '23 Buy 5.48 22,179 121,559 393,967 May 16 09:00 AM B. Riley Financial, Inc. 10% Owner May 15 '23 Buy 5.48 8,911 48,839 36,075 May 16 09:00 AM Salamone Louis Jr Chief Financial Officer May 15 '23 Buy 5.49 6,000 32,940 511,303 May 17 07:41 AM B. Riley Financial, Inc. 10% Owner May 12 '23 Buy 5.43 75,000 407,138 371,788 May 16 09:00 AM Young Kenneth M Chief Executive Officer May 12 '23 Buy 5.46 6,000 32,741 162,713 May 16 07:30 AM
Index RUT P/E 26.75 EPS (ttm) 0.06 Insider Own 26.60% Shs Outstand 36.38M Perf Week -4.97%
Market Cap 66.05M Forward P/E - EPS next Y -0.07 Insider Trans -0.71% Shs Float 31.69M Perf Month -7.27%
Income 1.78M PEG - EPS next Q -0.05 Inst Own 28.71% Short Float 0.71% Perf Quarter -31.08%
Sales 448.18M P/S 0.15 EPS this Y -729.14% Inst Trans 1.01% Short Ratio 1.99 Perf Half Y -33.19%
Book/sh -0.30 P/B - EPS next Y 21.77% ROA 0.42% Short Interest 0.23M Perf Year -1.79%
Cash/sh 3.59 P/C 0.43 EPS next 5Y - ROE - 52W Range 1.16 - 3.62 Perf YTD -43.96%
Dividend Est. 0.04 (2.61%) P/FCF 1.06 EPS past 5Y - ROI - 52W High -57.73% Beta 0.57
Dividend TTM 0.04 (2.61%) Quick Ratio 0.47 Sales past 5Y 10.52% Gross Margin 86.47% 52W Low 31.47% ATR (14) 0.09
Dividend Ex-Date May 14, 2024 Current Ratio 0.47 EPS Y/Y TTM -92.12% Oper. Margin 12.42% RSI (14) 40.96 Volatility 6.12% 5.54%
Employees 584 Debt/Eq - Sales Y/Y TTM -12.53% Profit Margin 0.40% Recom 3.00 Target Price 2.00
Option/Short Yes / Yes LT Debt/Eq - EPS Q/Q -97.43% Payout 56.07% Rel Volume 0.60 Prev Close 1.50
Sales Surprise 1.14% EPS Surprise -100.00% Sales Q/Q -12.14% Earnings Nov 13 AMC Avg Volume 113.23K Price 1.53
SMA20 -4.73% SMA50 -10.35% SMA200 -23.35% Trades
Volume 68,023 Change 2.00%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-01-23 Downgrade UBS
Buy → Neutral
$3 → $3.50
Mar-25-22 Downgrade Raymond James
Outperform → Mkt Perform
Mar-11-22 Downgrade Wedbush
Outperform → Neutral
$11 → $6
May-03-24 05:15PM
Mar-07-24 11:51AM
07:45AM
Mar-05-24 09:36AM
Nov-09-23 07:14AM
04:15PM
Loading…
Oct-27-23 04:15PM
Oct-20-23 07:40AM
Oct-18-23 08:40PM
Sep-13-23 09:04PM
Sep-08-23 04:30PM
Aug-24-23 04:10PM
Aug-10-23 07:30AM
Aug-03-23 04:15PM
Jul-27-23 04:10PM
Jul-06-23 05:15PM
07:30AM
Loading…
May-11-23 07:30AM
07:00AM
May-02-23 04:05PM
Apr-27-23 04:10PM
Mar-30-23 08:07AM
Mar-22-23 04:10PM
Feb-15-23 08:30AM
Nov-23-22 08:25AM
Nov-03-22 07:30AM
Oct-20-22 04:10PM
Oct-06-22 03:30PM
Sep-19-22 04:05PM
Sep-15-22 04:05PM
Aug-17-22 06:06AM
Aug-08-22 07:30AM
04:10PM
Loading…
Jul-25-22 04:10PM
Jun-21-22 04:15PM
May-09-22 07:30AM
May-05-22 07:00AM
Apr-25-22 07:30AM
Mar-10-22 07:30AM
Feb-24-22 07:30AM
Nov-18-21 04:38AM
Nov-10-21 04:45PM
04:30PM
Nov-01-21 07:35AM
07:30AM
Oct-22-21 10:50AM
Sep-01-21 04:10PM
Aug-24-21 03:53PM
Aug-12-21 06:25AM
Jul-29-21 04:10PM
MarketWise, Inc. develops and operates a multi-brand digital subscription services platform. It is a subscription services platform that provides independent financial research, analytical tools, and software primarily to retail investors across digital channels. The company was founded in 1999 and is headquartered in Baltimore, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mickels Erik Chief Financial Officer Mar 21 '24 Buy 1.73 11,363 19,667 817,998 Mar 21 04:52 PM Tongue Glenn H Director Mar 20 '24 Buy 1.65 5,000 8,250 148,540 Mar 20 04:08 PM Tongue Glenn H Director Mar 19 '24 Buy 1.75 10,000 17,500 143,540 Mar 20 04:08 PM Greenhaven Road Investment Man 10% Owner Dec 15 '23 Sale 2.90 10,051 29,180 1,940,793 Dec 19 09:03 PM Greenhaven Road Investment Man 10% Owner Dec 14 '23 Sale 2.88 7,456 21,496 1,945,403 Dec 19 09:03 PM Greenhaven Road Investment Man 10% Owner Dec 06 '23 Sale 3.26 300 978 2,465,300 Dec 11 09:44 PM Greenhaven Road Investment Man 10% Owner Nov 30 '23 Sale 3.34 4,230 14,139 1,948,823 Dec 04 04:21 PM Greenhaven Road Investment Man 10% Owner Nov 29 '23 Sale 3.33 5,743 19,122 1,950,763 Dec 04 04:21 PM Greenhaven Road Investment Man 10% Owner Nov 24 '23 Sale 3.25 8,173 26,534 1,953,397 Nov 29 05:00 PM Greenhaven Road Investment Man 10% Owner Nov 22 '23 Sale 3.22 17,385 56,011 1,956,625 Nov 29 05:00 PM Greenhaven Road Investment Man 10% Owner Nov 17 '23 Sale 3.01 24,981 75,220 1,963,492 Nov 17 08:46 PM Greenhaven Road Investment Man 10% Owner Nov 15 '23 Sale 2.99 5,663 16,932 1,973,359 Nov 17 08:46 PM Tongue Glenn H Director Nov 14 '23 Buy 2.79 30,000 83,700 133,540 Nov 15 04:25 PM Greenhaven Road Investment Man 10% Owner Nov 14 '23 Sale 2.85 41,256 117,468 1,975,596 Nov 17 08:46 PM SIMMONS VAN D Director Nov 13 '23 Buy 2.70 5,000 13,500 133,040 Nov 15 04:27 PM Greenhaven Road Investment Man 10% Owner Nov 13 '23 Sale 2.73 25,347 69,289 1,991,891 Nov 17 08:46 PM Tongue Glenn H Director Nov 10 '23 Buy 2.40 10,000 24,000 103,540 Nov 13 04:18 PM Greenhaven Road Investment Man 10% Owner Nov 10 '23 Sale 2.46 1,600 3,937 2,545,299 Nov 17 08:46 PM Greenhaven Road Investment Man 10% Owner Nov 08 '23 Sale 2.50 1,553 3,882 2,546,899 Nov 17 08:46 PM Tongue Glenn H Director Sep 12 '23 Buy 1.77 5,000 8,850 93,540 Sep 13 04:40 PM Tongue Glenn H Director Sep 11 '23 Buy 1.51 15,000 22,650 88,540 Sep 13 04:40 PM Tongue Glenn H Director Sep 11 '23 Buy 1.75 5,000 8,750 13,274 Sep 13 04:40 PM Stansberry Frank Porter Director Aug 31 '23 Sale 2.00 6,311,026 12,622,052 55,186,545 Sep 11 07:50 PM Stansberry Frank Porter 10% Owner Aug 31 '23 Sale 1.34 44,000 58,960 2,991,467 Aug 31 06:20 PM Stansberry Frank Porter 10% Owner Aug 30 '23 Sale 1.30 45,000 58,500 3,035,467 Aug 31 06:20 PM Stansberry Frank Porter 10% Owner Aug 29 '23 Sale 1.28 70,000 89,600 3,080,467 Aug 29 07:30 PM Mickels Erik Chief Financial Officer Aug 28 '23 Buy 1.36 14,285 19,428 14,885 Aug 29 04:13 PM Stansberry Frank Porter 10% Owner Aug 28 '23 Sale 1.35 40,000 54,000 3,150,467 Aug 29 07:30 PM Stansberry Frank Porter 10% Owner Aug 25 '23 Sale 1.39 37,000 51,430 3,190,467 Aug 29 07:30 PM Stansberry Frank Porter 10% Owner Aug 24 '23 Sale 1.42 55,000 78,100 3,227,467 Aug 24 05:37 PM Stansberry Frank Porter 10% Owner Aug 23 '23 Sale 1.44 36,000 51,840 3,282,467 Aug 24 05:37 PM Stansberry Frank Porter 10% Owner Aug 22 '23 Sale 1.49 32,547 48,495 3,318,467 Aug 24 05:37 PM Mason Amber Lee Chief Executive Officer Aug 11 '23 Buy 1.70 19,000 32,300 19,000 Aug 15 04:05 PM Tongue Glenn H Director Aug 11 '23 Buy 1.71 6,800 11,628 8,274 Aug 15 04:04 PM Stansberry Frank Porter 10% Owner Aug 10 '23 Sale 1.58 217,106 343,027 2,851,014 Aug 10 09:44 PM Stansberry Frank Porter 10% Owner Jul 26 '23 Sale 2.00 4,692 9,384 3,068,120 Jul 27 05:31 PM Stansberry Frank Porter 10% Owner Jul 25 '23 Sale 2.04 700 1,428 3,072,812 Jul 27 05:31 PM Stansberry Frank Porter 10% Owner Jul 07 '23 Sale 2.00 900 1,800 3,073,512 Jul 11 05:47 PM Stansberry Frank Porter 10% Owner Jul 05 '23 Sale 2.00 6,946 13,892 3,074,412 Jul 05 08:54 PM Stansberry Frank Porter 10% Owner Jul 03 '23 Sale 2.00 890 1,780 3,081,358 Jul 05 08:54 PM
Index - P/E - EPS (ttm) -2.97 Insider Own 15.32% Shs Outstand 27.78M Perf Week 2.70%
Market Cap 158.62M Forward P/E - EPS next Y -0.21 Insider Trans 9.18% Shs Float 23.53M Perf Month 14.20%
Income -47.68M PEG - EPS next Q -0.47 Inst Own 21.13% Short Float 3.95% Perf Quarter 20.21%
Sales 2.06M P/S 77.00 EPS this Y 55.36% Inst Trans -1.41% Short Ratio 4.38 Perf Half Y 81.85%
Book/sh 0.69 P/B 8.24 EPS next Y 84.19% ROA -168.85% Short Interest 0.93M Perf Year -5.31%
Cash/sh 1.17 P/C 4.88 EPS next 5Y 15.00% ROE -961.44% 52W Range 2.25 - 7.99 Perf YTD 37.26%
Dividend Est. - P/FCF - EPS past 5Y 64.26% ROI -286.92% 52W High -28.54% Beta 0.54
Dividend TTM - Quick Ratio 2.06 Sales past 5Y 3.79% Gross Margin 50.36% 52W Low 153.78% ATR (14) 0.30
Dividend Ex-Date - Current Ratio 2.26 EPS Y/Y TTM 24.95% Oper. Margin -1849.01% RSI (14) 63.79 Volatility 5.34% 6.49%
Employees 76 Debt/Eq 0.70 Sales Y/Y TTM -24.08% Profit Margin -2308.86% Recom 1.00 Target Price 15.68
Option/Short Yes / Yes LT Debt/Eq 0.05 EPS Q/Q 43.80% Payout - Rel Volume 1.15 Prev Close 5.56
Sales Surprise -1.59% EPS Surprise 10.93% Sales Q/Q -15.65% Earnings May 14 BMO Avg Volume 212.23K Price 5.71
SMA20 8.68% SMA50 19.82% SMA200 37.48% Trades
Volume 244,243 Change 2.70%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-26-22 Resumed Canaccord Genuity
Buy
$17
Dec-10-21 Initiated H.C. Wainwright
Buy
$25
Mar-09-21 Initiated Canaccord Genuity
Buy
$24
Jan-05-21 Initiated BTIG Research
Buy
$23
Jun-01-20 Initiated Laidlaw
Buy
$19
May-07-24 08:30AM
May-06-24 09:00AM
May-03-24 05:15PM
Apr-23-24 09:55AM
Apr-05-24 09:55AM
08:35AM
Loading…
Apr-04-24 08:35AM
Apr-02-24 12:00PM
Mar-27-24 11:50AM
Mar-26-24 11:52AM
09:12AM
08:40AM
07:30AM
Mar-22-24 02:43PM
Mar-20-24 08:15AM
Mar-19-24 09:00AM
05:20PM
Loading…
Mar-18-24 05:20PM
Mar-15-24 08:20AM
Mar-08-24 05:00PM
09:00AM
Feb-22-24 05:00PM
Feb-16-24 05:00PM
Jan-31-24 08:00AM
Jan-23-24 08:00AM
Jan-16-24 08:00AM
Jan-12-24 05:00PM
Dec-15-23 01:02PM
Dec-07-23 09:00AM
Nov-15-23 05:00PM
Nov-13-23 04:05PM
Nov-06-23 04:30PM
08:30AM
Loading…
Oct-16-23 08:30AM
Oct-10-23 08:30AM
Oct-03-23 08:30AM
Sep-27-23 04:05PM
Sep-14-23 09:59AM
Sep-11-23 08:00AM
Sep-05-23 04:00PM
Sep-01-23 02:07PM
Aug-29-23 08:00AM
Aug-14-23 09:10PM
Aug-12-23 09:02AM
Aug-09-23 05:33PM
Aug-03-23 08:30AM
Jun-21-23 04:10PM
Jun-20-23 08:30AM
Jun-07-23 04:10PM
May-12-23 08:00AM
May-09-23 09:00AM
May-03-23 08:30AM
Apr-03-23 04:30PM
Mar-29-23 09:41PM
Mar-27-23 03:15PM
08:20AM
08:15AM
08:10AM
Feb-16-23 08:30AM
Feb-14-23 08:49AM
Jan-30-23 08:30AM
Jan-17-23 08:00AM
Dec-16-22 04:15PM
Dec-13-22 08:30AM
Dec-08-22 08:30AM
Dec-05-22 09:00AM
Nov-09-22 04:15PM
Nov-08-22 08:00AM
Oct-24-22 04:05PM
Sep-01-22 04:15PM
Aug-08-22 07:45AM
Aug-05-22 08:30AM
Jul-27-22 04:30PM
04:15PM
Jul-20-22 04:10PM
Jul-18-22 08:30AM
Jun-07-22 07:06AM
Jun-06-22 04:15PM
May-10-22 07:30AM
May-09-22 08:30AM
May-02-22 03:02PM
Apr-28-22 09:00AM
Apr-08-22 09:00AM
Mar-29-22 09:00AM
Mar-25-22 07:30AM
Mar-15-22 04:30PM
Mar-10-22 09:00AM
Mar-02-22 04:01PM
Feb-22-22 09:00AM
Feb-10-22 04:30PM
Feb-07-22 04:01PM
Feb-04-22 09:00AM
Feb-03-22 04:30PM
Jan-25-22 04:01PM
Jan-07-22 09:00AM
Dec-02-21 08:00AM
Nov-30-21 08:30AM
Nov-11-21 06:06AM
Nov-09-21 07:30AM
Nov-08-21 12:49PM
09:00AM
Nov-05-21 09:00AM
Nov-02-21 03:02PM
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded in August 1988 and is headquartered in Queensbury, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Aharon Gil Director Mar 19 '24 Buy 3.72 26,882 100,001 1,069,710 Mar 20 08:00 PM SALAMON STEVEN A J Director Mar 19 '24 Buy 3.72 26,882 100,001 1,121,025 Mar 20 07:44 PM Vukovic Vojo Chief Medical Officer Dec 12 '23 Buy 3.00 40,000 120,000 100,000 Dec 14 04:20 PM MICHEL GERARD J Chief Executive Officer Dec 08 '23 Buy 2.94 34,000 99,960 262,345 Dec 11 05:02 PM Rosalind Advisors, Inc. Director Nov 17 '23 Buy 2.40 100,000 240,410 1,038,828 Nov 21 11:07 AM Pennell Sandra SVP of Finance, PFO and PAO Nov 17 '23 Buy 2.43 30,000 72,900 30,000 Nov 21 07:42 AM Vukovic Vojo Chief Medical Officer Nov 16 '23 Buy 2.48 60,000 148,800 60,000 Nov 20 04:22 PM Hoffman David L. See Remarks Nov 16 '23 Buy 2.48 40,000 99,200 40,000 Nov 20 04:20 PM Purpura John Chief Operating Officer Oct 13 '23 Buy 3.44 14,505 49,897 41,526 Oct 17 04:53 PM Sylvester John Richard Director Aug 21 '23 Buy 4.80 10,550 50,640 10,550 Aug 23 11:03 AM
Index RUT P/E - EPS (ttm) -0.80 Insider Own 74.86% Shs Outstand 111.13M Perf Week -16.96%
Market Cap 843.00M Forward P/E - EPS next Y -0.47 Insider Trans 0.81% Shs Float 28.29M Perf Month 0.67%
Income -87.00M PEG - EPS next Q -0.14 Inst Own 20.47% Short Float 40.42% Perf Quarter 69.84%
Sales 4.08M P/S 206.62 EPS this Y 2.53% Inst Trans -8.48% Short Ratio 12.09 Perf Half Y 53.48%
Book/sh 0.50 P/B 15.08 EPS next Y 26.17% ROA -61.56% Short Interest 11.44M Perf Year 221.46%
Cash/sh 0.70 P/C 10.64 EPS next 5Y - ROE -120.34% 52W Range 2.12 - 9.50 Perf YTD 68.31%
Dividend Est. - P/FCF - EPS past 5Y - ROI -72.03% 52W High -21.16% Beta 1.12
Dividend TTM - Quick Ratio 4.01 Sales past 5Y 149.00% Gross Margin -329.03% 52W Low 253.30% ATR (14) 0.65
Dividend Ex-Date - Current Ratio 4.01 EPS Y/Y TTM -78.04% Oper. Margin -1611.80% RSI (14) 42.98 Volatility 9.73% 8.18%
Employees 111 Debt/Eq 1.20 Sales Y/Y TTM 14.65% Profit Margin -2133.30% Recom 1.67 Target Price 12.00
Option/Short Yes / Yes LT Debt/Eq 1.16 EPS Q/Q -85.29% Payout - Rel Volume 1.15 Prev Close 8.07
Sales Surprise -14.26% EPS Surprise -100.00% Sales Q/Q 26.02% Earnings May 08 AMC Avg Volume 945.56K Price 7.49
SMA20 -11.44% SMA50 9.89% SMA200 50.10% Trades
Volume 1,091,454 Change -7.19%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-12-22 Downgrade Oppenheimer
Outperform → Perform
Jan-06-22 Initiated R. F. Lafferty
Buy
$16
May-09-24 04:08AM
May-08-24 10:57PM
04:05PM
11:20AM
May-07-24 04:55PM
02:59AM
Loading…
May-03-24 02:59AM
Apr-24-24 04:05PM
Apr-16-24 09:00AM
Apr-12-24 09:40AM
Mar-21-24 01:49PM
Mar-13-24 05:31PM
04:05PM
Mar-11-24 08:30AM
Mar-06-24 05:45PM
Jan-30-24 12:09AM
10:27AM
Loading…
Jan-29-24 10:27AM
Jan-22-24 09:00AM
Jan-12-24 01:03AM
Nov-30-23 09:00AM
Nov-08-23 04:05PM
Oct-26-23 04:05PM
Aug-22-23 01:01AM
Aug-09-23 04:05PM
Jul-27-23 04:30PM
Jul-20-23 09:00AM
Jun-22-23 09:03AM
Jun-12-23 04:05PM
Jun-01-23 09:00AM
May-10-23 05:00PM
04:05PM
04:05PM
Loading…
04:05PM
Apr-28-23 09:00AM
Apr-27-23 09:05AM
09:00AM
Apr-25-23 09:00AM
Apr-17-23 09:00AM
Mar-24-23 10:56AM
Mar-22-23 04:10PM
Mar-15-23 09:00AM
Mar-02-23 09:00AM
Feb-21-23 09:00AM
Jan-24-23 09:00AM
Dec-15-22 09:00AM
Dec-06-22 09:00AM
Nov-17-22 09:00AM
Nov-16-22 10:30AM
08:30AM
Nov-10-22 04:05PM
Nov-02-22 08:30AM
Nov-01-22 04:05PM
Sep-15-22 09:00AM
Aug-10-22 09:00AM
09:00AM
Aug-08-22 09:00AM
Aug-02-22 09:00AM
Jul-26-22 04:05PM
Jul-07-22 09:00AM
Jun-29-22 10:24AM
Jun-21-22 01:30PM
Jun-13-22 09:00AM
Jun-09-22 11:15AM
May-19-22 09:00AM
May-14-22 10:35AM
May-13-22 04:05PM
May-12-22 04:05PM
May-04-22 09:00AM
May-03-22 04:05PM
Apr-29-22 09:00AM
Apr-27-22 09:00AM
Apr-21-22 02:33PM
Mar-23-22 04:05PM
Mar-14-22 09:00AM
Mar-07-22 04:30PM
04:15PM
Mar-01-22 04:30PM
Feb-16-22 09:00AM
Feb-08-22 09:00AM
Feb-07-22 01:38PM
Feb-01-22 09:38PM
01:36PM
Jan-19-22 09:00AM
Jan-03-22 04:05PM
Dec-08-21 09:00AM
Dec-07-21 09:00AM
Nov-15-21 04:05PM
Nov-12-21 09:15AM
Nov-10-21 05:15PM
Nov-08-21 04:16PM
NextNav, Inc. develops next-generation positioning, navigation, and timing solutions. Through its Pinnacle system, it provides floor-level altitude service to devices with a barometric pressure sensor. The company was founded by Ganesh Pattabiraman and Arun Raghupathy in May 2021 and is headquartered in McLean, VA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SUBIN NEIL S Director Mar 20 '24 Buy 4.72 50,000 236,000 2,115,213 Mar 20 05:29 PM SUBIN NEIL S Director Mar 19 '24 Buy 4.76 50,000 238,000 2,065,213 Mar 20 05:29 PM Lantz Robert General Counsel Mar 19 '24 Sale 4.75 2,032 9,652 88,401 Mar 19 05:37 PM Shams Sammaad Chief Accounting Officer Mar 19 '24 Sale 4.69 116 544 74,006 Mar 19 05:38 PM SAMBERG JOSEPH D 10% Owner Mar 18 '24 Buy 4.52 483,000 2,181,663 9,800,000 Mar 20 06:10 PM SUBIN NEIL S Director Mar 18 '24 Buy 4.28 50,000 214,000 2,015,213 Mar 20 05:29 PM Gates Christian D. Chief Financial Officer Mar 18 '24 Sale 4.23 29,208 123,550 849,816 Mar 19 05:37 PM Raghupathy Arun Senior Vice President Mar 18 '24 Sale 4.23 23,547 99,604 1,130,538 Mar 19 05:37 PM Shams Sammaad Chief Accounting Officer Mar 18 '24 Sale 4.23 13,469 56,974 74,122 Mar 19 05:38 PM Lantz Robert General Counsel Mar 18 '24 Sale 4.23 8,776 37,122 90,433 Mar 19 05:37 PM Lantz Robert General Counsel Feb 01 '24 Sale 4.16 336 1,398 44,343 Feb 02 04:00 PM Knutson David L. Senior Vice President Jan 30 '24 Sale 4.14 1,002 4,148 654,657 Jan 31 04:00 PM SAMBERG JOSEPH D 10% Owner Jan 22 '24 Buy 3.96 150,000 594,435 9,500,000 Jan 23 06:41 PM SAMBERG JOSEPH D 10% Owner Jan 19 '24 Buy 3.86 150,000 578,340 9,350,000 Jan 23 06:41 PM Knutson David L. Senior Vice President Jan 09 '24 Sale 5.01 20,000 100,200 655,659 Jan 10 04:00 PM Shams Sammaad VP-Corporate Controller Dec 19 '23 Sale 4.29 119 511 32,718 Dec 20 04:00 PM Pattabiraman Ganesh Chief Executive Officer Nov 22 '23 Sale 4.34 62,128 269,636 1,839,927 Nov 24 02:00 PM Raghupathy Arun Senior Vice President Nov 22 '23 Sale 4.34 18,129 78,680 1,042,635 Nov 24 02:00 PM Lantz Robert General Counsel Nov 22 '23 Sale 4.57 342 1,563 44,679 Nov 24 02:00 PM Pattabiraman Ganesh Chief Executive Officer Nov 21 '23 Sale 4.61 22,500 103,725 1,902,055 Nov 24 02:00 PM Raghupathy Arun Senior Vice President Nov 21 '23 Sale 4.61 22,400 103,264 1,060,764 Nov 24 02:00 PM Knutson David L. Senior Vice President Nov 21 '23 Sale 4.60 18,424 84,750 675,659 Nov 24 02:00 PM Knutson David L. Senior Vice President Nov 14 '23 Sale 5.01 9,099 45,586 694,083 Nov 15 04:00 PM Knutson David L. Senior Vice President Nov 09 '23 Sale 5.00 901 4,505 703,182 Nov 13 04:01 PM Shams Sammaad VP-Corporate Controller Sep 22 '23 Sale 5.39 2,503 13,491 32,837 Sep 25 04:05 PM Shams Sammaad VP-Corporate Controller Sep 19 '23 Sale 5.47 118 645 35,340 Sep 19 05:22 PM Pattabiraman Ganesh Chief Executive Officer Sep 18 '23 Sale 5.66 8,133 46,033 1,924,555 Sep 19 05:20 PM Gates Christian D. Chief Financial Officer Sep 18 '23 Sale 5.66 7,726 43,729 766,698 Sep 19 05:13 PM Raghupathy Arun Senior Vice President Sep 18 '23 Sale 5.66 4,262 24,123 1,083,164 Sep 19 05:21 PM Knutson David L. Senior Vice President Sep 18 '23 Sale 5.66 3,439 19,465 704,083 Sep 19 05:16 PM Shams Sammaad VP-Corporate Controller Sep 18 '23 Sale 5.66 2,083 11,790 35,458 Sep 19 05:22 PM Lantz Robert General Counsel Sep 18 '23 Sale 5.66 1,550 8,773 45,021 Sep 19 05:19 PM Gates Christian D. Chief Financial Officer Aug 18 '23 Sale 4.08 37,377 152,498 774,424 Aug 21 05:06 PM Pattabiraman Ganesh Chief Executive Officer Aug 18 '23 Sale 4.08 3,166 12,917 1,932,688 Aug 21 05:08 PM Raghupathy Arun Senior Vice President Aug 18 '23 Sale 4.09 1,252 5,121 1,087,428 Aug 21 05:06 PM Knutson David L. Senior Vice President Aug 18 '23 Sale 4.08 895 3,652 707,522 Aug 21 05:07 PM Shams Sammaad VP-Corporate Controller Aug 18 '23 Sale 4.08 792 3,231 37,541 Aug 21 05:08 PM Lantz Robert General Counsel Aug 18 '23 Sale 4.13 336 1,388 46,571 Aug 21 05:07 PM Shams Sammaad VP-Corporate Controller Jun 20 '23 Sale 2.89 120 347 38,333 Jun 22 04:01 PM Shams Sammaad VP-Corporate Controller May 19 '23 Sale 2.25 6,744 15,174 38,453 May 19 04:43 PM Pattabiraman Ganesh Chief Executive Officer May 18 '23 Sale 2.20 84,269 185,392 1,935,854 May 19 04:41 PM Raghupathy Arun Senior Vice President May 18 '23 Sale 2.34 40,529 94,838 1,088,680 May 19 04:38 PM Gates Christian D. Chief Financial Officer May 18 '23 Sale 2.20 24,000 52,800 736,801 May 19 04:39 PM Knutson David L. Senior Vice President May 18 '23 Sale 2.35 17,401 40,892 708,417 May 19 04:39 PM Lantz Robert General Counsel May 18 '23 Sale 2.27 336 763 46,907 May 19 04:40 PM Shams Sammaad VP-Corporate Controller May 17 '23 Sale 2.46 7,014 17,254 45,197 May 19 04:43 PM Lantz Robert General Counsel May 17 '23 Sale 2.46 5,879 14,462 47,243 May 19 04:40 PM Raghupathy Arun Senior Vice President May 17 '23 Sale 2.46 4,371 10,753 1,129,209 May 19 04:38 PM Knutson David L. Senior Vice President May 17 '23 Sale 2.46 3,822 9,402 725,818 May 19 04:39 PM Pattabiraman Ganesh Chief Executive Officer May 17 '23 Sale 2.46 2,815 6,925 2,020,123 May 19 04:41 PM Shams Sammaad VP-Corporate Controller May 15 '23 Sale 2.66 2,040 5,426 52,211 May 16 04:50 PM
Index RUT P/E - EPS (ttm) -1.45 Insider Own 6.98% Shs Outstand 155.93M Perf Week -11.76%
Market Cap 193.98M Forward P/E - EPS next Y -0.31 Insider Trans -7.26% Shs Float 150.36M Perf Month -34.07%
Income -167.94M PEG - EPS next Q -0.20 Inst Own 62.80% Short Float 24.52% Perf Quarter -64.07%
Sales 419.58M P/S 0.46 EPS this Y 14.26% Inst Trans 2.03% Short Ratio 7.08 Perf Half Y -63.41%
Book/sh 2.30 P/B 0.52 EPS next Y 60.24% ROA -12.54% Short Interest 36.87M Perf Year -73.51%
Cash/sh 0.70 P/C 1.72 EPS next 5Y - ROE -37.81% 52W Range 1.27 - 7.78 Perf YTD -69.07%
Dividend Est. - P/FCF - EPS past 5Y -438.13% ROI -17.59% 52W High -84.59% Beta 1.84
Dividend TTM - Quick Ratio 1.53 Sales past 5Y 92.59% Gross Margin -2.95% 52W Low -5.51% ATR (14) 0.17
Dividend Ex-Date - Current Ratio 1.63 EPS Y/Y TTM -13.04% Oper. Margin -45.96% RSI (14) 31.80 Volatility 11.19% 9.16%
Employees 624 Debt/Eq 1.61 Sales Y/Y TTM 7.78% Profit Margin -40.03% Recom 2.33 Target Price 3.83
Option/Short Yes / Yes LT Debt/Eq 1.57 EPS Q/Q -58.17% Payout - Rel Volume 1.28 Prev Close 1.34
Sales Surprise -61.75% EPS Surprise -127.39% Sales Q/Q -62.21% Earnings May 02 AMC Avg Volume 5.21M Price 1.20
SMA20 -25.97% SMA50 -36.27% SMA200 -65.26% Trades
Volume 6,684,937 Change -10.45%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-22-24 Downgrade Goldman
Buy → Neutral
$5.50 → $2.50
Feb-29-24 Reiterated TD Cowen
Outperform
$7 → $5
Nov-03-23 Downgrade Guggenheim
Buy → Neutral
Oct-20-23 Initiated Exane BNP Paribas
Neutral
$5
Sep-06-23 Downgrade Morgan Stanley
Overweight → Equal-Weight
$12 → $8
Aug-30-23 Initiated Barclays
Equal Weight
$6
Jun-23-23 Initiated Piper Sandler
Neutral
$6
Jun-06-23 Initiated Janney
Buy
$12
May-24-23 Initiated Evercore ISI
Outperform
$11
May-05-23 Reiterated TD Cowen
Outperform
$11 → $8
Apr-17-23 Initiated BMO Capital Markets
Market Perform
$3.50
Apr-06-23 Downgrade Wolfe Research
Outperform → Peer Perform
Apr-04-23 Downgrade BofA Securities
Neutral → Underperform
$9 → $5
Apr-03-23 Resumed Morgan Stanley
Overweight
$15 → $12
Feb-10-23 Initiated BofA Securities
Neutral
$11
Jan-10-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$15
Dec-19-22 Initiated ROTH Capital
Neutral
Oct-25-22 Initiated UBS
Buy
$19
Sep-22-22 Initiated Cowen
Outperform
$22
Sep-07-22 Initiated Northland Capital
Outperform
$24
Show Previous Ratings
May-08-24 02:33PM
May-03-24 07:31AM
May-02-24 08:56PM
04:10PM
04:05PM
10:01AM
Loading…
Apr-25-24 10:01AM
Apr-19-24 04:30PM
Apr-16-24 08:30AM
Apr-05-24 04:09PM
Mar-19-24 08:30AM
Feb-29-24 10:28AM
Feb-28-24 04:07PM
04:05PM
Jan-23-24 08:30AM
Jan-12-24 03:31PM
(Morningstar Research) -7.04%
05:15PM
Loading…
Jan-09-24 05:15PM
Dec-01-23 07:00PM
(Morningstar Research) +14.98%
Nov-21-23 06:58PM
(Morningstar Research) -8.97%
Nov-16-23 08:30AM
Nov-15-23 09:53PM
(Morningstar Research) +6.23%
Nov-13-23 06:59PM
(Morningstar Research) -7.07%
Nov-03-23 05:29PM
Nov-02-23 04:07PM
04:05PM
Oct-31-23 04:30PM
06:00AM
Oct-26-23 10:02AM
Oct-25-23 04:00PM
Oct-24-23 08:30AM
Oct-05-23 08:30AM
06:52PM
Loading…
Oct-03-23 06:52PM
Sep-17-23 11:00PM
Sep-07-23 08:30AM
Sep-06-23 09:36AM
Aug-31-23 08:30AM
Aug-30-23 09:00AM
Aug-15-23 06:53PM
Aug-04-23 12:16PM
Aug-03-23 04:05PM
Jul-19-23 08:00AM
Jul-11-23 06:47PM
08:30AM
Jul-06-23 05:00AM
Jun-28-23 08:30AM
Jun-26-23 05:01PM
(The Wall Street Journal)
Jun-21-23 08:30AM
Jun-13-23 06:32PM
(Morningstar Research) +6.17%
May-31-23 08:00AM
May-19-23 02:43PM
May-05-23 06:25PM
(Morningstar Research) +12.66%
Apr-27-23 10:02AM
Apr-24-23 08:00AM
Apr-19-23 06:58PM
Apr-06-23 08:30AM
Apr-03-23 07:48PM
Mar-30-23 10:46AM
06:30AM
Mar-29-23 06:55PM
(Morningstar Research) -10.42%
07:46AM
Mar-21-23 08:30AM
Mar-14-23 11:48AM
(The Wall Street Journal)
Mar-10-23 08:00PM
Feb-17-23 05:31PM
(Morningstar Research) -14.78%
Feb-16-23 04:05PM
Jan-31-23 05:04PM
08:00AM
08:00AM
Jan-17-23 08:35AM
Jan-09-23 11:46AM
(Morningstar Research) +7.67%
Jan-03-23 08:30AM
Dec-27-22 06:52PM
(Morningstar Research) -7.30%
Dec-08-22 08:30AM
Nov-03-22 04:15PM
04:05PM
Oct-20-22 08:00AM
Oct-11-22 08:00AM
Sep-22-22 08:00AM
Sep-21-22 08:00AM
Sep-20-22 08:00AM
08:00AM
Sep-09-22 11:59AM
Sep-06-22 08:00AM
Aug-16-22 12:40PM
Aug-15-22 11:30AM
08:30AM
Aug-10-22 06:05AM
Aug-07-22 03:53PM
Aug-04-22 04:05PM
Aug-02-22 08:35AM
Jul-18-22 10:12AM
Jul-14-22 08:37AM
Jul-11-22 09:55AM
Jun-27-22 05:46PM
Jun-16-22 08:35AM
Jun-07-22 08:35AM
Jun-06-22 12:36PM
May-17-22 10:28AM
May-14-22 08:29AM
May-05-22 04:05PM
Apr-14-22 04:35PM
Stem, Inc. engages in the provision of an energy storage system, hardware, ongoing software platform and professional services, and solar asset performance monitoring and control. The company was founded in 2009 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Carrington John Eugene CEO and Director May 02 '24 Sale 1.85 194,171 359,216 506,585 May 07 07:49 AM Russo Alan Chief Revenue Officer Apr 30 '24 Sale 1.87 24,142 45,146 212,910 Apr 30 05:21 PM BUSH WILLIAM JOHN Chief Financial Officer Apr 30 '24 Sale 1.87 24,035 44,945 390,217 Apr 30 05:21 PM Patel Prakesh Chief Strategy Officer Apr 30 '24 Sale 1.87 23,863 44,624 181,668 Apr 30 05:22 PM Laureles Saul R. Chief Legal Officer Apr 30 '24 Sale 1.87 822 1,537 150,990 Apr 30 05:21 PM BUSH WILLIAM JOHN Chief Financial Officer Apr 28 '24 Option Exercise 0.00 68,946 0 414,252 Apr 30 05:21 PM Laureles Saul R. Chief Legal Officer Apr 28 '24 Option Exercise 0.00 3,453 0 151,812 Apr 30 05:21 PM Carrington John Eugene CEO and Director Apr 28 '24 Option Exercise 0.00 438,438 0 700,756 Apr 30 05:21 PM Patel Prakesh Chief Strategy Officer Apr 28 '24 Option Exercise 0.00 68,453 0 205,531 Apr 30 05:22 PM Russo Alan Chief Revenue Officer Apr 28 '24 Option Exercise 0.00 69,254 0 237,052 Apr 30 05:21 PM Schaefer Robert President, Transformational Mar 19 '24 Sale 1.82 100,000 182,000 716,110 Mar 20 06:08 PM Tappin Matthew President, Asset Management Mar 19 '24 Sale 1.82 26,640 48,485 15,248 Mar 20 06:07 PM BUZBY DAVID S Director Mar 18 '24 Buy 1.81 33,800 61,178 768,448 Mar 20 06:04 PM BUZBY DAVID S Director Mar 15 '24 Buy 1.84 62,500 115,000 734,648 Mar 18 06:13 PM Carlson Michael James Chief Operating Officer Mar 15 '24 Buy 1.75 44,882 78,544 128,903 Mar 18 05:15 PM Homenock Kim Chief People Officer Mar 15 '24 Buy 1.84 24,000 44,160 161,989 Mar 18 05:16 PM Homenock Kim Chief People Officer Mar 14 '24 Option Exercise 0.00 16,689 0 137,989 Mar 18 05:16 PM Carlson Michael James Chief Operating Officer Mar 14 '24 Buy 1.75 10,118 17,706 84,021 Mar 18 05:15 PM Johnson larsh Chief Technology Officer Mar 13 '24 Sale 2.00 21,428 42,856 78,739 Mar 14 04:12 PM Johnson larsh Chief Technology Officer Mar 12 '24 Sale 2.00 20,000 40,000 100,167 Mar 14 04:12 PM Shukla Rahul Chief Accounting Officer Mar 11 '24 Sale 2.21 21,332 47,144 0 Mar 12 04:16 PM Carrington John Eugene CEO and Director Mar 08 '24 Sale 2.19 85,038 186,233 262,318 Mar 12 04:15 PM BUSH WILLIAM JOHN Chief Financial Officer Mar 08 '24 Sale 2.19 46,034 100,814 345,306 Mar 12 04:14 PM Schaefer Robert President, Transformational Mar 08 '24 Sale 2.19 37,463 82,044 816,110 Mar 12 04:16 PM Patel Prakesh Chief Strategy Officer Mar 08 '24 Sale 2.19 35,902 78,625 137,078 Mar 12 04:15 PM Johnson larsh Chief Technology Officer Mar 08 '24 Sale 2.19 35,880 78,577 120,167 Mar 12 04:15 PM Carlson Michael James Chief Operating Officer Mar 08 '24 Sale 2.19 35,269 77,239 73,903 Mar 12 04:15 PM Laureles Saul R. Chief Legal Officer Mar 08 '24 Sale 2.19 26,602 58,258 148,359 Mar 12 04:17 PM Homenock Kim Chief People Officer Mar 08 '24 Sale 2.19 26,512 58,061 121,300 Mar 12 04:16 PM Tappin Matthew President, Asset Management Mar 08 '24 Sale 2.19 24,899 54,529 41,888 Mar 12 04:14 PM Shukla Rahul Chief Accounting Officer Mar 08 '24 Sale 2.19 19,899 43,579 21,332 Mar 12 04:16 PM Tappin Matthew President, Asset Management Mar 05 '24 Sale 2.41 3,837 9,247 66,787 Mar 07 05:04 PM Shukla Rahul Chief Accounting Officer Mar 04 '24 Sale 2.47 20,204 49,904 41,231 Mar 05 04:20 PM BUSH WILLIAM JOHN Chief Financial Officer Mar 04 '24 Sale 2.48 10,016 24,840 391,340 Mar 05 04:21 PM Carrington John Eugene CEO and Director Mar 04 '24 Sale 2.48 9,885 24,515 347,356 Mar 05 04:24 PM Patel Prakesh Chief Strategy Officer Mar 04 '24 Sale 2.48 7,153 17,739 172,980 Mar 05 04:23 PM Russo Alan Chief Revenue Officer Mar 04 '24 Sale 2.48 7,153 17,739 167,798 Mar 05 04:23 PM Schaefer Robert President, Transformational Mar 04 '24 Sale 2.48 5,945 14,744 853,573 Mar 05 04:23 PM Tappin Matthew President, Asset Management Mar 04 '24 Sale 2.48 5,724 14,196 70,624 Mar 05 04:25 PM Laureles Saul R. Chief Legal Officer Mar 04 '24 Sale 2.48 5,591 13,866 174,961 Mar 05 04:21 PM Carrington John Eugene CEO and Director Mar 01 '24 Option Exercise 0.00 26,795 0 165,357 Mar 05 04:24 PM Patel Prakesh Chief Strategy Officer Mar 01 '24 Option Exercise 0.00 16,747 0 102,825 Mar 05 04:23 PM BUSH WILLIAM JOHN Chief Financial Officer Mar 01 '24 Option Exercise 0.00 23,446 0 300,260 Mar 05 04:21 PM Tappin Matthew President, Asset Management Mar 01 '24 Option Exercise 0.00 13,398 0 24,809 Mar 05 04:25 PM Russo Alan Chief Revenue Officer Mar 01 '24 Option Exercise 0.00 16,747 0 174,951 Mar 05 04:23 PM Laureles Saul R. Chief Legal Officer Mar 01 '24 Option Exercise 0.00 18,087 0 98,090 Mar 05 04:21 PM Schaefer Robert President, Transformational Mar 01 '24 Option Exercise 0.00 16,747 0 758,422 Mar 05 04:23 PM Carrington John Eugene CEO and Director Feb 27 '24 Sale 2.70 13,863 37,430 138,562 Feb 27 05:25 PM Shukla Rahul Chief Accounting Officer Feb 26 '24 Sale 2.65 8,244 21,847 20,204 Feb 26 05:50 PM Carrington John Eugene CEO and Director Feb 24 '24 Option Exercise 0.00 34,737 0 152,425 Feb 27 05:25 PM Shukla Rahul Chief Accounting Officer Feb 23 '24 Option Exercise 0.00 19,951 0 28,448 Feb 26 05:50 PM Tappin Matthew President, Asset Management Feb 20 '24 Sale 3.05 6,857 20,914 11,411 Feb 21 05:07 PM BUSH WILLIAM JOHN Chief Financial Officer Feb 16 '24 Sale 3.17 20,367 64,563 276,814 Feb 20 04:47 PM Russo Alan Chief Revenue Officer Feb 16 '24 Sale 3.17 14,390 45,616 158,204 Feb 20 04:55 PM Patel Prakesh Chief Strategy Officer Feb 16 '24 Sale 3.17 14,389 45,613 86,078 Feb 20 04:51 PM Johnson larsh Chief Technology Officer Feb 16 '24 Sale 3.17 12,117 38,411 69,145 Feb 20 04:53 PM Laureles Saul R. Chief Legal Officer Feb 16 '24 Sale 3.17 10,959 34,740 80,003 Feb 20 04:57 PM Tappin Matthew President, Asset Management Feb 16 '24 Sale 3.17 10,602 33,608 18,268 Feb 20 04:48 PM Carlson Michael James Chief Operating Officer Feb 16 '24 Sale 3.17 9,952 31,548 20,367 Feb 20 04:44 PM Schaefer Robert President, Transformational Feb 16 '24 Sale 3.17 7,866 24,935 741,675 Feb 20 04:49 PM Patel Prakesh Chief Strategy Officer Feb 15 '24 Option Exercise 0.00 33,000 0 100,467 Feb 20 04:51 PM Johnson larsh Chief Technology Officer Feb 15 '24 Option Exercise 0.00 27,789 0 81,262 Feb 20 04:53 PM Russo Alan Chief Revenue Officer Feb 15 '24 Option Exercise 0.00 33,000 0 172,594 Feb 20 04:55 PM Laureles Saul R. Chief Legal Officer Feb 15 '24 Option Exercise 0.00 34,736 0 90,962 Feb 20 04:57 PM Carlson Michael James Chief Operating Officer Feb 15 '24 Option Exercise 0.00 26,052 0 30,319 Feb 20 04:44 PM Schaefer Robert President, Transformational Feb 15 '24 Option Exercise 0.00 21,710 0 749,541 Feb 20 04:49 PM BUSH WILLIAM JOHN Chief Financial Officer Feb 15 '24 Option Exercise 0.00 48,631 0 297,181 Feb 20 04:47 PM Tappin Matthew President, Asset Management Feb 15 '24 Option Exercise 0.00 24,315 0 28,870 Feb 20 04:48 PM Homenock Kim Chief People Officer Feb 15 '24 Option Exercise 0.00 22,578 0 92,309 Feb 20 04:50 PM Tappin Matthew President, Asset Management Feb 14 '24 Sale 3.15 4,556 14,351 4,555 Feb 16 05:12 PM Laureles Saul R. Chief Legal Officer Jan 30 '24 Sale 3.23 9,893 31,954 56,226 Jan 30 07:21 PM Laureles Saul R. Chief Legal Officer Jan 28 '24 Option Exercise 0.00 34,325 0 66,119 Jan 30 07:21 PM Shukla Rahul Chief Accounting Officer Jan 19 '24 Sale 2.73 3,310 9,036 8,497 Jan 19 05:14 PM Shukla Rahul Chief Accounting Officer Jan 18 '24 Option Exercise 0.00 8,000 0 11,807 Jan 19 05:14 PM Tappin Matthew President, Asset Management Jan 03 '24 Sale 3.56 5,207 18,537 9,111 Jan 03 05:23 PM Tappin Matthew President, Asset Management Dec 31 '23 Option Exercise 0.00 14,318 0 14,318 Jan 03 05:23 PM Carlson Michael James Chief Operating Officer Sep 27 '23 Sale 4.18 1,822 7,616 4,267 Sep 28 06:15 PM Carlson Michael James Chief Operating Officer Sep 26 '23 Option Exercise 0.00 6,089 0 6,089 Sep 28 06:15 PM BUZBY DAVID S Director Sep 15 '23 Buy 4.82 62,000 298,840 620,711 Sep 18 04:51 PM Russo Alan Chief Revenue Officer Aug 10 '23 Sale 6.50 13,427 87,276 139,594 Aug 14 05:06 PM TROE LISA L Director Jun 16 '23 Sale 6.40 6,150 39,360 19,872 Jun 20 04:10 PM TROE LISA L Director Jun 15 '23 Option Exercise 0.00 20,498 0 26,022 Jun 20 04:10 PM TYSON LAURA D Director Jun 15 '23 Option Exercise 0.00 20,498 0 26,022 Jun 20 04:12 PM Woodward Jane Director Jun 15 '23 Option Exercise 0.00 20,498 0 26,022 Jun 20 04:08 PM Daley Adam Director Jun 15 '23 Option Exercise 0.00 20,498 0 107,271 Jun 20 04:19 PM MORGAN MICHAEL C Director Jun 15 '23 Option Exercise 0.00 20,498 0 20,498 Jun 20 04:21 PM BUZBY DAVID S Director Jun 15 '23 Option Exercise 0.00 20,498 0 20,498 Jun 20 04:16 PM Tammineedi Anil Director Jun 15 '23 Option Exercise 0.00 20,498 0 26,022 Jun 20 04:14 PM
Index - P/E 7.51 EPS (ttm) 0.30 Insider Own 17.10% Shs Outstand 37.16M Perf Week -6.15%
Market Cap 85.51M Forward P/E 6.19 EPS next Y 0.37 Insider Trans 0.27% Shs Float 30.95M Perf Month -12.60%
Income 11.45M PEG - EPS next Q 0.08 Inst Own 33.69% Short Float 0.10% Perf Quarter -18.51%
Sales 56.09M P/S 1.52 EPS this Y -5.05% Inst Trans -10.33% Short Ratio 0.38 Perf Half Y -33.82%
Book/sh 1.71 P/B 1.34 EPS next Y 18.09% ROA 14.37% Short Interest 0.03M Perf Year -21.58%
Cash/sh 0.42 P/C 5.49 EPS next 5Y - ROE 20.03% 52W Range 2.33 - 4.08 Perf YTD -17.63%
Dividend Est. - P/FCF 12.16 EPS past 5Y 20.66% ROI 16.40% 52W High -43.87% Beta 1.19
Dividend TTM - Quick Ratio 1.73 Sales past 5Y 24.02% Gross Margin 67.05% 52W Low -1.72% ATR (14) 0.11
Dividend Ex-Date - Current Ratio 2.07 EPS Y/Y TTM -36.41% Oper. Margin 20.53% RSI (14) 30.71 Volatility 5.98% 4.30%
Employees 82 Debt/Eq 0.15 Sales Y/Y TTM 3.55% Profit Margin 20.40% Recom 1.00 Target Price 4.67
Option/Short No / Yes LT Debt/Eq 0.11 EPS Q/Q -36.54% Payout 0.00% Rel Volume 5.15 Prev Close 2.48
Sales Surprise -14.37% EPS Surprise -21.01% Sales Q/Q -26.79% Earnings May 09 AMC Avg Volume 77.54K Price 2.29
SMA20 -8.49% SMA50 -13.93% SMA200 -21.87% Trades
Volume 399,418 Change -7.66%
Date
Action
Analyst
Rating Change
Price Target Change
May-30-23 Initiated Craig Hallum
Buy
May-09-24 10:54PM
04:08PM
Apr-29-24 01:15PM
09:00AM
Apr-24-24 04:00PM
02:00PM
Loading…
Apr-18-24 02:00PM
Mar-26-24 01:00PM
Mar-15-24 01:56PM
Mar-14-24 04:05PM
Mar-07-24 08:30AM
Feb-21-24 06:39AM
Feb-14-24 04:05PM
Jan-23-24 01:00PM
Jan-16-24 01:00PM
Jan-11-24 01:00PM
09:30AM
Loading…
Nov-12-23 09:30AM
Nov-09-23 04:05PM
Nov-02-23 01:00PM
Oct-17-23 01:00PM
Oct-10-23 12:30PM
Oct-09-23 04:05PM
09:55AM
Sep-22-23 09:00AM
Sep-21-23 09:00AM
Sep-15-23 01:10AM
Aug-10-23 04:05PM
Jul-25-23 01:00PM
Jul-10-23 09:05AM
Jun-15-23 01:00PM
Jun-01-23 04:05PM
01:00PM
Loading…
May-23-23 01:00PM
May-11-23 04:05PM
Apr-24-23 09:00AM
09:00AM
Apr-19-23 01:00PM
06:53AM
Apr-05-23 01:00PM
Mar-22-23 04:05PM
Mar-09-23 04:05PM
Feb-16-23 12:10PM
Feb-15-23 08:30AM
Jan-17-23 10:52AM
Jan-11-23 08:30AM
Dec-19-22 08:30AM
Dec-12-22 08:30AM
Nov-16-22 12:42PM
Nov-13-22 07:48AM
Nov-10-22 04:10PM
Nov-07-22 08:30AM
Oct-20-22 08:25AM
Oct-18-22 07:30AM
Oct-10-22 08:30AM
Oct-05-22 08:30AM
Sep-06-22 08:30AM
Aug-23-22 08:30AM
Aug-16-22 03:00PM
Aug-15-22 09:04AM
Aug-10-22 04:10PM
Aug-09-22 08:00AM
Jul-27-22 08:30AM
Jul-11-22 08:30AM
May-31-22 04:05PM
May-26-22 01:15PM
May-12-22 04:15PM
Apr-28-22 08:30AM
Apr-08-22 11:16AM
Apr-06-22 05:13PM
Mar-24-22 04:05PM
Mar-22-22 08:30AM
Mar-17-22 04:10PM
Mar-14-22 04:09PM
Mar-09-22 02:21PM
Mar-01-22 08:30AM
Dec-22-21 04:05PM
Dec-07-21 10:15AM
Nov-16-21 08:30AM
Nov-10-21 04:05PM
Oct-28-21 08:30AM
Oct-27-21 08:30AM
Sep-30-21 08:30AM
Sep-01-21 11:44AM
Aug-30-21 08:30AM
Aug-26-21 04:15PM
Aug-23-21 04:15PM
Aug-12-21 04:09PM
Aug-06-21 02:36PM
Jul-27-21 08:30AM
Jul-22-21 08:30AM
Jun-16-21 08:30AM
Jun-01-21 10:00AM
May-13-21 04:15PM
03:15PM
May-05-21 04:10PM
Apr-02-21 08:44AM
Mar-30-21 08:30AM
Mar-12-21 08:30AM
Mar-11-21 08:30AM
Mar-09-21 04:01PM
Mar-08-21 04:11PM
01:45PM
Heritage Global, Inc. engages in the provision of corporate and financial asset liquidation transactions, valuations, and advisory services. It operates through the following segments: Auction and Liquidation, Refurbishment and Resale segment, Brokerage, and Specialty Lending. The Auction and Liquidation segment focuses on the operation of a global full-service auction, appraisal and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment. The Refurbishment and Resale segment acquires, refurbishes and supplies specialized laboratory equipment. The Brokerage segment is involved in charged-off receivables in the U.S. and Canada on behalf of financial institutions. The Specialty Lending segment provides specialty financing solutions to investors in charged-off and nonperforming asset portfolios. The company was founded in 1983 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DOVE ROSS CEO Mar 20 '24 Buy 2.75 7,297 20,067 2,302,656 Mar 20 05:37 PM Dove Nicholas Kirk President, Industrial Assets Mar 19 '24 Buy 2.88 5,000 14,400 100,000 Mar 19 12:13 PM Dove Nicholas Kirk President, Industrial Assets Nov 13 '23 Buy 2.85 5,000 14,250 95,000 Nov 13 01:29 PM SHIMER SAMUEL L Director Sep 13 '23 Buy 2.95 10,000 29,500 297,500 Sep 14 12:37 PM DOVE ROSS CEO Aug 24 '23 Buy 3.11 3,200 9,952 2,218,510 Aug 24 02:39 PM Dove Nicholas Kirk President, Industrial Assets Aug 17 '23 Buy 3.13 3,455 10,814 90,000 Aug 17 04:41 PM Ludwig David Van President of subsidiary Aug 15 '23 Buy 3.30 1,825 6,022 1,039,304 Aug 16 11:56 AM SHIMER SAMUEL L Director Aug 14 '23 Option Exercise 0.68 5,000 3,400 287,500 Aug 15 10:08 AM Hexner Michael Director Aug 14 '23 Buy 3.12 8,253 25,749 217,104 Aug 15 04:25 PM Dove Nicholas Kirk President, Industrial Assets Aug 14 '23 Buy 3.17 7,880 24,980 86,545 Aug 14 01:50 PM DOVE ROSS CEO Aug 14 '23 Buy 3.22 6,211 19,999 2,215,310 Aug 15 01:02 PM Ludwig David Van President of subsidiary Aug 14 '23 Buy 3.12 4,583 14,299 1,037,479 Aug 16 11:56 AM
Index RUT P/E - EPS (ttm) -0.26 Insider Own 27.26% Shs Outstand 100.47M Perf Week -2.22%
Market Cap 221.03M Forward P/E - EPS next Y - Insider Trans -0.84% Shs Float 73.09M Perf Month 12.82%
Income -25.80M PEG - EPS next Q - Inst Own 34.53% Short Float 0.91% Perf Quarter 23.60%
Sales 98.64M P/S 2.24 EPS this Y - Inst Trans -3.02% Short Ratio 3.33 Perf Half Y 34.15%
Book/sh 2.48 P/B 0.89 EPS next Y - ROA -1.94% Short Interest 0.67M Perf Year 7.84%
Cash/sh - P/C - EPS next 5Y 12.00% ROE -9.92% 52W Range 1.19 - 2.55 Perf YTD -3.93%
Dividend Est. - P/FCF - EPS past 5Y 41.39% ROI -5.12% 52W High -13.73% Beta 1.32
Dividend TTM - Quick Ratio - Sales past 5Y -37.01% Gross Margin - 52W Low 84.87% ATR (14) 0.11
Dividend Ex-Date Sep 28, 2018 Current Ratio 0.95 EPS Y/Y TTM 48.44% Oper. Margin -14.15% RSI (14) 57.19 Volatility 4.12% 5.27%
Employees 45 Debt/Eq 1.02 Sales Y/Y TTM 35.14% Profit Margin -26.15% Recom 3.00 Target Price 1.00
Option/Short Yes / Yes LT Debt/Eq 1.02 EPS Q/Q 112.90% Payout - Rel Volume 0.33 Prev Close 2.20
Sales Surprise - EPS Surprise - Sales Q/Q 48.28% Earnings May 09 AMC Avg Volume 200.71K Price 2.20
SMA20 3.47% SMA50 14.49% SMA200 18.87% Trades
Volume 66,915 Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
May-15-18 Downgrade JMP Securities
Mkt Outperform → Mkt Perform
Aug-10-17 Resumed JMP Securities
Mkt Outperform
$9
Aug-10-17 Downgrade Keefe Bruyette
Outperform → Mkt Perform
Jul-11-17 Reiterated FBR & Co.
Mkt Perform
$13 → $12
Apr-03-17 Reiterated FBR & Co.
Mkt Perform
$16 → $13
Jan-31-17 Resumed Keefe Bruyette
Outperform
Nov-28-16 Downgrade FBR & Co.
Outperform → Mkt Perform
Feb-24-16 Reiterated Compass Point
Buy
$19 → $18
Aug-06-15 Reiterated Compass Point
Buy
$18 → $19
May-06-15 Reiterated Compass Point
Buy
$17 → $18
Feb-20-15 Reiterated Compass Point
Buy
$16 → $17
Jun-24-14 Reiterated FBR Capital
Outperform
$14 → $16
Sep-26-13 Resumed FBR Capital
Outperform
$14
Jun-21-13 Reiterated FBR Capital
Outperform
$12 → $14
Mar-15-13 Initiated Compass Point
Buy
$14
Dec-08-11 Initiated JMP Securities
Mkt Outperform
$10
Jun-03-11 Reiterated Wunderlich
Buy
$10 → $12
May-05-11 Reiterated FBR Capital
Outperform
$10 → $11
Jul-01-10 Initiated Wunderlich
Buy
$9
Mar-04-10 Reiterated FBR Capital
Outperform
$10 → $11.50
Show Previous Ratings
May-10-24 03:13PM
May-09-24 08:58PM
04:00PM
May-06-24 07:00AM
May-02-24 04:00PM
05:38PM
Loading…
Mar-12-24 05:38PM
04:00PM
Mar-05-24 04:00PM
Jan-03-24 03:02PM
Nov-08-23 06:29PM
04:00PM
Nov-02-23 04:00PM
Aug-08-23 04:00PM
Aug-03-23 04:00PM
Jul-10-23 12:31PM
07:00AM
Loading…
Jun-26-23 07:00AM
May-09-23 05:00PM
May-02-23 04:00PM
Mar-15-23 08:00AM
Jan-31-23 11:23AM
Jan-04-23 10:01AM
Dec-27-22 04:00PM
Dec-12-22 08:00AM
Dec-08-22 07:51AM
Nov-16-22 11:21AM
Nov-11-22 05:10AM
Nov-09-22 08:00AM
07:00AM
Nov-01-22 04:01PM
Oct-10-22 12:23PM
08:53AM
Loading…
Aug-23-22 08:53AM
Aug-18-22 04:15PM
04:10PM
Aug-09-22 09:02AM
Aug-01-22 04:00PM
Jul-28-22 06:00AM
Jun-28-22 08:16AM
Jun-14-22 12:09PM
Jun-05-22 09:52AM
May-18-22 02:20PM
May-13-22 08:59AM
May-10-22 08:00AM
May-03-22 04:20PM
Apr-14-22 03:59PM
Mar-31-22 04:11PM
Mar-16-22 12:42PM
Mar-14-22 05:30PM
Mar-07-22 04:00PM
Jan-18-22 08:31PM
Nov-18-21 04:52PM
Nov-17-21 05:16PM
Nov-09-21 04:00PM
Nov-02-21 04:00PM
Oct-18-21 12:30PM
Aug-19-21 03:15PM
Aug-09-21 04:00PM
Aug-02-21 04:00PM
Jun-25-21 07:00AM
May-20-21 09:54AM
May-14-21 09:10AM
May-10-21 04:00PM
May-03-21 04:00PM
Apr-02-21 11:43AM
Apr-01-21 02:47PM
Mar-15-21 04:00PM
Mar-09-21 08:00AM
Mar-08-21 04:00PM
Dec-31-20 07:30PM
Dec-23-20 09:02AM
Dec-04-20 08:00AM
Dec-02-20 09:45PM
Nov-20-20 08:46AM
Nov-13-20 04:02PM
04:00PM
Nov-10-20 12:08PM
Oct-27-20 04:00PM
Oct-19-20 10:45AM
Oct-16-20 01:58PM
Aug-14-20 04:00PM
Aug-11-20 09:00AM
Aug-10-20 11:50AM
Jul-31-20 04:00PM
Jun-24-20 11:37AM
Jun-15-20 08:08PM
Jun-02-20 04:00PM
May-18-20 11:47AM
May-15-20 04:55PM
May-08-20 04:00PM
Mar-18-20 05:59PM
Dec-14-19 07:47PM
Nov-12-19 07:29PM
Oct-16-19 05:21PM
Oct-04-19 10:30AM
Aug-20-19 07:32AM
Aug-15-19 07:57AM
Aug-12-19 07:16PM
Aug-05-19 05:06PM
May-10-19 07:57PM
07:49PM
Apr-12-19 05:03PM
Maiden Holdings Ltd. engages in the provision of non-catastrophic, customized reinsurance products and services to small and mid-size insurance companies. It operates through the Diversified Reinsurance and AmTrust Reinsurance segments. The Diversified Reinsurance segment consists of a portfolio of property and casualty reinsurance business. The AmTrust Reinsurance segment includes business ceded by AmTrust to Maiden Bermuda. The company was founded in 2007 and is headquartered in Hamilton, Bermuda.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LYONS SIMCHA G Director Mar 19 '24 Buy 1.80 15,000 27,027 206,525 Mar 20 09:04 AM NIGRO STEVEN HAROLD Director Mar 15 '24 Buy 1.52 20,000 30,400 208,043 Mar 18 04:06 PM Haveron Patrick J See Remarks Mar 15 '24 Buy 1.50 10,000 14,998 2,175,803 Mar 18 04:08 PM NEUBERGER YEHUDA Director Dec 31 '23 Sale 2.29 277,000 634,330 0 Jan 02 05:57 PM Thomas Keith A Director Sep 26 '23 Sale 1.90 26,315 49,998 73,839 Sep 28 04:09 PM
Index - P/E - EPS (ttm) -1.07 Insider Own 38.93% Shs Outstand 19.80M Perf Week -3.63%
Market Cap 16.59M Forward P/E 11.77 EPS next Y 0.06 Insider Trans 3.68% Shs Float 14.35M Perf Month -6.40%
Income -21.05M PEG - EPS next Q -0.15 Inst Own 18.03% Short Float 0.36% Perf Quarter -33.98%
Sales 17.75M P/S 0.93 EPS this Y 52.42% Inst Trans 6.19% Short Ratio 1.14 Perf Half Y -20.60%
Book/sh 2.53 P/B 0.28 EPS next Y 120.34% ROA -25.09% Short Interest 0.05M Perf Year 6.66%
Cash/sh 0.13 P/C 5.53 EPS next 5Y 10.00% ROE -34.84% 52W Range 0.58 - 2.10 Perf YTD -45.24%
Dividend Est. - P/FCF - EPS past 5Y - ROI -36.28% 52W High -66.36% Beta 1.49
Dividend TTM - Quick Ratio 1.06 Sales past 5Y -9.23% Gross Margin -32.82% 52W Low 21.79% ATR (14) 0.07
Dividend Ex-Date - Current Ratio 1.13 EPS Y/Y TTM -417.09% Oper. Margin -108.07% RSI (14) 42.78 Volatility 9.44% 7.97%
Employees 36 Debt/Eq 0.20 Sales Y/Y TTM -31.13% Profit Margin -118.58% Recom 1.00 Target Price 3.00
Option/Short No / Yes LT Debt/Eq 0.16 EPS Q/Q -12.96% Payout - Rel Volume 0.56 Prev Close 0.70
Sales Surprise -7.22% EPS Surprise -23.08% Sales Q/Q -43.75% Earnings Apr 16 AMC Avg Volume 45.13K Price 0.71
SMA20 -2.57% SMA50 -12.65% SMA200 -37.30% Trades
Volume 25,087 Change 0.34%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-10-17 Reiterated FBR & Co.
Buy
$4 → $4.50
Jul-11-17 Resumed FBR & Co.
Outperform
$4
Aug-10-16 Reiterated Wunderlich
Buy
$11 → $9
Apr-29-24 09:00AM
Apr-22-24 10:00AM
Apr-16-24 09:53PM
04:53PM
(Associated Press Finance)
04:33PM
08:00AM
Loading…
08:00AM
Apr-15-24 01:51PM
Mar-29-24 10:30AM
Mar-28-24 04:53PM
Mar-15-24 07:30AM
Mar-14-24 04:10PM
Mar-07-24 12:00PM
Feb-28-24 03:00PM
Feb-20-24 08:00AM
Feb-09-24 09:00AM
05:00PM
Loading…
Jan-24-24 05:00PM
05:00PM
Jan-12-24 09:15AM
Dec-05-23 10:25AM
Dec-04-23 11:31AM
08:00AM
Dec-01-23 08:30AM
Nov-24-23 04:00PM
Nov-21-23 11:54AM
11:19AM
(Thomson Reuters StreetEvents)
Nov-20-23 04:32PM
(Associated Press Finance) +8.89%
04:18PM
Nov-15-23 04:15PM
Nov-13-23 08:00AM
Nov-06-23 10:00AM
08:30AM
Loading…
Nov-01-23 08:30AM
Sep-25-23 08:30AM
Sep-20-23 04:05PM
Aug-23-23 08:30AM
Aug-15-23 10:20AM
Aug-14-23 09:09AM
Aug-10-23 06:15PM
05:16PM
(Associated Press Finance)
04:45PM
Aug-09-23 04:30PM
Aug-08-23 04:30PM
Jun-29-23 08:00AM
Jun-13-23 08:00AM
Jun-12-23 08:00AM
Jun-06-23 07:09AM
May-19-23 06:24AM
(Thomson Reuters StreetEvents)
May-18-23 04:53PM
04:45PM
May-15-23 04:30PM
Apr-19-23 03:56PM
Apr-18-23 04:27PM
Apr-17-23 05:19PM
04:57PM
Apr-14-23 03:37PM
10:02AM
Apr-13-23 09:00AM
Mar-10-23 09:00AM
Dec-27-22 09:58PM
Dec-06-22 07:00AM
Dec-01-22 10:27AM
Nov-17-22 06:19AM
Nov-14-22 04:00PM
Nov-09-22 04:05PM
Oct-05-22 06:39AM
Sep-16-22 02:08PM
01:00PM
10:32AM
Aug-16-22 03:00PM
Aug-15-22 08:05AM
Aug-10-22 04:15PM
Jul-21-22 08:00AM
Jul-20-22 05:17PM
May-31-22 04:24PM
03:02PM
03:00PM
May-23-22 04:05PM
May-19-22 08:00AM
Apr-14-22 08:34AM
Apr-12-22 04:38PM
Nov-15-21 04:10PM
Nov-11-21 05:30PM
Aug-12-21 04:31PM
Jul-19-21 10:18AM
Jul-01-21 06:17AM
(Simply Wall St.) -11.04%
Jun-14-21 07:10PM
Jun-11-21 08:00AM
Jun-02-21 09:42AM
Jun-01-21 07:08PM
May-17-21 04:15PM
03:15PM
May-13-21 04:15PM
Apr-22-21 05:18PM
Apr-21-21 04:13PM
Apr-20-21 10:00AM
Apr-16-21 07:52PM
Apr-15-21 04:33PM
04:32PM
02:15PM
Apr-13-21 04:40PM
03:15PM
XCel Brands, Inc. engages in the design, production, marketing, wholesale, and direct-to-consumer sales of branded apparel, footwear, accessories, jewelry, home goods and other consumer products. It owns and manages Isaac Mizrahi, Judith Ripka, Halston, C Wonder, Longaberger, and Lori Goldstein brands. The company was founded by Robert W. D'Loren on August 31, 1989 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DiSanto Mark Director Mar 15 '24 Buy 0.65 146,250 95,062 1,174,263 Mar 19 09:26 PM D LOREN ROBERT W CEO & Chairman Mar 15 '24 Buy 0.65 146,250 95,062 1,885,240 Mar 19 08:49 PM Burroughs Seth EVP of BD Treasurer Secretary Mar 15 '24 Buy 0.65 32,500 21,125 343,049 Mar 19 08:48 PM
Index - P/E 34.57 EPS (ttm) 0.11 Insider Own 11.33% Shs Outstand 386.88M Perf Week 8.66%
Market Cap 647.12M Forward P/E 13.59 EPS next Y 0.27 Insider Trans 1.98% Shs Float 157.63M Perf Month 21.33%
Income -35.41M PEG - EPS next Q -0.02 Inst Own 7.50% Short Float 5.64% Perf Quarter -2.93%
Sales 561.04M P/S 1.15 EPS this Y 123.88% Inst Trans - Short Ratio 2.67 Perf Half Y -
Book/sh -1.75 P/B - EPS next Y 72.48% ROA -4.50% Short Interest 8.89M Perf Year -
Cash/sh 0.64 P/C 5.66 EPS next 5Y - ROE -7418.13% 52W Range 2.61 - 6.10 Perf YTD 5.81%
Dividend Est. - P/FCF 31.07 EPS past 5Y - ROI -11.49% 52W High -40.33% Beta -
Dividend TTM - Quick Ratio 1.04 Sales past 5Y -1.31% Gross Margin 30.18% 52W Low 39.46% ATR (14) 0.28
Dividend Ex-Date - Current Ratio 1.04 EPS Y/Y TTM 105.53% Oper. Margin 12.21% RSI (14) 57.32 Volatility 8.79% 8.04%
Employees 286 Debt/Eq - Sales Y/Y TTM -1.30% Profit Margin -6.31% Recom 1.67 Target Price 6.75
Option/Short Yes / Yes LT Debt/Eq - EPS Q/Q 2497.75% Payout - Rel Volume 2.46 Prev Close 3.90
Sales Surprise 20.74% EPS Surprise 630.34% Sales Q/Q 48.60% Earnings May 08 AMC Avg Volume 3.33M Price 3.64
SMA20 13.38% SMA50 8.13% SMA200 7.61% Trades
Volume 8,203,516 Change -6.67%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-31-24 Upgrade Compass Point
Neutral → Buy
$1 → $8.50
Jan-25-24 Upgrade H.C. Wainwright
Neutral → Buy
$5
May-10-24 02:27PM
May-09-24 03:51AM
May-08-24 04:10PM
May-06-24 09:10AM
May-03-24 04:07PM
09:10AM
Loading…
09:10AM
Apr-17-24 04:36PM
(The Wall Street Journal)
Apr-16-24 09:10AM
Apr-15-24 09:10AM
Apr-05-24 09:10AM
Mar-19-24 01:26AM
01:26AM
Mar-12-24 04:10PM
Mar-07-24 12:02PM
Mar-06-24 04:10PM
07:05AM
Loading…
07:05AM
Mar-05-24 04:30PM
04:19PM
Feb-05-24 09:10AM
Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Becker Todd A Director Mar 15 '24 Buy 3.16 130,000 410,163 134,250 Mar 19 04:17 PM Patten Jarrod M Director Mar 15 '24 Buy 3.32 100,000 332,220 100,000 Mar 19 04:17 PM Rozov Yadin Director Mar 15 '24 Buy 3.07 80,000 245,968 80,000 Mar 18 07:45 PM Sullivan Adam Taylor Chief Executive Officer Mar 15 '24 Buy 3.06 65,300 199,962 93,753 Mar 18 07:46 PM Weiss Eric Stanton Director Mar 15 '24 Buy 3.03 15,000 45,396 15,000 Mar 18 07:46 PM
Index - P/E - EPS (ttm) -1.11 Insider Own 23.13% Shs Outstand 36.83M Perf Week -9.67%
Market Cap 119.99M Forward P/E - EPS next Y -0.85 Insider Trans 82.45% Shs Float 30.85M Perf Month 15.00%
Income -56.83M PEG - EPS next Q -0.30 Inst Own 55.32% Short Float 1.02% Perf Quarter 182.08%
Sales 0.00M P/S - EPS this Y -10.89% Inst Trans -0.33% Short Ratio 0.91 Perf Half Y 199.00%
Book/sh 2.31 P/B 1.29 EPS next Y 24.49% ROA -45.04% Short Interest 0.31M Perf Year 43.06%
Cash/sh 2.31 P/C 1.30 EPS next 5Y - ROE -48.79% 52W Range 0.72 - 3.69 Perf YTD 201.26%
Dividend Est. - P/FCF - EPS past 5Y 48.08% ROI -60.65% 52W High -18.97% Beta 1.22
Dividend TTM - Quick Ratio 12.00 Sales past 5Y 0.00% Gross Margin - 52W Low 315.28% ATR (14) 0.32
Dividend Ex-Date - Current Ratio 12.00 EPS Y/Y TTM 21.54% Oper. Margin 0.00% RSI (14) 54.96 Volatility 11.71% 13.12%
Employees 51 Debt/Eq 0.03 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 9.67
Option/Short No / Yes LT Debt/Eq 0.02 EPS Q/Q -2.62% Payout - Rel Volume 0.35 Prev Close 2.85
Sales Surprise - EPS Surprise 10.98% Sales Q/Q - Earnings Feb 13 AMC Avg Volume 346.43K Price 2.99
SMA20 -0.25% SMA50 22.34% SMA200 101.22% Trades
Volume 121,132 Change 4.91%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-09-24 Initiated Maxim Group
Buy
$8
Aug-02-22 Resumed Canaccord Genuity
Buy
$17
Jun-15-22 Initiated Cantor Fitzgerald
Overweight
$9
Sep-08-21 Initiated ROTH Capital
Buy
$21
May-27-21 Initiated Oppenheimer
Outperform
$25
May-25-21 Initiated H.C. Wainwright
Buy
$21
Apr-23-24 08:00AM
Mar-20-24 02:33PM
Mar-06-24 07:30AM
Feb-13-24 04:05PM
Jan-24-24 08:00AM
08:00AM
Loading…
Jan-23-24 08:00AM
Dec-14-23 08:00AM
Dec-13-23 08:00AM
Nov-24-23 11:14AM
Nov-17-23 08:00AM
Nov-13-23 04:05PM
Oct-17-23 08:00AM
Oct-11-23 08:00AM
Sep-14-23 04:05PM
Sep-06-23 07:00AM
04:05PM
Loading…
Jun-27-23 04:05PM
Jun-01-23 12:45PM
May-11-23 04:05PM
Mar-23-23 04:50PM
Mar-08-23 07:00AM
Feb-10-23 04:05PM
Dec-15-22 07:00AM
Nov-09-22 04:05PM
Nov-01-22 07:00AM
Oct-20-22 07:00AM
Sep-15-22 04:05PM
Sep-07-22 07:00AM
Aug-15-22 08:36AM
Jun-01-22 07:00AM
May-12-22 04:05PM
04:01PM
Loading…
May-04-22 04:01PM
09:33AM
May-01-22 11:25PM
02:00PM
Apr-26-22 04:05PM
Mar-29-22 07:00AM
Mar-23-22 07:00AM
Feb-22-22 07:00AM
Feb-09-22 04:05PM
Nov-12-21 04:05PM
Oct-19-21 12:14PM
Oct-13-21 08:10AM
Oct-12-21 04:05PM
Sep-22-21 04:05PM
Sep-15-21 04:56PM
Sep-09-21 04:05PM
Sep-07-21 04:05PM
Aug-10-21 07:00AM
Aug-03-21 07:00AM
Jun-28-21 07:00AM
Jun-24-21 09:01PM
Jun-03-21 05:35AM
May-31-21 10:17AM
May-27-21 07:00AM
May-20-21 07:00AM
May-18-21 07:00AM
May-17-21 04:05PM
07:00AM
May-04-21 08:00AM
Apr-19-21 08:00AM
Mar-22-21 08:00AM
Mar-08-21 08:00AM
Mar-02-21 05:16PM
Feb-10-21 04:05PM
Jan-12-21 08:30AM
Jan-11-21 07:56AM
Dec-28-20 04:05PM
Dec-03-20 08:00AM
Nov-19-20 08:00AM
Nov-05-20 08:00AM
Oct-09-20 08:30AM
Sep-10-20 08:00AM
Jul-27-20 08:00AM
Jun-15-20 08:30AM
May-28-20 08:30AM
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperinsulinism, AB101-Phase 1, a once-weekly injectable basal insulin, and RZ402, which targets diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ROBERTS BRIAN KENNETH Chief Medical Officer Mar 28 '24 Buy 2.55 500 1,275 1,076 Mar 29 11:08 AM Evans Daron CFO Mar 15 '24 Buy 1.69 20,000 33,830 20,000 Mar 19 09:17 AM ROBERTS BRIAN KENNETH Chief Medical Officer Mar 14 '24 Buy 1.88 10,000 18,800 10,000 Mar 18 11:20 AM Evans Daron CFO Mar 08 '24 Buy 1.93 50,000 96,345 120,900 Mar 08 12:37 PM Kim Young-Jin Director Mar 07 '24 Buy 1.91 36,503 69,859 115,450 Mar 14 10:35 AM ROBERTS BRIAN KENNETH Chief Medical Officer Mar 07 '24 Buy 1.85 500 925 500 Mar 11 10:35 AM Elam Nevan C CEO Feb 26 '24 Buy 1.68 5,000 8,400 7,817 Feb 28 11:40 AM ROBERTS BRIAN KENNETH Chief Medical Officer Feb 26 '24 Buy 1.70 2,000 3,400 42,552 Feb 27 08:47 AM ROBERTS BRIAN KENNETH Chief Medical Officer Feb 23 '24 Buy 1.69 6,000 10,140 40,552 Feb 27 08:47 AM Evans Daron CFO Feb 16 '24 Buy 1.30 41,900 54,411 70,900 Feb 20 07:01 AM Evans Daron CFO Feb 16 '24 Buy 1.37 9,000 12,330 4,500 Feb 20 07:01 AM ROBERTS BRIAN KENNETH Chief Medical Officer Feb 16 '24 Buy 1.31 7,000 9,142 34,552 Feb 21 11:55 AM ROBERTS BRIAN KENNETH Chief Medical Officer Jul 03 '23 Buy 1.90 5,000 9,500 27,552 Jul 06 11:18 AM
Index RUT P/E 37.58 EPS (ttm) 0.13 Insider Own 38.59% Shs Outstand 52.75M Perf Week 2.33%
Market Cap 256.37M Forward P/E 66.00 EPS next Y 0.07 Insider Trans 8.37% Shs Float 32.53M Perf Month 8.52%
Income 6.93M PEG - EPS next Q 0.01 Inst Own 27.00% Short Float 3.69% Perf Quarter 54.14%
Sales 50.32M P/S 5.09 EPS this Y -63.89% Inst Trans 7.21% Short Ratio 2.53 Perf Half Y 105.96%
Book/sh 0.48 P/B 10.07 EPS next Y 69.23% ROA 4.80% Short Interest 1.20M Perf Year 44.05%
Cash/sh 2.18 P/C 2.22 EPS next 5Y - ROE 33.35% 52W Range 1.67 - 4.92 Perf YTD 72.86%
Dividend Est. - P/FCF 10.22 EPS past 5Y 19.26% ROI 24.49% 52W High -1.63% Beta 1.12
Dividend TTM - Quick Ratio 1.07 Sales past 5Y 18.62% Gross Margin 42.84% 52W Low 189.75% ATR (14) 0.25
Dividend Ex-Date - Current Ratio 1.07 EPS Y/Y TTM 484.00% Oper. Margin 0.63% RSI (14) 62.29 Volatility 5.98% 5.66%
Employees 123 Debt/Eq 0.13 Sales Y/Y TTM 25.94% Profit Margin 13.77% Recom 1.00 Target Price 6.12
Option/Short Yes / Yes LT Debt/Eq 0.11 EPS Q/Q 280.65% Payout 0.00% Rel Volume 0.41 Prev Close 4.92
Sales Surprise 6.42% EPS Surprise - Sales Q/Q 30.04% Earnings May 07 AMC Avg Volume 474.35K Price 4.84
SMA20 7.93% SMA50 24.25% SMA200 78.09% Trades
Volume 193,641 Change -1.63%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-30-22 Initiated Barrington Research
Mkt Perform
$4
Mar-24-22 Downgrade Ladenburg Thalmann
Buy → Neutral
Aug-19-21 Upgrade DA Davidson
Neutral → Buy
Aug-12-21 Upgrade Ladenburg Thalmann
Neutral → Buy
$3.50 → $3.75
May-12-21 Upgrade Ladenburg Thalmann
Sell → Neutral
$3.50
Dec-23-20 Downgrade Canaccord Genuity
Buy → Hold
$5
Nov-18-20 Downgrade Ladenburg Thalmann
Neutral → Sell
$8.75 → $3.30
Nov-18-20 Downgrade DA Davidson
Buy → Neutral
$9 → $6
Aug-17-20 Downgrade Ladenburg Thalmann
Buy → Neutral
$12 → $8.75
Apr-07-20 Reiterated Maxim Group
Buy
$14 → $10
Nov-15-19 Initiated DA Davidson
Buy
Aug-06-19 Upgrade BTIG Research
Sell → Neutral
Jul-22-19 Downgrade BTIG Research
Neutral → Sell
$12
Jul-02-19 Initiated Canaccord Genuity
Buy
$17
Jun-17-19 Downgrade BTIG Research
Buy → Neutral
May-16-19 Initiated Ladenburg Thalmann
Buy
$12
Show Previous Ratings
May-07-24 10:54PM
06:30PM
04:10PM
Apr-09-24 04:30PM
Mar-27-24 09:38AM
09:52PM
Loading…
Mar-26-24 09:52PM
05:32PM
05:15PM
Mar-14-24 04:30PM
Mar-13-24 04:30PM
Mar-12-24 04:30PM
Mar-11-24 04:30PM
Feb-27-24 04:30PM
Nov-13-23 08:57AM
Nov-07-23 04:00PM
05:01PM
Loading…
Oct-18-23 05:01PM
Aug-15-23 10:20AM
Aug-10-23 06:31AM
Aug-08-23 04:05PM
Aug-01-23 04:30PM
Jul-25-23 04:30PM
Jul-13-23 04:30PM
Jun-13-23 08:05AM
Jun-08-23 08:05AM
Jun-06-23 08:05AM
May-17-23 07:29AM
May-16-23 04:30PM
May-10-23 04:05PM
Apr-19-23 04:30PM
Apr-12-23 05:00PM
04:14PM
Loading…
Mar-21-23 04:14PM
04:05PM
Feb-23-23 05:00PM
Dec-15-22 08:10AM
Nov-30-22 04:15PM
Nov-29-22 04:30PM
Nov-17-22 04:30PM
Nov-08-22 04:10PM
Oct-11-22 05:00PM
Sep-27-22 08:05AM
Sep-08-22 05:05PM
Aug-16-22 05:05PM
03:00PM
Aug-12-22 06:22AM
Aug-09-22 04:11PM
04:05PM
Jul-19-22 05:00PM
Jul-15-22 09:50AM
Jun-15-22 09:28AM
May-16-22 08:06AM
Apr-26-22 05:00PM
Apr-07-22 03:59PM
Mar-22-22 04:10PM
Feb-23-22 05:00PM
Nov-09-21 04:10PM
Nov-02-21 12:42AM
Oct-14-21 05:00PM
Sep-13-21 03:16PM
08:01AM
Sep-09-21 12:00PM
10:50AM
Aug-10-21 04:10PM
Aug-07-21 08:00AM
Aug-05-21 08:05AM
Jul-20-21 05:00PM
Jun-10-21 08:05AM
May-11-21 04:10PM
03:15PM
May-04-21 06:23PM
Apr-30-21 04:55PM
Mar-31-21 08:05AM
Mar-25-21 04:10PM
03:15PM
Mar-19-21 04:28PM
Feb-24-21 05:00PM
Jan-20-21 12:25PM
Dec-25-20 07:55AM
Dec-15-20 07:15AM
Dec-10-20 08:00AM
Nov-30-20 09:15PM
Nov-17-20 04:14PM
03:15PM
Nov-12-20 08:22PM
Nov-02-20 07:10AM
Sep-22-20 10:10AM
Sep-21-20 06:00PM
Aug-13-20 04:01PM
Aug-07-20 07:30PM
Jul-05-20 02:42PM
Jun-19-20 05:34PM
Jun-18-20 02:15PM
Jun-01-20 08:31AM
May-27-20 08:05AM
May-18-20 12:20PM
11:17AM
08:45AM
08:34AM
May-17-20 07:45PM
06:01PM
01:00PM
PaySign, Inc. engages in the provision of prepaid card programs and processing services for corporate, consumer and government applications. It specializes in corporate incentive products, payroll cards, general purpose re-loadable cards, and travel cards. It markets its prepaid solutions through its PaySign brand. The company was founded by Mark R. Newcomer and Daniel H. Spencer on August 24, 1995 and is headquartered in Henderson, NV.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Topline Capital Management, LL Mar 18 '24 Buy 3.07 7,242 22,233 6,160,742 Mar 18 08:57 PM Topline Capital Partners, LP 10% Owner Mar 18 '24 Buy 3.07 7,242 22,233 6,160,742 Mar 18 08:51 PM Topline Capital Partners, LP 10% Owner Mar 15 '24 Buy 2.97 54,183 160,924 6,153,500 Mar 18 08:51 PM Topline Capital Management, LL Mar 15 '24 Buy 2.97 54,183 160,924 6,153,500 Mar 18 08:57 PM Topline Capital Management, LL Mar 14 '24 Buy 2.93 51,300 150,309 6,099,317 Mar 18 08:57 PM Topline Capital Partners, LP 10% Owner Mar 14 '24 Buy 2.93 51,300 150,309 6,099,317 Mar 18 08:51 PM Topline Capital Management, LL Mar 13 '24 Buy 3.04 36,781 111,814 6,048,017 Mar 13 09:20 PM Topline Capital Partners, LP 10% Owner Mar 13 '24 Buy 3.04 36,781 111,814 6,048,017 Mar 13 09:14 PM Topline Capital Partners, LP 10% Owner Mar 12 '24 Buy 3.01 37,517 112,926 6,011,236 Mar 13 09:14 PM Topline Capital Management, LL Mar 12 '24 Buy 3.01 37,517 112,926 6,011,236 Mar 13 09:20 PM Mina Bruce A Director Mar 12 '24 Sale 3.01 426 1,281 217,294 Mar 29 03:19 PM Topline Capital Management, LL Mar 11 '24 Buy 2.99 30,100 89,999 5,973,719 Mar 13 09:20 PM Topline Capital Partners, LP 10% Owner Mar 11 '24 Buy 2.99 30,100 89,999 5,973,719 Mar 13 09:14 PM Topline Capital Management, LL Mar 07 '24 Buy 2.99 86,978 260,064 5,943,619 Mar 07 06:22 PM Topline Capital Partners, LP 10% Owner Mar 07 '24 Buy 2.99 86,978 260,064 5,943,619 Mar 07 06:14 PM Topline Capital Partners, LP 10% Owner Mar 06 '24 Buy 2.90 55,049 159,642 5,856,641 Mar 07 06:14 PM Topline Capital Management, LL Mar 06 '24 Buy 2.90 55,049 159,642 5,856,641 Mar 07 06:22 PM Topline Capital Management, LL Mar 05 '24 Buy 2.86 39,674 113,468 5,801,592 Mar 07 06:22 PM Topline Capital Partners, LP 10% Owner Mar 05 '24 Buy 2.86 39,674 113,468 5,801,592 Mar 07 06:14 PM Baker Jeffery Bradford Chief Financial Officer Mar 04 '24 Sale 2.87 27,691 79,429 157,097 Mar 04 08:07 PM Baker Jeffery Bradford Chief Financial Officer Feb 28 '24 Option Exercise 0.00 60,000 0 184,788 Mar 04 07:51 AM Topline Capital Partners, LP 10% Owner Feb 21 '24 Buy 3.08 25,082 77,253 5,761,918 Feb 21 05:55 PM Topline Capital Management, LL Feb 21 '24 Buy 3.08 25,082 77,253 5,761,918 Feb 21 06:01 PM Topline Capital Management, LL Feb 20 '24 Buy 3.01 26,444 79,596 5,736,836 Feb 21 06:01 PM Topline Capital Partners, LP 10% Owner Feb 20 '24 Buy 3.01 26,444 79,596 5,736,836 Feb 21 05:55 PM Topline Capital Partners, LP 10% Owner Feb 16 '24 Buy 3.03 25,736 77,980 5,710,392 Feb 21 05:55 PM Topline Capital Management, LL Feb 16 '24 Buy 3.03 25,736 77,980 5,710,392 Feb 21 06:01 PM Topline Capital Partners, LP 10% Owner Feb 06 '24 Buy 3.05 38,544 117,559 5,684,656 Feb 06 06:44 PM Topline Capital Management, LL Feb 06 '24 Buy 3.05 38,544 117,559 3,684,656 Feb 06 06:50 PM Topline Capital Management, LL Feb 05 '24 Buy 2.91 43,607 126,896 5,646,112 Feb 06 06:50 PM Topline Capital Partners, LP 10% Owner Feb 05 '24 Buy 2.91 43,607 126,896 5,646,112 Feb 06 06:44 PM Topline Capital Partners, LP 10% Owner Feb 02 '24 Buy 2.98 30,149 89,844 5,602,505 Feb 06 06:44 PM Topline Capital Management, LL Feb 02 '24 Buy 2.98 30,149 89,844 5,602,505 Feb 06 06:50 PM Topline Capital Management, LL Jan 31 '24 Buy 3.08 87,344 269,020 5,572,356 Jan 31 06:57 PM Topline Capital Partners, LP 10% Owner Jan 31 '24 Buy 3.08 87,344 269,020 5,572,356 Jan 31 06:49 PM Topline Capital Partners, LP 10% Owner Jan 30 '24 Buy 3.03 12,604 38,190 5,485,012 Jan 31 06:49 PM Topline Capital Management, LL Jan 30 '24 Buy 3.03 12,604 38,190 5,485,012 Jan 31 06:57 PM Topline Capital Management, LL Jan 29 '24 Buy 2.87 8,379 24,048 5,472,408 Jan 31 06:57 PM Topline Capital Partners, LP 10% Owner Jan 29 '24 Buy 2.87 8,379 24,048 5,472,408 Jan 31 06:49 PM Topline Capital Management, LL Jan 25 '24 Buy 2.83 15,059 42,617 5,464,029 Jan 25 07:50 PM Topline Capital Partners, LP 10% Owner Jan 25 '24 Buy 2.83 15,059 42,617 5,464,029 Jan 25 07:03 PM Topline Capital Partners, LP 10% Owner Jan 24 '24 Buy 2.80 73,000 204,400 5,448,970 Jan 25 07:03 PM Topline Capital Management, LL Jan 24 '24 Buy 2.80 73,000 204,400 5,448,970 Jan 25 07:50 PM Topline Capital Management, LL Jan 23 '24 Buy 2.74 19,098 52,329 5,375,970 Jan 25 07:50 PM Topline Capital Partners, LP 10% Owner Jan 23 '24 Buy 2.74 19,098 52,329 5,375,970 Jan 25 07:03 PM Strobo Robert Chief Legal Officer Nov 01 '23 Sale 1.75 16,709 29,241 175,501 Nov 02 05:44 PM Strobo Robert Chief Legal Officer Oct 31 '23 Option Exercise 0.00 40,000 0 192,210 Nov 02 05:44 PM Mina Bruce A Director Aug 15 '23 Sale 1.94 780 1,514 217,720 Aug 28 07:18 PM Newcomer Mark CEO Aug 04 '23 Sale 1.84 7,152 13,144 9,468,479 Aug 07 08:00 PM Baker Jeffery Bradford Chief Financial Officer Aug 04 '23 Sale 1.84 3,498 6,429 124,788 Aug 07 07:58 PM Strobo Robert CLO Aug 04 '23 Sale 1.84 2,924 5,374 152,210 Aug 07 08:02 PM Lanford Matthew Louis COO, President Aug 04 '23 Sale 1.84 2,897 5,324 88,469 Aug 07 08:00 PM Herman Joan M Director Aug 04 '23 Sale 1.84 1,604 2,948 779,597 Aug 07 07:59 PM Newcomer Mark CEO Aug 03 '23 Sale 1.77 17,475 30,884 9,475,631 Aug 07 08:00 PM Baker Jeffery Bradford Chief Financial Officer Aug 03 '23 Sale 1.77 8,546 15,103 128,286 Aug 07 07:58 PM Strobo Robert CLO Aug 03 '23 Sale 1.77 7,143 12,624 155,134 Aug 07 08:02 PM Lanford Matthew Louis COO, President Aug 03 '23 Sale 1.77 7,077 12,507 91,366 Aug 07 08:00 PM Herman Joan M Director Aug 03 '23 Sale 1.77 3,920 6,928 781,201 Aug 07 07:59 PM Newcomer Mark CEO Aug 02 '23 Sale 1.82 17,793 32,296 9,493,106 Aug 03 06:00 AM Baker Jeffery Bradford Chief Financial Officer Aug 02 '23 Sale 1.82 8,701 15,793 136,832 Aug 02 09:59 PM Strobo Robert CLO Aug 02 '23 Sale 1.82 7,273 13,201 162,277 Aug 02 09:57 PM Lanford Matthew Louis COO, President Aug 02 '23 Sale 1.82 7,206 13,080 98,443 Aug 02 09:57 PM Herman Joan M EVP, Operations Aug 02 '23 Sale 1.82 3,992 7,246 785,121 Aug 03 06:00 AM Newcomer Mark CEO Aug 01 '23 Sale 1.88 20,303 38,243 9,510,899 Aug 03 06:00 AM Baker Jeffery Bradford Chief Financial Officer Aug 01 '23 Sale 1.88 9,928 18,700 145,533 Aug 02 09:59 PM Strobo Robert CLO Aug 01 '23 Sale 1.88 8,299 15,632 169,550 Aug 02 09:57 PM Lanford Matthew Louis COO, President Aug 01 '23 Sale 1.88 8,222 15,487 105,649 Aug 02 09:57 PM Herman Joan M EVP, Operations Aug 01 '23 Sale 1.88 4,555 8,580 789,113 Aug 03 06:00 AM Newcomer Mark CEO Jul 31 '23 Option Exercise 0.00 150,000 0 9,531,202 Aug 03 06:00 AM Herman Joan M EVP, Operations Jul 31 '23 Option Exercise 0.00 36,000 0 793,668 Aug 03 06:00 AM Baker Jeffery Bradford Chief Financial Officer Jul 31 '23 Option Exercise 0.00 64,000 0 155,461 Aug 02 09:59 PM Strobo Robert CLO Jul 31 '23 Option Exercise 0.00 64,000 0 177,849 Aug 02 09:57 PM Lanford Matthew Louis COO, President Jul 31 '23 Option Exercise 0.00 64,000 0 113,871 Aug 02 09:57 PM Lanford Matthew Louis COO, President Jul 03 '23 Sale 2.39 7,725 18,455 49,871 Jul 05 08:33 PM HENRY DANIEL R Director May 31 '23 Option Exercise 2.40 10,000 24,000 60,000 Jun 02 04:59 PM Mina Bruce A Director May 31 '23 Option Exercise 2.40 10,000 24,000 218,500 Jun 02 04:49 PM Triplett Dennis L Director May 31 '23 Option Exercise 2.40 10,000 24,000 210,000 Jun 02 04:48 PM NEWMAN JEFFREY B Director May 31 '23 Option Exercise 2.40 10,000 24,000 10,000 Jun 02 04:51 PM
Index - P/E - EPS (ttm) -1.45 Insider Own 22.12% Shs Outstand 16.99M Perf Week -6.10%
Market Cap 63.39M Forward P/E - EPS next Y - Insider Trans 15.76% Shs Float 16.03M Perf Month 26.75%
Income -19.77M PEG - EPS next Q -0.39 Inst Own 3.85% Short Float 6.31% Perf Quarter 108.11%
Sales 0.00M P/S - EPS this Y -6.02% Inst Trans 111.02% Short Ratio 2.71 Perf Half Y 48.08%
Book/sh 0.03 P/B 109.57 EPS next Y - ROA -201.88% Short Interest 1.01M Perf Year 13.65%
Cash/sh 0.35 P/C 8.87 EPS next 5Y - ROE -440.12% 52W Range 0.82 - 3.59 Perf YTD 163.25%
Dividend Est. - P/FCF - EPS past 5Y -25.01% ROI -4140.83% 52W High -14.21% Beta 0.06
Dividend TTM - Quick Ratio 1.53 Sales past 5Y 0.00% Gross Margin - 52W Low 275.61% ATR (14) 0.30
Dividend Ex-Date - Current Ratio 1.53 EPS Y/Y TTM 10.84% Oper. Margin 0.00% RSI (14) 59.93 Volatility 9.90% 11.71%
Employees 13 Debt/Eq 0.00 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 14.00
Option/Short No / Yes LT Debt/Eq 0.00 EPS Q/Q 2.67% Payout - Rel Volume 0.62 Prev Close 2.89
Sales Surprise - EPS Surprise 6.49% Sales Q/Q - Earnings Nov 07 BMO Avg Volume 373.54K Price 3.08
SMA20 15.11% SMA50 39.74% SMA200 72.48% Trades
Volume 230,922 Change 6.57%
Apr-30-24 08:08AM
Apr-29-24 08:08AM
Apr-23-24 08:51AM
Apr-05-24 08:01AM
Mar-28-24 03:00PM
03:00PM
Loading…
Mar-26-24 03:00PM
08:01AM
Mar-22-24 03:00PM
Mar-21-24 03:00PM
Mar-16-24 01:49AM
Mar-07-24 09:45AM
Mar-06-24 11:04AM
08:48AM
Mar-05-24 08:45AM
Feb-27-24 10:30AM
10:30AM
Loading…
Feb-22-24 10:30AM
Feb-07-24 08:01AM
Jan-24-24 07:15AM
Jan-17-24 09:00AM
Jan-05-24 08:00AM
Dec-19-23 07:00AM
Dec-01-23 09:55AM
Nov-17-23 03:52PM
09:00AM
Nov-15-23 09:35AM
Nov-10-23 07:01AM
Nov-07-23 09:01AM
08:15AM
Oct-31-23 09:00AM
Oct-30-23 08:41AM
08:00AM
Loading…
Oct-24-23 08:00AM
Oct-19-23 08:35AM
Oct-17-23 09:00AM
08:01AM
Oct-12-23 09:20AM
Oct-10-23 11:15AM
08:01AM
Oct-03-23 08:01AM
Sep-28-23 08:01AM
Aug-21-23 09:55AM
Aug-15-23 10:20AM
Aug-08-23 08:00AM
Jul-11-23 08:00AM
Jul-10-23 08:00AM
Jun-20-23 08:00AM
Jun-07-23 08:00AM
May-08-23 08:00AM
May-01-23 06:45AM
Apr-27-23 04:10PM
Apr-24-23 09:06PM
09:00AM
Apr-20-23 08:00AM
Apr-18-23 08:52AM
Apr-12-23 02:17PM
08:00AM
Apr-11-23 02:43PM
08:00AM
Mar-24-23 04:30PM
Mar-13-23 10:04AM
Mar-07-23 08:00AM
Feb-13-23 12:07PM
Jan-17-23 10:00AM
08:00AM
Jan-05-23 08:00AM
Dec-20-22 08:00AM
Dec-13-22 08:00AM
Dec-12-22 08:00AM
Nov-22-22 08:00AM
Nov-15-22 08:00AM
Nov-09-22 04:15PM
Nov-08-22 03:40PM
Oct-12-22 07:30AM
Oct-06-22 08:00AM
Oct-04-22 07:30AM
Sep-30-22 09:00AM
Sep-29-22 09:01AM
Sep-08-22 08:00AM
Sep-06-22 08:00AM
Aug-30-22 11:07AM
Aug-22-22 08:00AM
Aug-02-22 08:00AM
Aug-01-22 03:30PM
Jul-27-22 07:52PM
MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Smith Stan Director Apr 25 '24 Buy 2.03 147,492 299,409 1,005,060 Apr 26 05:30 PM Louie Ngar Yee Director Apr 25 '24 Buy 2.03 19,665 39,920 1,167,189 Apr 26 05:33 PM Smith Stan Director Mar 14 '24 Buy 1.17 170,940 200,000 857,568 Mar 15 07:11 PM Louie Ngar Yee Director Mar 14 '24 Buy 1.17 170,940 200,000 1,147,524 Mar 15 07:09 PM Luput Cristian Director Mar 14 '24 Buy 1.17 69,282 81,060 367,350 Mar 15 07:08 PM CHAOUKI STEVEN M Director Mar 14 '24 Buy 1.17 34,641 40,530 88,891 Mar 18 05:34 PM Guerrero Ramiro Director Mar 14 '24 Buy 1.17 6,928 8,106 319,600 Mar 15 07:04 PM Guerrero Ramiro Director May 18 '23 Buy 2.47 1,200 2,964 312,672 May 22 06:49 AM Luput Cristian Director May 15 '23 Buy 2.63 3,000 7,890 298,068 May 17 06:55 AM
Index RUT P/E 14.94 EPS (ttm) 0.20 Insider Own 16.97% Shs Outstand 104.06M Perf Week -16.34%
Market Cap 308.13M Forward P/E 18.71 EPS next Y 0.16 Insider Trans 0.18% Shs Float 84.71M Perf Month -9.99%
Income 21.55M PEG 0.48 EPS next Q 0.06 Inst Own 43.95% Short Float 10.24% Perf Quarter -14.45%
Sales 703.37M P/S 0.44 EPS this Y 316.67% Inst Trans 20.05% Short Ratio 8.25 Perf Half Y -49.16%
Book/sh 3.02 P/B 1.00 EPS next Y -35.42% ROA 4.80% Short Interest 8.68M Perf Year -64.92%
Cash/sh 0.40 P/C 7.47 EPS next 5Y 31.07% ROE 7.31% 52W Range 2.78 - 10.82 Perf YTD -45.97%
Dividend Est. - P/FCF - EPS past 5Y - ROI 6.59% 52W High -72.09% Beta 0.93
Dividend TTM - Quick Ratio 2.09 Sales past 5Y 106.22% Gross Margin 30.41% 52W Low 8.63% ATR (14) 0.22
Dividend Ex-Date - Current Ratio 2.09 EPS Y/Y TTM 1.12% Oper. Margin 5.38% RSI (14) 33.03 Volatility 7.89% 5.84%
Employees 4100 Debt/Eq 0.17 Sales Y/Y TTM 61.46% Profit Margin 3.06% Recom 1.00 Target Price 6.21
Option/Short Yes / Yes LT Debt/Eq 0.05 EPS Q/Q 406.21% Payout 0.00% Rel Volume 1.40 Prev Close 3.08
Sales Surprise 2.20% EPS Surprise 23.92% Sales Q/Q 69.98% Earnings May 08 AMC Avg Volume 1.05M Price 3.02
SMA20 -12.58% SMA50 -17.95% SMA200 -43.19% Trades
Volume 1,477,157 Change -1.79%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-18-23 Initiated BTIG Research
Buy
$15
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$11
Apr-19-22 Initiated Deutsche Bank
Buy
$11
Jan-19-22 Initiated Stifel
Buy
$14
Dec-21-21 Initiated Canaccord Genuity
Buy
$13
Dec-07-21 Initiated Needham
Buy
$14
May-10-24 03:25PM
May-09-24 04:09AM
May-08-24 10:57PM
04:05PM
May-01-24 10:01AM
10:02AM
Loading…
Apr-29-24 10:02AM
Apr-25-24 11:07PM
Apr-22-24 07:35AM
Apr-10-24 02:13PM
Apr-02-24 11:00AM
Mar-20-24 07:35AM
Mar-14-24 07:35AM
Feb-29-24 09:33AM
Feb-28-24 04:47PM
04:05PM
07:35AM
Loading…
Feb-20-24 07:35AM
Feb-14-24 10:25AM
Feb-13-24 07:35AM
Feb-12-24 11:40AM
Feb-08-24 01:54PM
Feb-05-24 07:35AM
Feb-01-24 04:39PM
Jan-31-24 07:35AM
Jan-26-24 09:00PM
Jan-25-24 12:42PM
Jan-18-24 09:00PM
11:21AM
Jan-16-24 07:35AM
Jan-10-24 03:59PM
02:44PM
12:00PM
Loading…
12:00PM
Jan-09-24 07:35AM
Jan-04-24 01:04PM
(The Wall Street Journal)
Dec-21-23 07:35AM
Dec-19-23 07:45AM
Dec-12-23 09:51PM
Dec-01-23 07:20PM
Nov-28-23 07:15PM
Nov-08-23 02:26PM
08:00AM
07:35AM
Nov-06-23 10:15PM
04:33PM
04:05PM
Nov-04-23 08:00AM
Oct-23-23 07:35AM
Oct-18-23 07:35AM
Oct-17-23 05:34PM
Oct-13-23 09:00PM
Oct-11-23 07:35AM
Oct-09-23 07:35AM
Oct-04-23 07:35AM
Sep-28-23 07:35AM
Sep-18-23 08:15AM
Sep-05-23 07:35AM
Aug-15-23 07:35AM
Aug-11-23 06:03AM
Aug-07-23 04:05PM
Jul-31-23 07:35AM
Jul-26-23 01:30PM
Jul-24-23 07:35AM
Jul-20-23 07:35AM
Jun-14-23 07:35AM
May-24-23 07:30AM
May-08-23 04:05PM
May-05-23 07:35AM
May-03-23 02:00PM
May-02-23 07:35AM
Apr-25-23 07:37AM
07:35AM
Apr-04-23 07:35AM
Mar-31-23 07:00AM
(Investor's Business Daily)
Mar-28-23 07:30AM
Mar-13-23 04:06PM
04:05PM
Feb-27-23 07:35AM
Feb-21-23 07:35AM
Jan-12-23 07:35AM
Jan-03-23 07:35AM
Dec-29-22 07:35AM
Dec-19-22 07:35AM
Dec-06-22 07:35AM
Nov-22-22 07:35AM
Nov-14-22 07:35AM
Nov-11-22 07:35AM
Nov-09-22 09:15AM
Nov-07-22 04:35PM
Nov-02-22 07:35AM
Nov-01-22 07:35AM
Oct-26-22 04:35PM
07:35AM
Oct-20-22 07:35AM
Oct-12-22 06:19AM
Oct-11-22 07:35AM
Oct-04-22 07:35AM
Sep-20-22 07:35AM
Sep-07-22 07:35AM
Aug-29-22 08:00AM
Aug-16-22 07:35AM
Aug-15-22 07:35AM
DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services, Mobile Health Solutions, and Corporate. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The Corporate segment consists of information technology expenses. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
KATZ STEVEN Director Mar 15 '24 Buy 3.64 13,500 49,140 69,534 Mar 18 04:38 PM ROSENBERG NORMAN CFO and Treasurer Mar 14 '24 Buy 3.61 10,000 36,100 274,222 Mar 18 04:32 PM Burdiek Michael J Director Mar 14 '24 Buy 3.61 10,000 36,100 571,595 Mar 14 04:47 PM Burdiek Michael J Director Dec 15 '23 Option Exercise 0.00 23,088 0 561,595 Dec 18 05:11 PM TRAVERS JAMES M Director Dec 15 '23 Option Exercise 0.00 23,088 0 56,034 Dec 18 07:19 PM Sugrue Stephen Chief Compliance Officer Nov 28 '23 Sale 5.75 2,859 16,439 32,257 Nov 28 05:28 PM Bienstock Lee Chief Executive Officer Oct 16 '23 Sale 5.89 1,667 9,819 299,037 Oct 17 05:31 PM Tendler Ely D General Counsel and Secretary Oct 02 '23 Option Exercise 1.59 10,000 15,900 33,088 Oct 04 05:32 PM Tendler Ely D General Counsel and Secretary Oct 02 '23 Sale 5.29 10,000 52,900 23,088 Oct 04 05:32 PM Tendler Ely D General Counsel and Secretary Sep 15 '23 Option Exercise 1.59 10,000 15,900 33,088 Sep 19 05:33 PM Tendler Ely D General Counsel and Secretary Sep 15 '23 Sale 5.91 10,000 59,100 23,088 Sep 19 05:33 PM Bienstock Lee Chief Executive Officer Sep 15 '23 Sale 6.32 1,667 10,535 300,704 Sep 19 05:37 PM Capone Anthony Chief Executive Officer Sep 01 '23 Sale 9.00 2,000 18,000 404,275 Sep 06 09:51 PM Tendler Ely D General Counsel and Secretary Aug 22 '23 Option Exercise 1.59 10,000 15,900 33,088 Aug 24 05:02 PM Tendler Ely D General Counsel and Secretary Aug 22 '23 Sale 8.75 10,000 87,500 23,088 Aug 24 05:02 PM Capone Anthony Chief Executive Officer Aug 16 '23 Sale 10.01 15,000 150,150 406,275 Aug 17 04:30 PM Bienstock Lee President & COO Aug 16 '23 Sale 10.19 1,667 16,987 302,371 Aug 17 04:30 PM Oberholzer Adriaan Stephanus See Remarks Aug 15 '23 Sale 10.33 79,029 816,370 1,114,384 Aug 16 04:30 PM Oberholzer Adriaan Stephanus See Remarks Aug 14 '23 Sale 10.15 50,000 507,500 1,193,413 Aug 16 04:30 PM Capone Anthony Chief Executive Officer Jun 08 '23 Sale 9.50 5,400 51,300 421,275 Jun 09 04:30 PM Oberholzer Adriaan Stephanus See Remarks Jun 01 '23 Sale 9.07 42,497 385,448 1,243,413 Jun 01 07:09 PM Oberholzer Adriaan Stephanus See Remarks May 31 '23 Sale 9.01 22,366 201,518 1,285,910 Jun 01 07:09 PM Oberholzer Adriaan Stephanus See Remarks May 30 '23 Sale 9.02 16,271 146,764 1,308,276 Jun 01 07:09 PM Oberholzer Adriaan Stephanus See Remarks May 25 '23 Sale 9.07 300 2,721 1,324,547 May 25 06:48 PM Oberholzer Adriaan Stephanus See Remarks May 24 '23 Sale 9.14 40,000 365,600 1,324,847 May 25 06:48 PM Oberholzer Adriaan Stephanus See Remarks May 23 '23 Sale 9.11 7,595 69,190 1,364,847 May 25 06:48 PM Sugrue Stephen Chief Compliance Officer May 19 '23 Option Exercise 3.25 16,129 52,419 32,257 May 23 04:01 PM TRAVERS JAMES M Director May 17 '23 Sale 8.51 65,000 553,150 391,028 May 18 04:30 PM TRAVERS JAMES M Director May 16 '23 Sale 8.55 60,000 513,000 456,028 May 18 04:30 PM
Index - P/E - EPS (ttm) -0.76 Insider Own 24.72% Shs Outstand 9.38M Perf Week 7.60%
Market Cap 25.77M Forward P/E - EPS next Y -0.20 Insider Trans 2.91% Shs Float 7.21M Perf Month 3.46%
Income -7.04M PEG - EPS next Q -0.11 Inst Own 9.10% Short Float 1.82% Perf Quarter 258.62%
Sales 36.02M P/S 0.72 EPS this Y 74.92% Inst Trans -36.90% Short Ratio 0.23 Perf Half Y 216.40%
Book/sh 1.33 P/B 2.02 EPS next Y 26.83% ROA -33.03% Short Interest 0.13M Perf Year 186.17%
Cash/sh 0.76 P/C 3.54 EPS next 5Y 30.00% ROE -45.11% 52W Range 0.65 - 3.48 Perf YTD 195.60%
Dividend Est. - P/FCF - EPS past 5Y -0.81% ROI -54.59% 52W High -22.67% Beta 2.06
Dividend TTM - Quick Ratio 2.19 Sales past 5Y 38.09% Gross Margin 34.43% 52W Low 313.85% ATR (14) 0.27
Dividend Ex-Date - Current Ratio 3.37 EPS Y/Y TTM 77.14% Oper. Margin -20.78% RSI (14) 59.10 Volatility 10.51% 10.85%
Employees 27 Debt/Eq 0.03 Sales Y/Y TTM 4.10% Profit Margin -19.53% Recom 1.00 Target Price 4.33
Option/Short No / Yes LT Debt/Eq 0.02 EPS Q/Q 75.97% Payout - Rel Volume 0.39 Prev Close 2.77
Sales Surprise 9.14% EPS Surprise 45.00% Sales Q/Q 22.14% Earnings May 08 AMC Avg Volume 574.10K Price 2.69
SMA20 17.85% SMA50 24.88% SMA200 115.84% Trades
Volume 224,845 Change -2.89%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-12-21 Downgrade ROTH Capital
Buy → Neutral
$43 → $23
Oct-19-20 Initiated ROTH Capital
Buy
$57
Oct-19-20 Initiated Canaccord Genuity
Buy
$70
May-09-24 02:10PM
(Thomson Reuters StreetEvents)
01:36PM
05:01AM
May-08-24 05:15PM
04:00PM
05:00PM
Loading…
Apr-24-24 05:00PM
Apr-10-24 01:42PM
Apr-01-24 08:50AM
Mar-20-24 09:55AM
Mar-19-24 12:08AM
Mar-18-24 09:15AM
Mar-15-24 08:50AM
Mar-13-24 09:04AM
(Insider Monkey) +104.30%
07:36AM
(Thomson Reuters StreetEvents)
Mar-12-24 05:47PM
07:00PM
Loading…
Feb-29-24 07:00PM
Dec-26-23 08:50AM
Dec-05-23 09:40AM
08:50AM
Nov-13-23 09:57AM
Nov-08-23 05:00PM
Nov-03-23 09:00AM
Oct-26-23 05:00PM
Sep-28-23 08:50AM
Sep-19-23 09:40AM
Sep-01-23 09:40AM
Aug-28-23 09:07AM
Aug-16-23 09:40AM
Aug-10-23 10:38AM
(Thomson Reuters StreetEvents) -8.91%
Aug-09-23 05:50PM
04:30PM
Loading…
04:30PM
04:15PM
Aug-08-23 07:15PM
Jul-26-23 12:39PM
Jul-10-23 07:24AM
May-22-23 09:55AM
May-10-23 06:25PM
May-09-23 05:45PM
Apr-27-23 05:57PM
Mar-17-23 05:00AM
Mar-14-23 06:15PM
04:15PM
Mar-13-23 08:15AM
Mar-08-23 08:15AM
Mar-02-23 04:35PM
08:05AM
Feb-28-23 08:15AM
08:00AM
Nov-30-22 07:56AM
Nov-10-22 06:25PM
04:05PM
Nov-09-22 08:05AM
Nov-04-22 08:05AM
Oct-27-22 04:05PM
Oct-13-22 10:35AM
(American City Business Journals)
Oct-12-22 04:05PM
Aug-17-22 03:07PM
(American City Business Journals) +22.67%
08:05AM
08:00AM
Aug-10-22 05:45PM
04:05PM
Aug-09-22 09:15AM
Aug-08-22 04:05PM
Aug-05-22 09:46AM
Jul-27-22 04:05PM
Jul-14-22 08:30AM
May-19-22 05:42PM
(American City Business Journals)
May-18-22 07:31AM
May-12-22 05:55PM
04:05PM
May-10-22 06:15PM
May-02-22 06:05PM
Apr-28-22 04:05PM
Apr-27-22 08:25AM
Apr-26-22 08:00AM
Apr-04-22 04:00PM
Mar-30-22 08:02PM
Mar-18-22 01:34PM
Mar-08-22 05:35PM
04:05PM
Mar-01-22 03:00PM
Feb-25-22 02:30PM
10:47AM
(American City Business Journals)
Feb-10-22 09:15AM
Feb-08-22 07:45AM
Feb-02-22 05:43PM
(American City Business Journals) -10.48%
05:58AM
Jan-31-22 04:05PM
Dec-10-21 08:00AM
Nov-10-21 06:35PM
04:05PM
Nov-03-21 03:01PM
Oct-27-21 04:10PM
Oct-22-21 06:00AM
Sep-29-21 03:24PM
Sep-27-21 04:15PM
Aug-24-21 10:18AM
Aug-11-21 04:16PM
04:15PM
Aug-03-21 01:34PM
Laird Superfood, Inc. engages in the manufacturing and marketing of plant-based and functional foods. Its products include creamers, coffees, instafuels, functional mushroom blends, active mixes, hydrate coconut waters, renew plant-based protein, and harvest snacks. The company was founded by Laird Hamilton and Paul W. Hodge Jr. in June 2015 and is headquartered in Boulder, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Barker Geoffrey T Director Mar 15 '24 Buy 2.79 50,000 139,469 179,057 Mar 18 04:37 PM Naylor Maile Director Mar 15 '24 Buy 2.27 8,850 20,049 91,807 Mar 18 04:29 PM Hamill Anna Chief Financial Officer Mar 15 '24 Buy 2.03 4,600 9,338 108,534 Mar 18 04:22 PM Gaston Patrick Director Mar 15 '24 Buy 2.61 2,000 5,229 57,718 Mar 18 04:25 PM Vieth Jason D. Chief Executive Officer Mar 15 '24 Buy 2.82 1,611 4,543 1,611 Mar 18 04:27 PM
Index RUT P/E - EPS (ttm) -0.65 Insider Own 31.77% Shs Outstand 121.83M Perf Week -7.61%
Market Cap 241.09M Forward P/E - EPS next Y -0.81 Insider Trans 0.19% Shs Float 96.76M Perf Month -6.59%
Income -91.82M PEG - EPS next Q -0.19 Inst Own 30.94% Short Float 7.96% Perf Quarter 10.39%
Sales 1.28M P/S 188.35 EPS this Y -6.12% Inst Trans -1.77% Short Ratio 10.20 Perf Half Y 37.10%
Book/sh 1.79 P/B 0.95 EPS next Y -11.80% ROA -28.67% Short Interest 7.70M Perf Year 4.29%
Cash/sh 1.66 P/C 1.02 EPS next 5Y - ROE -30.98% 52W Range 1.12 - 3.90 Perf YTD -15.42%
Dividend Est. - P/FCF - EPS past 5Y - ROI -34.44% 52W High -56.42% Beta 3.10
Dividend TTM - Quick Ratio 30.03 Sales past 5Y 0.00% Gross Margin -322.41% 52W Low 51.79% ATR (14) 0.13
Dividend Ex-Date - Current Ratio 30.65 EPS Y/Y TTM 25.10% Oper. Margin -7897.90% RSI (14) 47.38 Volatility 5.99% 7.33%
Employees 165 Debt/Eq 0.06 Sales Y/Y TTM 405.91% Profit Margin -7145.76% Recom 2.00 Target Price 2.75
Option/Short Yes / Yes LT Debt/Eq 0.05 EPS Q/Q 18.36% Payout - Rel Volume 0.74 Prev Close 1.83
Sales Surprise 7.15% EPS Surprise 30.00% Sales Q/Q 79.92% Earnings May 09 AMC Avg Volume 754.90K Price 1.70
SMA20 0.62% SMA50 -4.63% SMA200 -6.19% Trades
Volume 562,291 Change -7.10%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-08-23 Initiated H.C. Wainwright
Buy
$3
Sep-25-23 Downgrade Canaccord Genuity
Buy → Hold
$3.50 → $2
Oct-20-21 Initiated Canaccord Genuity
Buy
$13
May-09-24 04:01PM
Apr-30-24 08:30AM
Apr-18-24 04:05PM
Mar-21-24 04:05PM
Mar-07-24 12:01PM
04:05PM
Loading…
Feb-29-24 04:05PM
Feb-27-24 08:30AM
Feb-09-24 08:00AM
Feb-05-24 08:00AM
Jan-18-24 08:30AM
Dec-12-23 08:30AM
Nov-15-23 08:30AM
Nov-11-23 09:18AM
Nov-09-23 04:05PM
Nov-08-23 08:15AM
08:30AM
Loading…
Nov-01-23 08:30AM
Oct-31-23 08:00AM
Oct-17-23 08:30AM
Oct-05-23 06:36PM
08:00AM
Oct-03-23 08:00AM
Sep-21-23 08:00AM
Aug-22-23 07:05AM
Aug-16-23 04:00PM
Aug-14-23 06:02PM
Aug-07-23 08:00AM
Jul-26-23 08:00AM
Jul-18-23 04:00PM
Jun-21-23 08:00AM
Jun-07-23 08:00AM
08:00AM
Loading…
May-25-23 08:00AM
May-22-23 08:00AM
May-15-23 08:00AM
May-11-23 04:00PM
May-02-23 08:00AM
Apr-24-23 08:00AM
Apr-20-23 08:00AM
Apr-14-23 08:00AM
Mar-24-23 08:00AM
Mar-06-23 08:00AM
Feb-17-23 08:00AM
Feb-13-23 04:00PM
Jan-09-23 08:00AM
08:00AM
08:00AM
Dec-22-22 04:05PM
Dec-20-22 08:00AM
Dec-08-22 08:00AM
Nov-07-22 04:05PM
Nov-03-22 04:00PM
Oct-17-22 04:05PM
Oct-13-22 02:00PM
Oct-04-22 08:00AM
Aug-26-22 08:00AM
Aug-08-22 04:02PM
Jul-29-22 08:30AM
Jul-18-22 04:42PM
Jun-22-22 08:45AM
Jun-16-22 04:30PM
Jun-01-22 08:45AM
May-25-22 08:00AM
May-17-22 11:00AM
May-10-22 08:00AM
May-09-22 04:05PM
04:01PM
Apr-18-22 04:13PM
Mar-28-22 04:05PM
Mar-14-22 12:39PM
Feb-28-22 04:05PM
Feb-18-22 09:21AM
Feb-14-22 04:05PM
Feb-07-22 04:05PM
Jan-10-22 04:10PM
Jan-04-22 08:00AM
Dec-21-21 08:00AM
Dec-14-21 09:25AM
Dec-02-21 10:15AM
Nov-10-21 04:05PM
Nov-09-21 08:00AM
Nov-04-21 04:05PM
Oct-19-21 04:15PM
Sep-21-21 04:15PM
Sep-13-21 11:26AM
Aug-16-21 04:05PM
Aug-11-21 07:00AM
Jul-27-21 08:30AM
Jun-24-21 04:05PM
Quantum-Si, Inc. engages in the development of a proprietary universal single-molecule detection platform to enable Next-Generation Protein Sequencing, the ability to sequence proteins in a massively parallel fashion. It can be used for the study of nucleic acids. Its platform includes Carbon automated sample preparation instrument, Platinum NGPS instrument, Quantum-Si Cloud software service, and reagent kits and chips for use with its instruments. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Branford, CT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LaPointe Christian General Counsel & Corp. Secr. Mar 15 '24 Buy 1.74 10,000 17,400 257,693 Mar 18 08:07 AM Hawkins Jeffrey Alan President & CEO Mar 14 '24 Buy 1.76 25,000 44,000 25,000 Mar 18 08:21 AM Keyes Jeffry R. Chief Financial Officer Mar 05 '24 Buy 1.61 50,000 80,500 50,000 Mar 06 05:09 PM
Index RUT P/E - EPS (ttm) -0.34 Insider Own 18.11% Shs Outstand 172.08M Perf Week -0.32%
Market Cap 545.76M Forward P/E 9.77 EPS next Y 0.32 Insider Trans 0.04% Shs Float 141.44M Perf Month 12.86%
Income -58.26M PEG - EPS next Q 0.05 Inst Own 71.23% Short Float 2.36% Perf Quarter 0.96%
Sales 819.84M P/S 0.67 EPS this Y 22.62% Inst Trans 17.30% Short Ratio 7.07 Perf Half Y 56.44%
Book/sh 2.63 P/B 1.20 EPS next Y 25.57% ROA -5.13% Short Interest 3.33M Perf Year 20.15%
Cash/sh 0.18 P/C 17.65 EPS next 5Y 20.00% ROE -12.98% 52W Range 1.78 - 3.65 Perf YTD 8.97%
Dividend Est. - P/FCF 69.17 EPS past 5Y 12.07% ROI -12.63% 52W High -13.42% Beta 1.11
Dividend TTM - Quick Ratio 0.57 Sales past 5Y 9.05% Gross Margin 47.64% 52W Low 77.53% ATR (14) 0.15
Dividend Ex-Date - Current Ratio 0.73 EPS Y/Y TTM 19.49% Oper. Margin 1.54% RSI (14) 57.19 Volatility 3.01% 5.05%
Employees 3107 Debt/Eq 0.66 Sales Y/Y TTM -1.55% Profit Margin -7.11% Recom 1.40 Target Price 6.00
Option/Short Yes / Yes LT Debt/Eq 0.09 EPS Q/Q 22.53% Payout - Rel Volume 0.33 Prev Close 3.23
Sales Surprise -2.42% EPS Surprise 0.00% Sales Q/Q -3.49% Earnings Apr 24 BMO Avg Volume 471.61K Price 3.16
SMA20 7.06% SMA50 6.42% SMA200 15.06% Trades
Volume 154,849 Change -2.17%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-29-24 Resumed JMP Securities
Mkt Outperform
$6
Jul-19-23 Initiated Craig Hallum
Buy
$5.50
Apr-10-23 Initiated JMP Securities
Mkt Outperform
$6
Jan-19-22 Resumed Northland Capital
Outperform
$10
Jan-26-21 Initiated B. Riley Securities
Buy
$10
Jun-15-20 Upgrade Northland Capital
Market Perform → Outperform
Nov-14-19 Downgrade National Securities
Buy → Neutral
$8 → $3.50
Oct-31-19 Downgrade Northland Capital
Outperform → Market Perform
$9 → $6
Apr-29-24 08:00AM
Apr-25-24 09:58AM
Apr-24-24 11:23PM
(Thomson Reuters StreetEvents) +26.46%
04:22PM
09:32AM
09:10AM
Loading…
09:10AM
08:12AM
(Associated Press Finance)
08:00AM
07:00AM
Apr-17-24 09:00AM
Apr-11-24 04:00PM
Mar-19-24 08:00AM
Mar-18-24 11:00AM
Mar-01-24 05:00PM
Feb-28-24 11:26PM
08:00AM
Loading…
Feb-23-24 08:00AM
Feb-15-24 10:11AM
Feb-14-24 05:15PM
05:15PM
04:23PM
(Associated Press Finance)
04:03PM
Feb-13-24 01:51PM
Feb-08-24 08:00AM
Jan-31-24 04:01PM
Jan-25-24 08:00AM
Dec-14-23 08:00AM
Dec-13-23 08:00AM
Dec-12-23 08:00AM
Nov-08-23 08:00AM
Nov-07-23 08:00AM
02:13AM
Loading…
Oct-30-23 02:13AM
Oct-26-23 10:25AM
(Thomson Reuters StreetEvents)
08:50AM
Oct-25-23 06:00PM
05:30PM
04:28PM
(Associated Press Finance)
04:03PM
Oct-23-23 08:00AM
Oct-20-23 10:15AM
Oct-11-23 04:00PM
Sep-13-23 08:00AM
Aug-24-23 08:00AM
Aug-23-23 08:00AM
Aug-22-23 08:00AM
Jul-27-23 10:43AM
(Thomson Reuters StreetEvents)
Jul-26-23 05:25PM
04:17PM
(Associated Press Finance)
04:03PM
01:30PM
Jul-25-23 08:58PM
08:00AM
Jul-19-23 08:00AM
Jul-18-23 10:25AM
08:00AM
Jul-17-23 08:00AM
Jul-12-23 04:00PM
Jul-10-23 08:00AM
Jul-03-23 06:30AM
Jun-12-23 09:15AM
Jun-08-23 08:00AM
Jun-05-23 09:38AM
08:00AM
May-26-23 01:35PM
May-25-23 07:12PM
08:00AM
May-22-23 09:15AM
May-17-23 08:00AM
May-15-23 08:00AM
May-03-23 01:06PM
May-02-23 09:35AM
Apr-27-23 09:33AM
(Thomson Reuters StreetEvents) +11.52%
Apr-26-23 05:25PM
04:03PM
08:00AM
Apr-25-23 10:28AM
Apr-24-23 08:00AM
06:57AM
Apr-19-23 10:00AM
Apr-18-23 04:00PM
10:00AM
Apr-17-23 10:00AM
Apr-11-23 03:05PM
Apr-04-23 07:08AM
Mar-30-23 04:05PM
Mar-27-23 11:00AM
(Simply Wall St.) -14.97%
08:00AM
Mar-24-23 04:45PM
Mar-13-23 04:38PM
Mar-09-23 05:05AM
Mar-06-23 12:39PM
08:00AM
Feb-27-23 01:00AM
Feb-18-23 07:41AM
Feb-16-23 06:18PM
01:06PM
Feb-15-23 05:45PM
04:03PM
Feb-14-23 04:30PM
Feb-09-23 08:00AM
Feb-01-23 08:00AM
Ribbon Communications, Inc. delivers communications software, IP and optical networking solutions to service providers, enterprises, and infrastructure sectors. It operates through the Cloud and Edge, and IP Optical Networks segments. The Cloud and Edge segment provides secure and reliable software and hardware products, solutions, and services for enabling Voice over Internet Protocol (VoIP) communications, Voice over Long-Term Evolution (VoLTE) and Voice Over 5G (VoNR) communications, and Unified Communications and Collaboration (UC&C) within service provider and enterprise networks and from the cloud. The IP Optical Networks segment provides secure, and reliable hardware and software products solutions for IP networking, switching, routing, and optical transport designed to support and enable technologies like 5G, distributed cloud computing and corresponding applications by delivering ultra-low cost-per-bit transport and multi-service flexibility. The company was founded in 1997 and is headquartered in Plano, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GRAYSON BRUNS H Director Mar 15 '24 Buy 2.89 100,000 289,000 590,175 Mar 18 07:57 AM LOPEZ MIGUEL A EVP, CFO Mar 15 '24 Buy 2.90 2,000 5,798 280,875 Mar 18 07:57 AM LOPEZ MIGUEL A EVP, CFO Mar 05 '24 Buy 2.98 1,000 2,979 278,875 Mar 06 08:42 AM LOPEZ MIGUEL A EVP, CFO Mar 05 '24 Buy 2.88 1,000 2,880 276,875 Mar 05 04:56 PM LOPEZ MIGUEL A EVP, CFO Mar 04 '24 Buy 2.92 1,000 2,917 277,875 Mar 06 08:42 AM McClelland Bruce William President & CEO Mar 01 '24 Buy 3.02 9,900 29,901 1,161,863 Mar 01 04:16 PM Macken Patrick W EVP, CLO & Secretary Feb 28 '24 Sale 3.07 42,094 129,102 161,948 Mar 01 04:15 PM Redington Dan EVP, Global Sales Feb 26 '24 Sale 3.10 34,452 106,660 66,839 Feb 28 04:39 PM Redington Dan EVP, Global Sales Feb 23 '24 Sale 3.09 23,964 74,116 101,291 Feb 23 08:09 PM Redington Dan EVP, Global Sales Feb 21 '24 Sale 3.20 7,584 24,270 125,255 Feb 23 08:09 PM Macken Patrick W EVP, CLO & Secretary Jan 18 '24 Option Exercise 0.00 40,983 0 223,332 Jan 19 04:56 PM Bucci Sam EVP & COO Jan 18 '24 Option Exercise 0.00 81,967 0 310,271 Jan 19 04:56 PM Marmurek Eric S SVP, Finance & CAO Jan 18 '24 Option Exercise 0.00 15,000 0 252,143 Jan 19 04:55 PM Redington Dan EVP, Global Sales Dec 15 '23 Option Exercise 0.00 175,596 0 175,596 Dec 18 04:46 PM LOPEZ MIGUEL A EVP, CFO Dec 08 '23 Buy 2.19 3,526 7,708 247,691 Dec 11 07:53 AM LOPEZ MIGUEL A EVP, CFO Dec 07 '23 Buy 2.19 2,000 4,390 244,165 Dec 11 07:53 AM Marmurek Eric S SVP, Finance & CAO Oct 18 '23 Option Exercise 0.00 13,355 0 240,394 Oct 23 08:36 AM Macken Patrick W EVP, CLO & Secretary Oct 18 '23 Option Exercise 0.00 21,367 0 190,462 Oct 23 08:36 AM Bucci Sam EVP & COO Oct 18 '23 Option Exercise 0.00 26,709 0 242,601 Oct 23 08:36 AM Marmurek Eric S SVP, Finance & CAO Sep 15 '23 Option Exercise 0.00 4,117 0 228,041 Sep 19 05:01 PM Bucci Sam EVP & COO Sep 15 '23 Option Exercise 0.00 24,670 0 229,097 Sep 19 05:01 PM Macken Patrick W EVP, CLO & Secretary Sep 15 '23 Option Exercise 0.00 7,964 0 171,530 Sep 19 05:02 PM Macken Patrick W EVP, CLO & Secretary Jun 19 '23 Option Exercise 0.00 25,000 0 173,653 Jun 20 04:10 PM Marmurek Eric S SVP, Finance & CAO Jun 16 '23 Option Exercise 0.00 48,231 0 234,749 Jun 20 04:10 PM
Index - P/E - EPS (ttm) -0.35 Insider Own 4.75% Shs Outstand 31.15M Perf Week 2.04%
Market Cap 95.70M Forward P/E - EPS next Y -0.45 Insider Trans 3.77% Shs Float 30.39M Perf Month -6.83%
Income -10.74M PEG - EPS next Q -0.11 Inst Own 14.62% Short Float 2.08% Perf Quarter -33.48%
Sales 0.21M P/S 455.71 EPS this Y -37.50% Inst Trans 6.50% Short Ratio 5.25 Perf Half Y 5.26%
Book/sh 0.77 P/B 3.87 EPS next Y -2.27% ROA -40.03% Short Interest 0.63M Perf Year -20.84%
Cash/sh 0.75 P/C 4.02 EPS next 5Y - ROE -41.01% 52W Range 2.75 - 5.13 Perf YTD -22.68%
Dividend Est. - P/FCF - EPS past 5Y 16.79% ROI -43.48% 52W High -41.52% Beta 0.89
Dividend TTM - Quick Ratio 15.19 Sales past 5Y -55.51% Gross Margin 77.14% 52W Low 9.09% ATR (14) 0.19
Dividend Ex-Date - Current Ratio 15.19 EPS Y/Y TTM 12.81% Oper. Margin -5744.76% RSI (14) 46.65 Volatility 5.06% 5.58%
Employees 5 Debt/Eq 0.01 Sales Y/Y TTM - Profit Margin -5116.19% Recom 1.00 Target Price 12.00
Option/Short Yes / Yes LT Debt/Eq 0.00 EPS Q/Q -37.82% Payout - Rel Volume 0.97 Prev Close 2.87
Sales Surprise - EPS Surprise - Sales Q/Q - Earnings - Avg Volume 120.41K Price 3.00
SMA20 -1.72% SMA50 -7.13% SMA200 -15.70% Trades
Volume 117,105 Change 4.53%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-23-22 Initiated Chardan Capital Markets
Buy
$8
Apr-12-21 Initiated H.C. Wainwright
Buy
$11
May-09-24 04:21AM
(Pharmaceutical Technology)
May-08-24 08:25AM
May-07-24 09:15AM
May-06-24 08:05AM
Apr-30-24 07:45AM
08:20AM
Loading…
Apr-18-24 08:20AM
Mar-14-24 08:45AM
Mar-11-24 08:00AM
Feb-12-24 07:30AM
Jan-29-24 08:50AM
Jan-23-24 07:55AM
Jan-16-24 08:47AM
Jan-10-24 09:00AM
Dec-14-23 07:15AM
Dec-11-23 12:26PM
06:00PM
Loading…
Dec-06-23 06:00PM
04:05PM
Nov-27-23 08:30AM
Oct-31-23 08:30AM
Oct-30-23 07:38AM
Oct-23-23 08:30AM
Oct-20-23 05:36AM
Oct-13-23 09:55AM
08:30AM
Oct-12-23 11:08AM
Oct-03-23 08:30AM
Sep-21-23 12:00PM
Sep-19-23 08:30AM
Sep-11-23 10:11PM
Aug-31-23 08:30AM
08:30AM
Loading…
Aug-28-23 08:30AM
Aug-14-23 08:30AM
Aug-10-23 09:30AM
Aug-07-23 08:30AM
Jul-27-23 08:30AM
Jul-24-23 10:44AM
Jul-21-23 12:05PM
Jul-14-23 10:56AM
Jul-13-23 07:08AM
Jul-11-23 10:24AM
08:30AM
Jul-07-23 10:42AM
Jun-22-23 12:00PM
May-22-23 08:30AM
Apr-25-23 09:40AM
Apr-18-23 11:43AM
Apr-17-23 03:27PM
01:35PM
Apr-14-23 08:50AM
Apr-03-23 08:47AM
Mar-27-23 08:30AM
Mar-13-23 08:30AM
Mar-02-23 08:30AM
Feb-27-23 08:30AM
Feb-21-23 08:30AM
Jan-24-23 07:59AM
Dec-28-22 10:39AM
06:11AM
Dec-19-22 08:30AM
Dec-08-22 08:30AM
Nov-08-22 08:30AM
Oct-31-22 08:30AM
Oct-26-22 08:30AM
Oct-25-22 07:51AM
Oct-10-22 08:30AM
Sep-12-22 08:30AM
Aug-31-22 08:30AM
Aug-15-22 08:30AM
Jul-21-22 08:30AM
Jun-21-22 08:30AM
May-18-22 06:16AM
May-05-22 08:30AM
May-02-22 09:40AM
Apr-28-22 08:30AM
Apr-06-22 08:30AM
Mar-30-22 12:45PM
Mar-17-22 08:30AM
Jan-25-22 08:30AM
Jan-24-22 08:30AM
Dec-16-21 08:30AM
Dec-09-21 04:38AM
Dec-08-21 07:47AM
Dec-07-21 08:30AM
Oct-26-21 08:35AM
Oct-06-21 08:30AM
Oct-01-21 08:30AM
Sep-27-21 02:01PM
Sep-14-21 08:31AM
Sep-08-21 08:30AM
Sep-07-21 08:30AM
Aug-31-21 11:08AM
Aug-30-21 08:30AM
Aug-25-21 03:14PM
08:30AM
Aug-23-21 08:30AM
Aug-18-21 08:30AM
Jun-12-21 03:12AM
May-26-21 08:30AM
May-20-21 08:30AM
May-07-21 08:30AM
Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, and Other. The CAR-T Therapeutics segment involves the development of immuno-therapy drugs against cancer. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Titterton Lewis H jr Director Apr 09 '24 Buy 3.28 15,009 49,230 838,037 Apr 10 09:44 AM KUMAR AMIT Chief Executive Officer Mar 15 '24 Buy 3.22 30,000 96,600 491,925 Mar 15 10:49 AM Baskies Arnold M Director Mar 15 '24 Buy 3.63 10,000 36,300 110,000 Mar 15 02:15 PM Titterton Lewis H jr Director Oct 10 '23 Option Exercise 2.58 16,000 41,200 823,028 Oct 11 10:35 AM KUMAR AMIT Chief Executive Officer Jul 31 '23 Sale 3.57 11,800 42,126 461,925 Jul 31 06:34 PM KUMAR AMIT Chief Executive Officer Jul 28 '23 Option Exercise 2.58 40,000 103,000 502,100 Jul 31 06:34 PM Titterton Lewis H jr Director Jul 27 '23 Option Exercise 2.58 120,000 309,000 894,070 Jul 31 06:36 PM Catelani Michael President, COO & CFO Jul 20 '23 Buy 3.64 5,500 20,020 26,655 Jul 21 10:06 AM
Index RUT P/E - EPS (ttm) -8.85 Insider Own 2.07% Shs Outstand 212.11M Perf Week 5.85%
Market Cap 222.88M Forward P/E 1.92 EPS next Y 0.55 Insider Trans 15.70% Shs Float 207.88M Perf Month -7.08%
Income -1876.00M PEG - EPS next Q -0.07 Inst Own 82.18% Short Float 5.74% Perf Quarter -51.83%
Sales 5.87B P/S 0.04 EPS this Y -111.83% Inst Trans -0.33% Short Ratio 3.39 Perf Half Y -33.12%
Book/sh -15.70 P/B - EPS next Y 822.02% ROA -15.31% Short Interest 11.94M Perf Year -75.52%
Cash/sh 1.68 P/C 0.62 EPS next 5Y - ROE -1838.38% 52W Range 0.86 - 6.64 Perf YTD -62.77%
Dividend Est. - P/FCF 1.97 EPS past 5Y - ROI -25.96% 52W High -84.20% Beta 1.98
Dividend TTM - Quick Ratio 1.30 Sales past 5Y 10.02% Gross Margin 28.43% 52W Low 22.09% ATR (14) 0.13
Dividend Ex-Date - Current Ratio 2.30 EPS Y/Y TTM -53.25% Oper. Margin 5.04% RSI (14) 48.86 Volatility 13.97% 11.96%
Employees 20000 Debt/Eq - Sales Y/Y TTM -34.76% Profit Margin -31.95% Recom 3.33 Target Price 1.21
Option/Short Yes / Yes LT Debt/Eq - EPS Q/Q -3055.89% Payout - Rel Volume 0.51 Prev Close 1.11
Sales Surprise 9.53% EPS Surprise 63.96% Sales Q/Q -41.62% Earnings May 09 BMO Avg Volume 3.53M Price 1.05
SMA20 6.57% SMA50 -9.23% SMA200 -53.91% Trades
Volume 1,805,070 Change -5.41%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-04-24 Downgrade JP Morgan
Neutral → Underweight
Mar-01-24 Downgrade Northland Capital
Outperform → Market Perform
Jan-22-24 Downgrade BofA Securities
Neutral → Underperform
$2
Nov-16-23 Upgrade Raymond James
Underperform → Mkt Perform
Nov-10-23 Downgrade BofA Securities
Buy → Neutral
$2.25 → $1.75
Jul-24-23 Downgrade Credit Suisse
Outperform → Neutral
$11 → $5.10
Jul-18-23 Downgrade Deutsche Bank
Buy → Hold
$8 → $6
May-05-23 Upgrade Northland Capital
Market Perform → Outperform
$7
Apr-17-23 Downgrade Jefferies
Buy → Hold
$15 → $5.50
Jan-12-23 Upgrade BofA Securities
Underperform → Buy
$8 → $15
Oct-04-22 Upgrade Credit Suisse
Neutral → Outperform
$11 → $17
Aug-05-22 Downgrade Morgan Stanley
Overweight → Equal-Weight
$9 → $11
Apr-11-22 Downgrade Raymond James
Mkt Perform → Underperform
Apr-01-22 Downgrade Goldman
Buy → Neutral
$18 → $9
Mar-25-22 Downgrade BofA Securities
Neutral → Underperform
$12 → $8
Jan-10-22 Downgrade Evercore ISI
Outperform → In-line
$12
Dec-13-21 Downgrade JP Morgan
Overweight → Neutral
$15 → $13
Dec-07-21 Upgrade Jefferies
Hold → Buy
$11 → $15
Oct-05-21 Downgrade Credit Suisse
Outperform → Neutral
$23 → $12
Sep-23-21 Downgrade BofA Securities
Buy → Neutral
$15
Show Previous Ratings
May-10-24 03:48PM
03:31PM
09:39AM
02:03AM
(Thomson Reuters StreetEvents)
May-09-24 03:57PM
10:53AM
Loading…
10:53AM
09:30AM
07:32AM
(Associated Press Finance)
06:30AM
May-08-24 09:15AM
Apr-17-24 07:47PM
11:52AM
Apr-16-24 08:15AM
08:05AM
Apr-15-24 08:05AM
08:05AM
Loading…
Apr-09-24 08:05AM
Mar-14-24 07:00PM
Mar-07-24 08:05AM
Mar-01-24 09:37AM
08:37AM
Feb-29-24 11:40PM
(Thomson Reuters StreetEvents) -37.03%
09:30AM
07:55AM
(Associated Press Finance)
07:54AM
07:30AM
Feb-27-24 08:05AM
Feb-26-24 09:15AM
Feb-22-24 10:00AM
08:05AM
Feb-21-24 08:05AM
12:56PM
Loading…
Feb-08-24 12:56PM
08:05AM
Feb-06-24 04:15PM
Jan-31-24 10:46AM
Jan-30-24 08:05AM
Jan-10-24 08:27AM
Jan-09-24 04:15PM
Jan-08-24 09:00AM
Dec-21-23 06:54PM
08:05AM
Dec-08-23 04:09AM
Nov-16-23 11:18PM
Nov-14-23 03:08PM
Nov-10-23 02:58PM
08:41AM
Nov-09-23 11:24PM
(Thomson Reuters StreetEvents)
09:30AM
07:50AM
07:14AM
06:55AM
(Associated Press Finance)
06:30AM
Nov-08-23 11:23AM
Nov-06-23 08:05AM
Nov-02-23 10:00AM
Oct-30-23 01:46PM
11:59AM
08:05AM
Oct-24-23 06:34PM
Oct-17-23 08:05AM
08:04AM
Oct-16-23 04:15PM
Oct-13-23 08:05AM
Oct-12-23 08:00AM
Oct-10-23 08:05AM
Oct-05-23 08:56PM
Oct-03-23 08:30AM
07:42AM
04:02AM
03:46AM
03:19AM
Sep-15-23 08:05AM
Sep-11-23 08:05AM
Aug-10-23 08:05AM
Aug-05-23 04:49AM
Aug-04-23 01:33PM
Aug-03-23 11:30AM
08:05AM
06:56AM
06:30AM
Jul-26-23 08:00AM
Jul-25-23 02:25PM
(American City Business Journals)
Jul-19-23 01:08AM
Jul-11-23 05:00PM
Jun-28-23 07:19AM
Jun-27-23 12:27PM
Jun-26-23 06:38PM
08:05AM
Jun-22-23 08:32AM
Jun-21-23 10:16AM
Jun-20-23 08:00AM
Jun-15-23 08:00AM
Jun-02-23 05:00AM
Jun-01-23 08:26AM
May-24-23 12:01AM
12:01AM
May-19-23 01:34PM
May-18-23 08:00AM
May-14-23 08:15AM
May-11-23 02:00PM
May-10-23 08:05AM
CommScope Holding Co., Inc. engages in the provision of infrastructure solutions for communications networks. It operates through the following segments: Broadband, Home, Outdoor Wireless Networks (OWN), and Venue and Campus Networks (VCN). The company was founded by Frank M. Drendel in 1976 and is headquartered in Claremont, NC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Lorentzen Kyle David EVP & CFO Mar 27 '24 Buy 1.25 11,600 14,500 712,475 Mar 29 03:06 PM KRAUSE L WILLIAM Director Mar 13 '24 Buy 1.60 92,127 147,154 320,000 Mar 14 04:58 PM KRAUSE L WILLIAM Director Mar 12 '24 Buy 1.59 57,300 90,952 227,873 Mar 14 04:58 PM Watts Claudius E. IV Director Mar 05 '24 Buy 1.05 15,000 15,769 941,830 Mar 07 04:17 PM ter Linde Koen SVP & President, CCS Dec 07 '23 Buy 1.84 13,513 24,857 236,300 Dec 08 05:44 PM Watts Claudius E. IV Director Nov 30 '23 Buy 1.67 25,000 41,630 841,030 Dec 04 04:58 PM Choi Justin C SVP, Chief Legal Officer & Sec Nov 27 '23 Buy 1.74 28,600 49,750 360,913 Nov 29 04:11 PM Watts Claudius E. IV Director Nov 21 '23 Buy 1.74 20,000 34,768 816,030 Nov 22 05:29 PM Yates Timothy T Director Nov 17 '23 Buy 1.86 60,000 111,318 225,751 Nov 21 04:08 PM Lorentzen Kyle David EVP & CFO Nov 17 '23 Buy 1.85 40,000 73,956 521,189 Nov 27 04:27 PM Watts Claudius E. IV Director Nov 16 '23 Buy 1.63 20,000 32,574 796,030 Nov 17 05:20 PM Treadway Charles L. President and CEO Nov 15 '23 Buy 1.63 153,019 249,926 2,213,206 Nov 16 05:50 PM Watts Claudius E. IV Director Nov 13 '23 Buy 1.39 60,000 83,388 776,030 Nov 15 06:28 PM Watts Claudius E. IV Director Aug 25 '23 Buy 3.34 10,000 33,432 716,030 Aug 29 04:14 PM Watts Claudius E. IV Director Aug 22 '23 Buy 3.43 10,000 34,264 706,030 Aug 24 04:58 PM Watts Claudius E. IV Director Aug 17 '23 Buy 3.70 10,000 36,987 696,030 Aug 21 06:36 PM Treadway Charles L. President and CEO Aug 11 '23 Buy 3.65 27,400 99,985 2,125,771 Aug 14 04:05 PM
Index - P/E - EPS (ttm) -0.97 Insider Own 56.32% Shs Outstand 32.18M Perf Week 7.01%
Market Cap 64.13M Forward P/E - EPS next Y -0.09 Insider Trans 0.14% Shs Float 16.67M Perf Month 1.82%
Income -44.42M PEG - EPS next Q -0.16 Inst Own 15.06% Short Float 6.58% Perf Quarter -7.18%
Sales 259.28M P/S 0.25 EPS this Y 52.16% Inst Trans 76.97% Short Ratio 12.61 Perf Half Y -7.18%
Book/sh 0.21 P/B 7.84 EPS next Y 84.63% ROA -26.62% Short Interest 1.10M Perf Year -26.88%
Cash/sh 2.41 P/C 0.70 EPS next 5Y - ROE -193.63% 52W Range 1.37 - 3.81 Perf YTD -5.08%
Dividend Est. - P/FCF - EPS past 5Y - ROI -42.64% 52W High -55.91% Beta 0.95
Dividend TTM - Quick Ratio 2.72 Sales past 5Y -17.78% Gross Margin 52.98% 52W Low 22.63% ATR (14) 0.12
Dividend Ex-Date - Current Ratio 3.54 EPS Y/Y TTM 83.53% Oper. Margin -12.34% RSI (14) 54.21 Volatility 9.05% 7.69%
Employees 560 Debt/Eq 4.94 Sales Y/Y TTM 12.22% Profit Margin -17.13% Recom 1.00 Target Price 3.00
Option/Short Yes / Yes LT Debt/Eq 4.75 EPS Q/Q -242.15% Payout - Rel Volume 0.67 Prev Close 1.71
Sales Surprise -2.63% EPS Surprise -17.85% Sales Q/Q -19.15% Earnings Mar 06 AMC Avg Volume 86.97K Price 1.68
SMA20 6.90% SMA50 -2.08% SMA200 -17.65% Trades
Volume 58,089 Change -1.75%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-17-22 Initiated Canaccord Genuity
Buy
$2
Jun-27-22 Initiated Telsey Advisory Group
Outperform
$10
May-08-24 03:01PM
May-01-24 08:00AM
Apr-30-24 04:05PM
Mar-28-24 09:00AM
Mar-07-24 05:58PM
04:05PM
Loading…
Mar-06-24 04:05PM
Feb-22-24 04:05PM
Jan-18-24 09:00AM
Jan-11-24 09:00AM
Nov-13-23 06:43AM
Nov-12-23 11:44AM
Nov-10-23 08:58AM
Nov-09-23 04:05PM
Oct-26-23 04:05PM
Oct-20-23 08:00AM
05:01AM
Loading…
Aug-23-23 05:01AM
Aug-19-23 10:44AM
Aug-15-23 11:37AM
(Yahoo Finance Video) +30.14%
07:37AM
(Thomson Reuters StreetEvents)
Aug-14-23 08:06PM
04:06PM
04:05PM
04:05PM
Aug-08-23 04:05PM
May-31-23 09:01AM
May-28-23 08:09AM
May-25-23 04:05PM
May-17-23 09:01AM
May-12-23 06:38AM
(Thomson Reuters StreetEvents)
May-11-23 04:33PM
04:05PM
Loading…
04:05PM
Apr-16-23 09:15AM
Mar-23-23 06:22AM
Mar-17-23 06:28AM
04:56AM
Mar-16-23 04:05PM
Mar-15-23 07:10AM
(Thomson Reuters StreetEvents) -10.49%
Mar-14-23 08:14PM
04:06PM
04:05PM
Mar-08-23 05:31AM
Mar-07-23 05:44PM
08:01AM
Feb-14-23 08:01AM
Jan-10-23 05:23AM
Dec-28-22 06:02PM
(American City Business Journals)
05:40AM
Dec-27-22 04:49PM
Dec-21-22 02:44PM
(American City Business Journals) +7.58%
Dec-20-22 04:05PM
Nov-30-22 04:10PM
Nov-12-22 07:59AM
Nov-11-22 09:15AM
Nov-10-22 05:26PM
04:05PM
Nov-02-22 08:30AM
Oct-27-22 09:00AM
Oct-26-22 04:06PM
Oct-19-22 10:04AM
08:31AM
Sep-27-22 08:31AM
Sep-12-22 09:00AM
Aug-22-22 04:20PM
Aug-11-22 04:52PM
Aug-07-22 10:10AM
Aug-04-22 07:00AM
Jul-28-22 08:30AM
Jul-14-22 09:21AM
(American City Business Journals)
Jul-07-22 08:23AM
08:01AM
Jul-01-22 10:39AM
(American City Business Journals) -7.13%
Jun-23-22 08:01AM
Jun-22-22 08:56AM
(Simply Wall St.) +11.97%
Jun-17-22 03:27PM
(American City Business Journals) +67.79%
11:37AM
08:00AM
Jun-16-22 04:15PM
Grove Collaborative Holdings, Inc. engages in the business of innovating sustainability-oriented consumer products. The firm is also involved in transforming consumer products into a positive force for human and environmental good. The company was founded by Stuart Landesberg and Christopher Clark in 2012 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Clark Christopher Chief Technology Officer May 01 '24 Sale 1.50 6,485 9,728 88,471 May 02 03:52 PM Clark Christopher Chief Technology Officer Apr 09 '24 Sale 1.67 4,060 6,775 94,956 Apr 10 01:33 PM Clark Christopher Chief Technology Officer Apr 01 '24 Sale 1.63 2,425 3,953 99,016 Apr 02 06:39 PM REPLOGLE JOHN B Director Mar 11 '24 Buy 1.93 25,900 49,987 349,605 Mar 13 08:32 PM Yurcisin Jeffrey Michael President & CEO Mar 11 '24 Buy 1.85 5,406 10,001 25,823 Mar 12 03:23 PM Landesberg Stuart Executive Chairman Mar 08 '24 Buy 2.15 10,800 23,220 965,614 Mar 11 06:25 PM Yurcisin Jeffrey Michael President & CEO Mar 08 '24 Buy 1.94 10,417 20,238 20,417 Mar 11 06:21 PM Clark Christopher Chief Technology Officer Mar 01 '24 Sale 1.82 6,485 11,779 101,441 Mar 01 05:34 PM Clark Christopher Chief Digital Officer Feb 01 '24 Sale 1.74 6,485 11,288 87,306 Feb 01 05:11 PM Clark Christopher Chief Digital Officer Jan 02 '24 Sale 1.70 6,485 11,044 93,791 Jan 04 12:51 PM Yurcisin Jeffrey Michael President & CEO Dec 14 '23 Buy 1.98 10,000 19,750 10,000 Dec 14 06:07 PM Landesberg Stuart Executive Director Dec 14 '23 Buy 1.89 5,400 10,226 882,850 Dec 14 04:04 PM Clark Christopher Chief Digital Officer Dec 01 '23 Sale 1.96 6,485 12,724 100,276 Dec 01 03:21 PM Clark Christopher Chief Digital Officer Nov 01 '23 Sale 1.54 6,485 9,971 83,950 Nov 01 05:49 PM Clark Christopher Chief Digital Officer Oct 02 '23 Sale 2.69 6,485 17,469 90,435 Oct 03 12:48 PM Clark Christopher Chief Digital Officer Sep 20 '23 Sale 2.85 6,485 18,460 96,920 Sep 20 06:47 PM Clark Christopher Chief Digital Officer Aug 16 '23 Sale 2.96 15,000 44,355 118,405 Aug 17 08:11 PM MAYFIELD XV, A CAYMAN ISLANDS 10% Owner Jul 14 '23 Sale 1.60 930,000 1,488,000 322,296 Jul 17 04:22 PM REPLOGLE JOHN B Director Jun 09 '23 Buy 1.72 60,242 103,556 298,746 Jun 12 01:36 PM Landesberg Stuart President & CEO Jun 09 '23 Buy 1.68 3,636 6,118 713,798 Jun 12 01:42 PM Clark Christopher Chief Digital Officer Jun 02 '23 Sale 0.46 32,400 14,833 552,977 Jun 02 04:25 PM Landesberg Stuart President & CEO Jun 01 '23 Buy 0.43 3,618 1,553 3,550,813 Jun 01 06:18 PM Landesberg Stuart President & CEO May 30 '23 Buy 0.44 3,600 1,574 3,547,195 May 31 02:35 PM Clark Christopher Chief Digital Officer May 30 '23 Sale 0.47 17,600 8,344 585,377 May 31 02:31 PM Landesberg Stuart President & CEO May 26 '23 Buy 0.51 3,600 1,825 3,543,595 May 26 12:54 PM Landesberg Stuart President & CEO May 25 '23 Buy 0.51 3,600 1,820 3,539,995 May 25 03:32 PM Landesberg Stuart President & CEO May 24 '23 Buy 0.51 3,600 1,841 3,536,395 May 25 03:32 PM REPLOGLE JOHN B Director May 23 '23 Buy 0.48 207,300 100,043 1,192,521 May 25 03:37 PM Landesberg Stuart President & CEO May 23 '23 Buy 0.46 3,600 1,656 3,532,795 May 23 02:07 PM Clark Christopher Chief Digital Officer May 23 '23 Sale 0.46 50,000 22,795 544,653 May 23 02:02 PM Landesberg Stuart President & CEO May 22 '23 Buy 0.45 3,600 1,634 3,529,195 May 22 02:09 PM Landesberg Stuart President & CEO May 18 '23 Buy 0.47 5,400 2,523 3,525,595 May 18 06:14 PM Landesberg Stuart President & CEO May 17 '23 Buy 0.45 10,000 4,500 3,520,195 May 18 06:14 PM Clark Christopher Chief Digital Officer May 17 '23 Sale 0.46 25,151 11,444 594,653 May 18 06:06 PM Clark Christopher Chief Digital Officer May 16 '23 Sale 0.45 14,849 6,730 619,804 May 17 06:09 PM Clark Christopher Chief Digital Officer May 15 '23 Sale 0.47 10,000 4,691 634,653 May 17 06:09 PM
Index RUT P/E - EPS (ttm) -0.07 Insider Own 92.86% Shs Outstand 318.64M Perf Week -22.86%
Market Cap 1.14B Forward P/E 5.73 EPS next Y 0.61 Insider Trans 0.09% Shs Float 23.13M Perf Month -18.94%
Income -20.98M PEG - EPS next Q 0.11 Inst Own 19.03% Short Float 33.62% Perf Quarter -11.14%
Sales 4.09B P/S 0.28 EPS this Y 483.77% Inst Trans -7.36% Short Ratio 10.53 Perf Half Y 76.38%
Book/sh 3.49 P/B 1.01 EPS next Y 20.05% ROA -1.57% Short Interest 7.78M Perf Year 134.00%
Cash/sh 0.44 P/C 7.96 EPS next 5Y -5.10% ROE -5.64% 52W Range 1.27 - 4.95 Perf YTD -3.04%
Dividend Est. - P/FCF 5.90 EPS past 5Y - ROI -0.70% 52W High -29.09% Beta 1.61
Dividend TTM - Quick Ratio 1.81 Sales past 5Y 7.72% Gross Margin 8.32% 52W Low 176.38% ATR (14) 0.28
Dividend Ex-Date - Current Ratio 1.87 EPS Y/Y TTM 98.57% Oper. Margin 3.21% RSI (14) 28.33 Volatility 9.09% 5.74%
Employees 70000 Debt/Eq 1.72 Sales Y/Y TTM -1.33% Profit Margin -0.51% Recom 2.33 Target Price 4.50
Option/Short Yes / Yes LT Debt/Eq 1.69 EPS Q/Q 88.87% Payout - Rel Volume 1.75 Prev Close 3.74
Sales Surprise 1.32% EPS Surprise 72.04% Sales Q/Q -13.14% Earnings May 09 BMO Avg Volume 738.15K Price 3.51
SMA20 -19.42% SMA50 -16.56% SMA200 4.33% Trades
Volume 1,292,183 Change -6.15%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-06-23 Initiated Canaccord Genuity
Buy
$4
May-11-23 Resumed Morgan Stanley
Equal-Weight
$3
Mar-30-22 Initiated Deutsche Bank
Hold
$7
Mar-04-22 Downgrade Goldman
Buy → Neutral
$12 → $7
Apr-01-21 Initiated Morgan Stanley
Equal-Weight
$13
Nov-20-20 Initiated Deutsche Bank
Buy
$12
May-09-24 07:00AM
May-01-24 05:00PM
Apr-26-24 11:45AM
Mar-06-24 08:00AM
Feb-29-24 08:25AM
07:00AM
Loading…
07:00AM
Feb-09-24 10:00AM
Jan-31-24 05:30PM
05:00PM
05:00PM
Jan-17-24 10:00AM
Dec-20-23 08:42AM
Dec-12-23 08:00AM
Dec-05-23 10:16AM
Nov-30-23 08:00AM
11:04AM
Loading…
Nov-16-23 11:04AM
Nov-15-23 09:00AM
03:03AM
Nov-13-23 09:03PM
11:00AM
Nov-11-23 03:06PM
Nov-10-23 10:00AM
Nov-08-23 09:00AM
Nov-07-23 09:58PM
(Thomson Reuters StreetEvents) -13.50%
07:00AM
Oct-31-23 10:30AM
Oct-30-23 01:00PM
Oct-23-23 10:19AM
Oct-10-23 08:00AM
Oct-05-23 09:22AM
09:00AM
Loading…
Oct-04-23 09:00AM
Sep-27-23 12:00PM
09:40AM
Sep-20-23 12:28PM
Aug-16-23 09:00AM
Aug-13-23 08:05AM
Aug-11-23 07:01AM
07:01AM
Aug-10-23 06:24AM
Aug-09-23 06:26AM
Aug-08-23 06:28AM
Aug-07-23 06:35AM
Aug-05-23 08:54AM
Aug-04-23 08:25AM
07:14AM
07:00AM
Aug-03-23 07:15AM
Aug-02-23 07:52AM
Aug-01-23 06:51AM
Jul-31-23 06:44AM
Jul-28-23 07:58AM
Jul-27-23 07:10AM
Jul-26-23 01:12PM
Jul-25-23 07:16AM
Jul-24-23 09:00AM
Jul-14-23 06:36AM
Jun-20-23 12:21PM
Jun-13-23 06:41AM
Jun-07-23 08:25AM
Jun-06-23 06:34AM
May-24-23 08:02AM
May-17-23 06:03AM
May-10-23 10:20PM
(Thomson Reuters StreetEvents) +15.38%
08:35AM
07:00AM
May-03-23 10:00AM
Apr-26-23 10:00AM
Apr-19-23 09:00AM
Apr-17-23 10:15AM
Apr-06-23 05:04PM
(The Wall Street Journal)
Apr-03-23 04:35PM
Mar-29-23 05:30PM
Mar-14-23 04:30PM
Mar-07-23 07:52AM
Mar-03-23 05:19AM
05:18AM
Mar-01-23 08:45PM
04:05PM
Feb-19-23 02:42PM
Feb-01-23 09:00AM
Jan-18-23 04:30PM
Dec-12-22 09:54AM
Nov-09-22 07:15PM
04:05PM
Oct-19-22 09:00AM
Oct-12-22 08:52AM
Oct-10-22 04:05PM
Oct-09-22 08:20AM
Aug-09-22 06:45PM
04:05PM
Jul-19-22 09:00AM
Jul-04-22 09:38AM
Jun-28-22 03:00PM
Jun-16-22 09:00AM
Jun-06-22 08:00AM
Jun-02-22 09:00AM
May-12-22 09:00AM
May-10-22 06:45PM
04:05PM
May-04-22 10:00AM
Advantage Solutions, Inc. is a business solutions provider, which is committed to driving growth for consumer goods manufacturers and retailers through winning insights and execution. It operates through the following segments: Sales and Marketing. The company was founded by Sonny King in 1987 and is headquartered in Clayton, MO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Conley Bevin Chief Accounting Officer Mar 15 '24 Option Exercise 0.00 19,748 0 191,270 Mar 19 05:00 PM PEACOCK DAVID A Chief Executive Officer Mar 15 '24 Option Exercise 0.00 188,678 0 2,156,790 Mar 19 05:00 PM Pestello Jack Anthony COO, Branded Services Mar 11 '24 Buy 3.87 10,000 38,700 146,279 Mar 13 06:23 PM Growe Christopher Chief Financial Officer Mar 06 '24 Buy 3.49 10,000 34,868 110,000 Mar 08 04:30 PM PEACOCK DAVID A Chief Executive Officer Mar 04 '24 Buy 3.60 15,000 54,026 1,968,112 Mar 06 04:30 PM KILTS JAMES M Director Nov 16 '23 Buy 2.39 5,468 13,066 780,922 Nov 17 04:05 PM KILTS JAMES M Director Nov 15 '23 Buy 2.40 17,595 42,205 775,454 Nov 17 04:05 PM KILTS JAMES M Director Nov 14 '23 Buy 2.38 29,720 70,775 757,859 Nov 15 04:05 PM KILTS JAMES M Director Nov 13 '23 Buy 2.11 25,754 54,266 728,139 Nov 15 04:05 PM KILTS JAMES M Director Nov 10 '23 Buy 1.93 60,968 117,668 702,385 Nov 13 05:30 PM Growe Christopher Chief Financial Officer Nov 10 '23 Buy 1.91 25,000 47,840 100,000 Nov 13 05:30 PM KILTS JAMES M Director Nov 09 '23 Buy 2.00 35,976 71,938 641,417 Nov 13 05:30 PM PEACOCK DAVID A Chief Executive Officer Nov 09 '23 Buy 2.08 30,000 62,400 1,953,112 Nov 09 04:05 PM Growe Christopher Chief Financial Officer Nov 09 '23 Buy 2.06 25,000 51,552 75,000 Nov 13 05:30 PM KILTS JAMES M Director Sep 07 '23 Buy 2.66 15,700 41,776 605,441 Sep 08 05:00 PM KILTS JAMES M Director Sep 06 '23 Buy 2.66 19,167 50,954 589,741 Sep 08 05:00 PM PEACOCK DAVID A Chief Executive Officer Sep 06 '23 Buy 2.68 15,000 40,274 1,923,112 Sep 07 05:01 PM KILTS JAMES M Director Aug 29 '23 Buy 2.70 6,795 18,345 570,574 Aug 31 04:45 PM KILTS JAMES M Director Aug 28 '23 Buy 2.69 1,202 3,233 563,779 Aug 29 04:37 PM KILTS JAMES M Director Aug 25 '23 Buy 2.66 11,618 30,946 562,577 Aug 29 04:37 PM KILTS JAMES M Director Aug 24 '23 Buy 2.69 7,061 19,023 550,959 Aug 25 04:30 PM KILTS JAMES M Director Aug 23 '23 Buy 2.70 6,488 17,516 543,898 Aug 25 04:30 PM KILTS JAMES M Director Aug 21 '23 Buy 2.64 4,000 10,564 537,410 Aug 22 05:01 PM KILTS JAMES M Director Aug 18 '23 Buy 2.65 1,100 2,915 533,410 Aug 22 05:01 PM KILTS JAMES M Director Aug 15 '23 Buy 2.65 100 265 532,310 Aug 17 05:00 PM PEACOCK DAVID A Chief Executive Officer Aug 09 '23 Buy 2.66 25,000 66,415 1,908,112 Aug 10 04:31 PM PEACOCK DAVID A Chief Executive Officer Aug 08 '23 Buy 2.65 25,000 66,155 1,883,112 Aug 10 04:31 PM KILTS JAMES M Director Jun 02 '23 Buy 1.88 10,119 19,067 532,210 Jun 05 04:35 PM Kaye Dean CFO - North America Jun 01 '23 Option Exercise 0.00 7,462 0 347,988 Jun 05 04:36 PM KILTS JAMES M Director Jun 01 '23 Buy 1.89 9,023 17,023 522,091 Jun 05 04:35 PM KILTS JAMES M Director May 26 '23 Buy 1.90 22,196 42,168 513,068 May 30 05:27 PM KILTS JAMES M Director May 25 '23 Buy 1.85 14,251 26,409 490,872 May 30 05:27 PM KILTS JAMES M Director May 24 '23 Buy 1.73 13,325 23,094 476,621 May 26 04:34 PM KILTS JAMES M Director May 23 '23 Buy 1.89 15,200 28,663 364,982 May 24 04:30 PM KILTS JAMES M Director May 22 '23 Buy 1.86 24,803 46,196 349,782 May 24 04:30 PM KILTS JAMES M Director May 19 '23 Buy 1.85 35,000 64,894 324,979 May 22 04:30 PM KILTS JAMES M Director May 18 '23 Buy 1.87 56,089 105,144 289,979 May 22 04:30 PM PEACOCK DAVID A Chief Executive Officer May 16 '23 Buy 1.64 80,000 131,032 1,858,112 May 17 04:30 PM PEACOCK DAVID A Chief Executive Officer May 15 '23 Buy 1.58 80,000 126,720 1,778,112 May 17 04:30 PM Growe Christopher Chief Financial Officer May 12 '23 Buy 1.43 50,000 71,265 50,000 May 15 04:30 PM
Index RUT P/E - EPS (ttm) - Insider Own 0.21% Shs Outstand 1.07B Perf Week -0.64%
Market Cap 5.00B Forward P/E 13.36 EPS next Y 0.35 Insider Trans 0.85% Shs Float 1.07B Perf Month 5.92%
Income - PEG - EPS next Q 0.05 Inst Own 18.98% Short Float 6.56% Perf Quarter 0.87%
Sales - P/S - EPS this Y -88.91% Inst Trans - Short Ratio 6.08 Perf Half Y -
Book/sh 1.83 P/B 2.53 EPS next Y 66.06% ROA - Short Interest 70.38M Perf Year -
Cash/sh 0.48 P/C 9.79 EPS next 5Y - ROE - 52W Range 3.67 - 7.27 Perf YTD -31.72%
Dividend Est. - P/FCF - EPS past 5Y - ROI - 52W High -36.04% Beta -
Dividend TTM - Quick Ratio 1.37 Sales past 5Y 41.81% Gross Margin - 52W Low 26.70% ATR (14) 0.26
Dividend Ex-Date - Current Ratio 1.98 EPS Y/Y TTM - Oper. Margin - RSI (14) 56.40 Volatility 4.51% 5.94%
Employees 2900 Debt/Eq 0.08 Sales Y/Y TTM - Profit Margin - Recom 1.77 Target Price 7.08
Option/Short Yes / Yes LT Debt/Eq 0.08 EPS Q/Q - Payout - Rel Volume 0.45 Prev Close 4.76
Sales Surprise -8.12% EPS Surprise 70.45% Sales Q/Q - Earnings May 07 AMC Avg Volume 11.59M Price 4.65
SMA20 10.06% SMA50 4.31% SMA200 -2.39% Trades
Volume 5,205,650 Change -2.31%
Date
Action
Analyst
Rating Change
Price Target Change
May-03-24 Initiated Argus
Buy
$6.25
Apr-03-24 Upgrade Raymond James
Outperform → Strong Buy
$9
Mar-01-24 Initiated Wolfe Research
Peer Perform
Feb-07-24 Initiated Piper Sandler
Underweight
$4.50
Jan-29-24 Initiated JP Morgan
Neutral
$5
Jan-22-24 Initiated Macquarie
Outperform
$7.30
Jan-10-24 Resumed Vertical Research
Hold
May-10-24 07:00AM
06:30AM
May-08-24 09:53AM
May-07-24 09:57PM
04:05PM
08:02AM
Loading…
May-06-24 08:02AM
May-04-24 03:50PM
May-01-24 11:00AM
Apr-30-24 10:01AM
07:07AM
Apr-29-24 04:51PM
(Morningstar Research) +16.49%
12:10PM
Apr-11-24 04:05PM
Apr-02-24 08:45AM
Mar-15-24 01:58PM
08:00AM
Loading…
Mar-06-24 08:00AM
Feb-27-24 10:40AM
Feb-23-24 12:34PM
11:20AM
Feb-22-24 04:19PM
Feb-19-24 04:05PM
Feb-15-24 08:00AM
Feb-02-24 07:45PM
Jan-26-24 04:27PM
Jan-23-24 05:00PM
Jan-18-24 08:30AM
Jan-12-24 11:45PM
02:18PM
Jan-04-24 11:22AM
08:39AM
Arcadium Lithium Plc operates as a lithium chemicals production company. It engages in lithium production process including hard-rock mining, conventional pond based brine extraction, direct lithium brine extraction (DLE) and lithium chemicals manufacturing. The company's products include lithium hydroxide and lithium carbonate. Arcadium Lithium was founded on May 5, 2023 and is headquartered in Shannon, Ireland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Oris de Roa Fernando Director Mar 06 '24 Buy 4.89 5,000 24,450 91,000 Mar 08 04:21 PM Marcet Pablo Director Feb 27 '24 Buy 4.75 14,034 66,662 30,876 Feb 29 06:54 PM
Index - P/E - EPS (ttm) -1.29 Insider Own 15.37% Shs Outstand 34.25M Perf Week -2.64%
Market Cap 157.89M Forward P/E - EPS next Y -1.04 Insider Trans 0.38% Shs Float 28.99M Perf Month 5.01%
Income -27.32M PEG - EPS next Q -0.25 Inst Own 21.51% Short Float 2.52% Perf Quarter 2.44%
Sales 0.00M P/S - EPS this Y 24.22% Inst Trans 1.44% Short Ratio 6.87 Perf Half Y 7.21%
Book/sh 1.44 P/B 3.19 EPS next Y 8.50% ROA -60.15% Short Interest 0.73M Perf Year -53.58%
Cash/sh 1.94 P/C 2.38 EPS next 5Y 15.00% ROE -109.49% 52W Range 3.03 - 10.30 Perf YTD 11.89%
Dividend Est. - P/FCF - EPS past 5Y 53.91% ROI -55.23% 52W High -55.24% Beta 1.32
Dividend TTM - Quick Ratio 3.29 Sales past 5Y 0.00% Gross Margin - 52W Low 52.15% ATR (14) 0.23
Dividend Ex-Date - Current Ratio 3.29 EPS Y/Y TTM 65.82% Oper. Margin 0.00% RSI (14) 52.32 Volatility 5.40% 4.88%
Employees 22 Debt/Eq 0.35 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 19.29
Option/Short Yes / Yes LT Debt/Eq 0.00 EPS Q/Q 48.33% Payout - Rel Volume 1.48 Prev Close 4.53
Sales Surprise - EPS Surprise -7.57% Sales Q/Q - Earnings May 09 AMC Avg Volume 106.51K Price 4.61
SMA20 1.43% SMA50 2.42% SMA200 1.43% Trades
Volume 157,203 Change 1.77%
Date
Action
Analyst
Rating Change
Price Target Change
May-10-23 Reiterated Maxim Group
Buy
$8 → $20
Jun-23-21 Initiated Oppenheimer
Outperform
$23
May-10-24 03:47PM
12:41PM
May-09-24 04:01PM
May-06-24 11:16AM
Apr-29-24 09:00AM
08:00AM
Loading…
Apr-25-24 08:00AM
Apr-11-24 08:00AM
Apr-01-24 03:30PM
Mar-29-24 06:24AM
(Thomson Reuters StreetEvents)
Mar-28-24 08:53PM
05:32PM
04:01PM
Mar-20-24 08:00AM
Mar-14-24 08:00AM
Mar-08-24 08:35AM
08:00AM
Loading…
Mar-06-24 08:00AM
Mar-05-24 08:35AM
Feb-29-24 08:01AM
08:00AM
Dec-15-23 08:35AM
Dec-13-23 08:00AM
Dec-12-23 01:02PM
09:10AM
Dec-11-23 04:30PM
Nov-11-23 10:36AM
Nov-10-23 10:01AM
(Thomson Reuters StreetEvents)
Nov-09-23 04:00PM
Oct-26-23 08:00AM
Oct-03-23 08:00AM
Sep-11-23 08:00AM
08:00AM
Loading…
Sep-07-23 08:00AM
Aug-16-23 10:30AM
Aug-15-23 10:25PM
(Thomson Reuters StreetEvents)
Aug-14-23 04:00PM
Aug-01-23 08:00AM
Jul-18-23 08:00AM
Jul-11-23 11:23AM
May-25-23 09:00AM
07:16AM
(Zacks Small Cap Research)
May-24-23 06:10AM
May-23-23 02:46PM
06:00AM
May-17-23 08:00AM
May-10-23 09:08AM
(Zacks Small Cap Research) +12.71%
05:57AM
(Thomson Reuters StreetEvents)
May-09-23 04:05PM
Apr-26-23 08:00AM
Apr-24-23 05:27AM
(Zacks Small Cap Research)
Apr-20-23 02:22PM
08:00AM
Apr-14-23 08:00AM
Mar-30-23 08:00AM
Mar-29-23 08:00AM
Mar-20-23 10:46PM
05:27AM
(Zacks Small Cap Research)
Mar-17-23 08:00AM
05:48AM
(Thomson Reuters StreetEvents)
Mar-16-23 04:05PM
Mar-08-23 08:00AM
Mar-03-23 08:00AM
Mar-02-23 08:00AM
Feb-15-23 05:42AM
(Simply Wall St.) -15.52%
Feb-07-23 08:00AM
Feb-02-23 08:00AM
Jan-27-23 04:30PM
Jan-09-23 08:00AM
Dec-29-22 06:02AM
Dec-21-22 08:00AM
Nov-21-22 06:01AM
(Zacks Small Cap Research)
Nov-15-22 08:00AM
Nov-14-22 04:05PM
Nov-08-22 08:00AM
Oct-31-22 08:00AM
Sep-27-22 08:00AM
Sep-07-22 08:00AM
Aug-15-22 06:16AM
(Zacks Small Cap Research) +12.80%
Aug-11-22 04:05PM
Jul-28-22 08:00AM
Jul-01-22 04:05PM
Jun-29-22 08:00AM
Jun-21-22 08:00AM
Jun-01-22 08:00AM
May-26-22 08:00AM
May-16-22 01:20PM
May-13-22 08:00AM
06:30AM
(Zacks Small Cap Research)
May-12-22 04:00PM
May-05-22 02:59PM
Apr-28-22 05:22AM
(Zacks Small Cap Research) -6.46%
Apr-27-22 09:40AM
08:00AM
Apr-21-22 08:00AM
Mar-15-22 08:00AM
Mar-14-22 08:00AM
Mar-11-22 08:06AM
(Zacks Small Cap Research)
08:00AM
Mar-10-22 08:00AM
Mar-08-22 08:00AM
Feb-24-22 08:00AM
Feb-04-22 04:37AM
(Zacks Small Cap Research)
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Wan Jerry Principal Accounting Officer Apr 19 '24 Option Exercise 0.00 5,625 0 12,057 Apr 23 04:39 PM JACOBS CINDY President & CMO Apr 19 '24 Option Exercise 0.00 16,250 0 34,511 Apr 23 04:35 PM Stewart Richard Alistair Executive Chairman Apr 19 '24 Option Exercise 0.00 22,500 0 61,001 Apr 23 04:31 PM Bencich John CEO Apr 19 '24 Option Exercise 0.00 25,000 0 101,724 Apr 23 04:26 PM Stewart Richard Alistair Executive Chairman Mar 04 '24 Buy 4.58 10,000 45,850 38,501 Mar 06 04:49 PM Bencich John CEO Mar 04 '24 Buy 4.58 10,000 45,850 76,724 Mar 06 04:43 PM Bencich John CEO May 30 '23 Buy 5.50 5,000 27,500 66,730 Jun 01 05:42 PM
Index - P/E - EPS (ttm) -0.55 Insider Own 23.85% Shs Outstand 5.74M Perf Week -1.04%
Market Cap 13.69M Forward P/E - EPS next Y -0.08 Insider Trans 6.21% Shs Float 4.74M Perf Month -0.59%
Income -3.16M PEG - EPS next Q -0.18 Inst Own 2.02% Short Float 0.37% Perf Quarter -4.06%
Sales 4.09M P/S 3.35 EPS this Y -19.64% Inst Trans 13.42% Short Ratio 0.79 Perf Half Y 22.06%
Book/sh 0.82 P/B 2.69 EPS next Y 88.06% ROA -31.09% Short Interest 0.02M Perf Year 36.46%
Cash/sh 0.43 P/C 5.07 EPS next 5Y - ROE -51.19% 52W Range 1.45 - 3.14 Perf YTD 3.15%
Dividend Est. - P/FCF - EPS past 5Y - ROI -45.51% 52W High -30.03% Beta 0.80
Dividend TTM - Quick Ratio 1.46 Sales past 5Y 37.64% Gross Margin 11.93% 52W Low 51.52% ATR (14) 0.13
Dividend Ex-Date - Current Ratio 1.98 EPS Y/Y TTM 34.86% Oper. Margin -84.99% RSI (14) 45.65 Volatility 4.01% 4.25%
Employees 19 Debt/Eq 0.60 Sales Y/Y TTM 99.61% Profit Margin -77.19% Recom 1.00 Target Price 6.00
Option/Short No / Yes LT Debt/Eq 0.48 EPS Q/Q -64.54% Payout - Rel Volume 0.38 Prev Close 2.23
Sales Surprise 0.09% EPS Surprise -72.73% Sales Q/Q 106.49% Earnings May 13 AMC Avg Volume 22.25K Price 2.20
SMA20 -0.05% SMA50 -9.28% SMA200 0.96% Trades
Volume 8,514 Change -1.48%
May-09-24 08:00AM
May-06-24 04:05PM
Apr-29-24 09:00AM
Apr-18-24 08:00AM
Apr-02-24 10:28AM
12:52PM
Loading…
Apr-01-24 12:52PM
07:50AM
Mar-27-24 09:00AM
Mar-21-24 09:00AM
Mar-11-24 11:00AM
Mar-04-24 08:30AM
Feb-21-24 04:05PM
Jan-18-24 09:00AM
Jan-09-24 08:30AM
Dec-11-23 08:00AM
08:00AM
Loading…
Dec-05-23 08:00AM
Nov-20-23 10:00AM
Nov-16-23 06:35AM
Nov-13-23 04:05PM
Nov-02-23 09:00AM
Oct-30-23 08:00AM
Sep-26-23 09:49AM
Sep-15-23 11:02AM
Aug-14-23 04:05PM
Aug-11-23 07:01AM
Aug-10-23 06:24AM
Aug-09-23 06:26AM
Aug-08-23 06:28AM
Aug-07-23 06:35AM
Aug-04-23 07:14AM
07:15AM
Loading…
Aug-03-23 07:15AM
Aug-02-23 09:00AM
07:52AM
Aug-01-23 06:51AM
Jul-31-23 06:44AM
Jul-28-23 07:58AM
Jul-27-23 07:10AM
Jul-26-23 01:12PM
Jul-25-23 07:16AM
Jul-24-23 07:12AM
Jul-21-23 07:23AM
Jul-20-23 06:55AM
Jul-19-23 09:10AM
07:10AM
Jul-18-23 06:53AM
Jul-17-23 07:10AM
Jul-14-23 06:50AM
Jul-13-23 07:02AM
Jul-12-23 07:22AM
Jul-11-23 06:08AM
Jul-10-23 06:56AM
Jul-05-23 06:46AM
Jul-03-23 06:50AM
Jun-30-23 06:52AM
Jun-29-23 06:49AM
Jun-28-23 06:58AM
Jun-27-23 06:46AM
Jun-26-23 06:41AM
Jun-23-23 09:24AM
Jun-22-23 07:05AM
Jun-21-23 07:05AM
Jun-20-23 06:35AM
Jun-15-23 09:00AM
06:38AM
Jun-14-23 06:39AM
Jun-13-23 06:37AM
Jun-12-23 06:47AM
May-24-23 09:00AM
May-15-23 04:05PM
May-09-23 09:15AM
Mar-30-23 06:44AM
Mar-27-23 04:05PM
Mar-15-23 07:30AM
Mar-07-23 07:30AM
Mar-02-23 08:30AM
Jan-17-23 07:30AM
Dec-27-22 11:40AM
(American City Business Journals) -13.24%
Dec-08-22 07:30AM
Dec-07-22 07:30AM
Dec-01-22 11:00AM
Nov-08-22 04:11PM
Nov-02-22 09:00AM
Oct-25-22 11:52AM
08:00AM
Oct-20-22 08:00AM
Oct-04-22 07:30AM
Oct-03-22 07:30AM
Sep-29-22 07:30AM
Sep-07-22 07:30AM
Aug-10-22 04:05PM
Aug-04-22 07:30AM
Jul-26-22 07:30AM
Jul-18-22 07:05AM
Jul-06-22 07:30AM
Jun-01-22 07:30AM
May-16-22 08:00AM
May-12-22 04:05PM
May-09-22 07:30AM
Apr-28-22 08:30AM
Apr-27-22 09:00AM
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The company was founded on January 13, 2009 and is headquartered in Langhorne, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Drapczuk Adam E III Chief Financial Officer Mar 01 '24 Buy 2.11 47,394 100,001 47,394 Mar 05 09:04 AM Henry Scott Robert Director Mar 01 '24 Buy 2.11 23,697 50,001 135,735 Mar 05 09:07 AM glassman steven mark Director Mar 01 '24 Buy 2.11 11,848 24,999 135,025 Mar 05 09:05 AM glassman steven mark Director Dec 22 '23 Buy 2.20 3,885 8,535 123,177 Dec 26 04:15 PM Stein John Nachum Director Sep 26 '23 Buy 1.96 2,500 4,900 500,019 Sep 28 05:28 PM Henry Scott Robert Director Sep 14 '23 Buy 2.27 500 1,135 112,038 Sep 14 06:51 PM Henry Scott Robert Director Sep 13 '23 Buy 2.25 6,000 13,499 111,538 Sep 14 06:51 PM Henry Scott Robert Director Sep 12 '23 Buy 2.28 4,000 9,115 105,538 Sep 14 06:51 PM Henry Scott Robert Director Aug 22 '23 Buy 1.92 980 1,882 101,538 Aug 23 06:06 PM Henry Scott Robert Director Aug 21 '23 Buy 1.95 2,000 3,900 100,558 Aug 23 06:06 PM Stein John Nachum Director Jun 08 '23 Buy 2.28 5,000 11,400 497,458 Jun 09 08:30 AM Henry Scott Robert Director Jun 08 '23 Buy 2.24 3,558 7,984 98,558 Jun 12 08:30 AM STEFANSKY DAVID Director Jun 08 '23 Buy 2.22 1,000 2,220 50,091 Jun 09 08:30 AM Stein John Nachum Director Jun 07 '23 Buy 2.69 5,000 13,450 492,458 Jun 09 08:30 AM STEFANSKY DAVID Director Jun 07 '23 Buy 2.50 2,000 5,000 49,091 Jun 09 08:30 AM Henry Scott Robert Director Jun 02 '23 Buy 2.40 2,000 4,800 95,000 Jun 02 07:20 PM STEFANSKY DAVID Director May 31 '23 Buy 2.42 2,000 4,840 47,091 Jun 01 08:30 AM Henry Scott Robert Director May 31 '23 Buy 2.25 1,000 2,250 93,000 Jun 02 07:20 PM STEFANSKY DAVID Director May 30 '23 Buy 2.53 5,000 12,650 45,091 Jun 01 08:30 AM glassman steven mark Director May 30 '23 Buy 2.38 4,200 9,996 119,292 Jun 01 08:30 AM ZELDIS JEROME B Director May 26 '23 Buy 2.34 5,000 11,688 93,028 May 30 04:05 PM Henry Scott Robert Director May 24 '23 Buy 2.01 2,000 4,020 92,000 May 24 05:40 PM Henry Scott Robert Director May 23 '23 Buy 1.90 1,000 1,900 90,000 May 24 05:40 PM Henry Scott Robert Director May 22 '23 Buy 1.95 4,000 7,800 89,000 May 24 05:40 PM
Index - P/E - EPS (ttm) -0.21 Insider Own 37.64% Shs Outstand 141.19M Perf Week -13.36%
Market Cap 290.26M Forward P/E 43.07 EPS next Y 0.05 Insider Trans 0.27% Shs Float 90.06M Perf Month -16.60%
Income -29.58M PEG - EPS next Q -0.01 Inst Own 23.55% Short Float 0.46% Perf Quarter 29.68%
Sales 146.14M P/S 1.99 EPS this Y 89.86% Inst Trans 6.91% Short Ratio 1.34 Perf Half Y 58.27%
Book/sh 1.38 P/B 1.45 EPS next Y 300.00% ROA -11.96% Short Interest 0.41M Perf Year 118.48%
Cash/sh 0.22 P/C 9.19 EPS next 5Y - ROE -14.92% 52W Range 0.85 - 2.58 Perf YTD 34.00%
Dividend Est. - P/FCF 18.80 EPS past 5Y - ROI -14.46% 52W High -22.09% Beta 3.22
Dividend TTM - Quick Ratio 3.23 Sales past 5Y 27.35% Gross Margin 67.25% 52W Low 136.47% ATR (14) 0.19
Dividend Ex-Date - Current Ratio 3.23 EPS Y/Y TTM -46.73% Oper. Margin -9.13% RSI (14) 41.77 Volatility 9.11% 9.37%
Employees 466 Debt/Eq 0.06 Sales Y/Y TTM 10.93% Profit Margin -20.24% Recom 1.67 Target Price 2.73
Option/Short No / Yes LT Debt/Eq 0.05 EPS Q/Q 30.48% Payout - Rel Volume 0.37 Prev Close 2.03
Sales Surprise 4.52% EPS Surprise -100.00% Sales Q/Q 20.51% Earnings May 07 BMO Avg Volume 306.08K Price 2.01
SMA20 -10.63% SMA50 -9.65% SMA200 30.65% Trades
Volume 114,483 Change -0.99%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-13-22 Initiated Morgan Stanley
Underweight
$2.70
May-08-24 03:21AM
May-07-24 07:30AM
May-02-24 04:30PM
09:00AM
Apr-19-24 08:45AM
04:30PM
Loading…
Apr-16-24 04:30PM
Apr-09-24 09:00AM
Mar-20-24 09:00AM
Feb-28-24 08:33AM
08:30AM
Feb-27-24 08:40AM
07:30AM
Feb-22-24 09:00AM
Feb-08-24 09:00AM
Jan-30-24 04:10PM
09:00AM
Loading…
Dec-18-23 09:00AM
Dec-07-23 04:05PM
Nov-11-23 09:22AM
Nov-08-23 07:30AM
Nov-02-23 09:00AM
Oct-16-23 08:00AM
Oct-12-23 08:00AM
Oct-10-23 09:00AM
Sep-27-23 09:00AM
Aug-30-23 09:00AM
Aug-08-23 08:00AM
Jul-27-23 04:31PM
Jul-26-23 09:00AM
Jul-20-23 09:00AM
Jul-19-23 04:31PM
08:00AM
Loading…
Jul-05-23 08:00AM
Jun-29-23 09:00AM
Jun-28-23 09:00AM
Jun-15-23 09:00AM
Jun-06-23 09:00AM
Jun-05-23 04:30PM
May-19-23 08:00AM
May-16-23 08:00AM
May-11-23 09:00AM
May-10-23 08:00AM
May-09-23 08:00AM
Apr-19-23 08:00AM
Apr-17-23 08:00AM
Mar-30-23 10:00AM
Mar-21-23 09:00AM
Mar-02-23 04:00PM
Feb-24-23 07:30AM
Feb-09-23 08:00AM
Feb-08-23 09:00AM
Feb-02-23 08:00AM
Jan-04-23 09:00AM
Dec-19-22 09:30AM
Dec-06-22 09:30AM
Nov-14-22 09:00AM
Nov-11-22 07:00AM
Nov-10-22 09:00AM
Nov-08-22 07:30AM
Nov-03-22 09:30AM
Oct-25-22 08:30AM
Oct-12-22 11:00AM
Sep-22-22 09:00AM
Aug-30-22 04:30PM
Aug-13-22 08:31AM
Aug-10-22 07:00AM
Jul-21-22 08:30AM
Jul-15-22 06:17AM
Jul-11-22 07:30AM
Jul-08-22 07:30AM
Jun-22-22 07:59AM
Jun-07-22 07:30AM
Jun-03-22 08:30AM
May-11-22 04:30PM
08:30AM
May-06-22 12:02PM
07:27AM
Apr-21-22 08:00AM
Mar-28-22 03:13PM
Mar-03-22 08:30AM
Feb-25-22 08:30AM
Innovid Corp. engages in the operation of a software platform of technology infrastructure for the creation, delivery, and measurement of TV/video ads across CTV, linear TV, and mobile and desktop TV environments. The company was founded by Zvika Netter and Tal Chalozin in 2007 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Callini Anthony Chief Financial Officer Feb 29 '24 Buy 1.82 11,000 20,061 499,000 Mar 01 05:21 PM Netter Zvika Chief Executive Officer Feb 28 '24 Buy 1.84 25,000 45,970 4,085,733 Feb 29 04:36 PM Callini Anthony Chief Financial Officer Nov 22 '23 Buy 1.34 18,000 24,077 488,000 Nov 24 01:18 PM Callini Anthony Chief Financial Officer Nov 21 '23 Buy 1.31 20,000 26,220 470,000 Nov 22 05:03 PM Helmreich David Chief Commercial Officer Nov 20 '23 Buy 1.31 20,000 26,200 788,857 Nov 21 04:35 PM Callini Anthony Chief Financial Officer Nov 20 '23 Buy 1.29 750 968 750 Nov 22 05:03 PM Netter Zvika Chief Executive Officer Nov 10 '23 Buy 1.29 50,000 64,385 4,060,733 Nov 13 04:53 PM Helmreich David Chief Commercial Officer Aug 18 '23 Buy 1.14 20,000 22,826 768,857 Aug 21 04:45 PM Shany Gilad Director Aug 16 '23 Buy 1.09 17,340 18,973 1,283,002 Aug 17 04:38 PM Netter Zvika Chief Executive Officer Aug 15 '23 Buy 1.09 50,000 54,730 4,010,733 Aug 16 04:53 PM Shany Gilad Director Aug 15 '23 Buy 1.10 45,000 49,536 1,265,662 Aug 16 04:53 PM Lam Rachel Director Aug 15 '23 Buy 1.09 10,000 10,945 287,695 Aug 16 04:52 PM Helmreich David Chief Commercial Officer Aug 11 '23 Buy 1.09 50,000 54,475 748,857 Aug 14 04:10 PM Markus Kenneth Chief Operating Officer Jun 05 '23 Option Exercise 0.61 177,186 108,450 720,519 Jun 06 07:23 PM Helmreich David Chief Commercial Officer May 25 '23 Buy 1.24 100,000 123,810 698,857 May 25 04:23 PM Shany Gilad Director May 25 '23 Buy 1.19 28,328 33,631 191,624 May 26 04:29 PM Shany Gilad Director May 23 '23 Buy 1.07 32,660 35,067 163,296 May 24 04:30 PM Netter Zvika Chief Executive Officer May 19 '23 Buy 0.97 100,000 96,840 3,960,733 May 22 01:54 PM
Index - P/E - EPS (ttm) -0.53 Insider Own 12.01% Shs Outstand 809.03M Perf Week 3.41%
Market Cap 4.72B Forward P/E 16.06 EPS next Y 0.36 Insider Trans 2.07% Shs Float 721.19M Perf Month -7.40%
Income -391.00M PEG - EPS next Q -0.07 Inst Own 68.80% Short Float 17.75% Perf Quarter 11.84%
Sales 2.95B P/S 1.60 EPS this Y 93.82% Inst Trans 2.90% Short Ratio 6.75 Perf Half Y -13.64%
Book/sh 12.84 P/B 0.45 EPS next Y 704.47% ROA -1.95% Short Interest 127.99M Perf Year -3.19%
Cash/sh 0.87 P/C 6.59 EPS next 5Y - ROE -3.75% 52W Range 4.45 - 8.88 Perf YTD -9.29%
Dividend Est. - P/FCF - EPS past 5Y 21.86% ROI -2.26% 52W High -35.14% Beta 2.82
Dividend TTM - Quick Ratio 1.04 Sales past 5Y -0.59% Gross Margin 3.36% 52W Low 29.44% ATR (14) 0.26
Dividend Ex-Date Aug 21, 2015 Current Ratio 1.35 EPS Y/Y TTM 59.56% Oper. Margin -3.22% RSI (14) 49.61 Volatility 3.46% 4.52%
Employees 5800 Debt/Eq 0.69 Sales Y/Y TTM 11.68% Profit Margin -13.27% Recom 2.40 Target Price 7.02
Option/Short Yes / Yes LT Debt/Eq 0.65 EPS Q/Q 116.06% Payout - Rel Volume 0.72 Prev Close 5.88
Sales Surprise -1.86% EPS Surprise 80.39% Sales Q/Q 17.57% Earnings Apr 29 AMC Avg Volume 18.95M Price 5.76
SMA20 0.66% SMA50 -1.04% SMA200 -12.36% Trades
Volume 13,589,606 Change -2.04%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-08-24 Upgrade Susquehanna
Neutral → Positive
$5.50 → $9
Nov-28-23 Initiated CapitalOne
Equal Weight
$8
Jul-05-23 Upgrade Citigroup
Neutral → Buy
$6.50 → $9.50
Mar-22-23 Upgrade Compass Point
Neutral → Buy
$7.50
Feb-16-23 Downgrade Barclays
Overweight → Equal Weight
$7
Jan-19-23 Initiated The Benchmark Company
Buy
$7.50
Oct-06-22 Upgrade Barclays
Underweight → Overweight
$3.50 → $5
Sep-06-22 Upgrade BTIG Research
Neutral → Buy
$8
Aug-02-22 Upgrade CapitalOne
Equal Weight → Overweight
Mar-24-22 Upgrade Pareto
Sell → Hold
$5
Feb-08-22 Resumed Evercore ISI
Outperform
$6
Mar-05-21 Downgrade Barclays
Equal Weight → Underweight
Sep-16-20 Downgrade Susquehanna
Positive → Neutral
$2.50 → $1.15
Aug-06-20 Resumed Evercore ISI
In-line
$4
Jul-08-20 Downgrade Morgan Stanley
Overweight → Equal-Weight
Jun-15-20 Downgrade Clarksons Platou
Buy → Neutral
May-21-20 Downgrade Tudor Pickering
Buy → Hold
Apr-29-20 Downgrade DNB Markets
Hold → Sell
Apr-22-20 Downgrade RBC Capital Mkts
Sector Perform → Underperform
$2.50 → $1.50
Apr-01-20 Downgrade BTIG Research
Buy → Neutral
Show Previous Ratings
May-01-24 12:20PM
08:25AM
06:43AM
Apr-30-24 05:15PM
07:33AM
05:12AM
Loading…
05:12AM
Apr-29-24 09:52PM
06:35PM
05:41PM
05:33PM
(Associated Press Finance)
05:24PM
07:57AM
Apr-25-24 10:31AM
Apr-22-24 10:00AM
Apr-18-24 07:23AM
04:49PM
Loading…
Apr-17-24 04:49PM
01:46PM
Apr-15-24 01:05PM
Apr-11-24 06:25PM
08:54AM
08:54AM
Apr-10-24 04:23PM
Apr-08-24 01:29PM
Apr-07-24 12:45PM
07:00AM
Apr-05-24 06:00PM
02:57AM
Apr-04-24 05:03PM
09:03AM
Apr-02-24 04:00PM
02:02PM
Loading…
02:02PM
06:59AM
Apr-01-24 04:24PM
Mar-27-24 09:00AM
Mar-26-24 06:00PM
Mar-25-24 06:37AM
Mar-20-24 06:00PM
11:30AM
Mar-14-24 03:53PM
Mar-13-24 09:00AM
Mar-12-24 06:00PM
09:30AM
Mar-11-24 07:00PM
09:03AM
Mar-07-24 10:08AM
Mar-04-24 08:00AM
Mar-03-24 11:33PM
07:00PM
Mar-01-24 01:00PM
Feb-28-24 09:00AM
Feb-25-24 07:04AM
Feb-22-24 01:43PM
Feb-21-24 11:00AM
09:19AM
09:11AM
Feb-20-24 06:00PM
09:30AM
06:32AM
05:04AM
(Associated Press Finance)
Feb-19-24 05:21PM
Feb-14-24 05:50PM
04:20PM
Feb-13-24 01:06PM
Feb-08-24 06:10AM
Feb-06-24 05:50PM
04:18PM
Jan-29-24 06:00PM
05:36AM
Jan-24-24 07:04PM
Jan-23-24 06:00PM
Jan-17-24 06:00PM
Jan-15-24 04:51PM
Jan-12-24 08:50AM
Jan-11-24 06:00PM
Jan-02-24 06:00PM
Dec-14-23 03:12AM
Dec-13-23 07:12AM
Dec-12-23 06:31AM
Dec-08-23 02:11PM
Dec-04-23 09:31AM
Nov-29-23 11:30AM
Nov-28-23 07:00AM
Nov-17-23 05:15AM
Nov-07-23 07:36AM
Nov-03-23 01:05PM
Nov-01-23 10:02AM
07:52AM
Oct-31-23 04:00PM
08:04AM
Oct-30-23 08:30PM
07:05PM
05:59PM
(Associated Press Finance)
05:38PM
Oct-26-23 07:15AM
Oct-25-23 08:15AM
Oct-23-23 07:30PM
06:00PM
10:00AM
Oct-20-23 12:00PM
Oct-18-23 04:26PM
Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
THIGPEN JEREMY D CEO Mar 01 '24 Option Exercise 5.09 941,192 4,790,667 5,551,127 Mar 05 07:10 PM Mey Mark-Anthony Lovell EVP & CFO Mar 01 '24 Option Exercise 5.09 325,805 1,658,347 1,724,606 Mar 05 07:12 PM Adamson Keelan PRESIDENT AND COO Mar 01 '24 Option Exercise 5.09 312,510 1,590,676 1,144,550 Mar 05 07:13 PM DAVIS HOWARD E EVP, CAO & CIO Mar 01 '24 Option Exercise 5.09 259,437 1,320,534 1,529,840 Mar 05 07:15 PM Long Brady K EVP & GENERAL COUNSEL Mar 01 '24 Option Exercise 5.09 254,493 1,295,369 1,547,974 Mar 05 07:17 PM Tonnel David A SVP - CHIEF ACCOUNTING OFFICER Mar 01 '24 Option Exercise 5.09 171,392 872,385 794,877 Mar 05 07:19 PM Mohn Frederik Wilhelm Director Feb 27 '24 Buy 4.89 1,000,000 4,890,000 85,574,894 Feb 29 04:28 PM Perestroika (Cyprus) Ltd Director Feb 27 '24 Buy 4.89 1,000,000 4,890,000 85,574,894 Feb 29 04:32 PM Long Brady K EVP & GENERAL COUNSEL Feb 08 '24 Option Exercise 0.00 516,094 0 1,473,027 Feb 12 05:15 PM Tonnel David A SVP - CHIEF ACCOUNTING OFFICER Feb 08 '24 Option Exercise 0.00 345,780 0 763,569 Feb 12 05:16 PM DAVIS HOWARD E EVP, CAO & CIO Feb 08 '24 Option Exercise 0.00 554,801 0 1,479,407 Feb 12 05:14 PM Adamson Keelan PRESIDENT AND COO Feb 08 '24 Option Exercise 0.00 587,055 0 1,069,868 Feb 12 05:11 PM THIGPEN JEREMY D CEO Feb 08 '24 Option Exercise 0.00 1,935,353 0 5,393,945 Feb 12 05:10 PM Mey Mark-Anthony Lovell EVP & CFO Feb 08 '24 Option Exercise 0.00 696,727 0 1,681,044 Feb 12 05:12 PM Tonnel David A SVP - CHIEF ACCOUNTING OFFICER Aug 31 '23 Sale 8.22 57,259 470,669 417,789 Sep 05 04:57 PM Mey Mark-Anthony Lovell EVP & CFO Aug 03 '23 Sale 8.50 396,170 3,367,445 984,317 Aug 04 04:17 PM Tonnel David A SVP - CHIEF ACCOUNTING OFFICER Jul 18 '23 Sale 8.76 1,754 15,365 475,048 Jul 20 05:12 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
